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IV  Abstract 
Abstract 
The interaction of RING-finger ubiquitin (Ub) ligases (E3 enzymes) with Ub 
conjugating enzymes (E2 enzymes) dictates how fast a Ub modification is 
synthesized on a client protein. This thesis addresses the catalytic stimulation of the 
E2 enzymes Ubc6 and Ubc7 by their cognate E3 enzymes Hrd1 and Doa10. Results 
show that Ubc6~Ub conjugates adopt closed conformations more readily than 
Ubc7~Ub conjugates, indicative for an inherently higher propensity to transfer Ub. 
The catalytic activity of Ubc7 can be stimulated by a RING domain which relies on 
so-called linchpin allostery. This drives Ubc7~Ub intermediates into a closed 
conformation. In addition, specific contacts of the RING-finger domain and the Ub 
moiety in an E2~Ub conjugate were identified which further restrict the flexibility of 
the conjugate and thereby increase the reactivity of the E2~Ub intermediate. This 
seems to represent a common mechanism for the stimulation of E2 enzymes 
because similar contacts of RING-finger proteins with Ub have been observed for 
other Ub ligases. 
Poly-Ub signals on proteins are generated in successive steps. The first reaction, 
called ―priming‖, comprises the attachment of an initial Ub moiety to the target. This 
requires high flexibility of the involved enzymes to modify acceptor sites in a versatile 
environment. The second step is the sequential addition of Ub to previously attached 
Ub molecules in a process termed elongation. In contrast to priming, the formation of 
uniform Ub chains relies on the repeated and robust conjugation of Ub moieties in a 
mostly invariant setting. Ub ligases employ different strategies to meet the divergent 
requirements of these reactions. Doa10 uses separate E2 enzymes for priming and 
elongation. This thesis shows that Hrd1 efficiently stimulates a single E2 enzyme for 
the catalysis of both steps via linchpin allostery. 
Furthermore, a nuclear Ub ligase, termed the Asi complex, is analyzed. This complex 
harbors two RING-finger proteins which both are required for the poly-ubiquitination 
of client proteins. However, due to technical restraints, their individual contribution to 
the poly-Ub reaction could not be determined. 
Key words: PQC, ERAD, E3-mediated E2 stimulation, linchpin allostery, priming, 
elongation 
Zusammenfassung  V 
Zusammenfassung 
Die Interaktion von RING-finger-Ubiquitin (Ub)-Ligasen (E3-Enzyme) mit Ub-konju-
gierenden Enzymen (E2-Enzyme) bestimmt wie schnell ein Zielprotein mit einer Ub-
Modifikation versehen wird. In dieser Arbeit wird die Stimulation der E2-Enzyme 
Ubc6 und Ubc7 durch die E3-Enzyme Hrd1 und Doa10 untersucht. Es wird gezeigt, 
dass Ubc6~Ub-Konjugate bereitwilliger sogenannte closed conformations annehmen 
als Ubc7~Ub-Konjugate, was wiederum die Tendenz, Ub zu übertragen, steigert. Die 
katalytische Aktivität von Ubc7 kann durch RING-Domänen stimuliert werden. Durch 
einen allosterischen Mechanismus, der linchpin allostery, werden Ubc7~Ub-Inter-
mediate in closed conformations gedrängt. Zusätzlich werden spezifische Kontakte 
zwischen RING-finger-Domänen und der Ub-Einheit in einem E2~Ub-Konjugat 
identifiziert. Diese schränken die Flexibilität des Konjugates weiter ein und 
begünstigen dadurch die Reaktivität des E2~Ub-Intermediates. Dieser Mechanismus 
scheint weit verbreitet zu sein und wurde schon bei anderen Ub-Ligasen beobachtet. 
Poly-Ub-Signale werden in mehreren Schritten generiert. In einer Priming genannten 
Reaktion wird die erste Ub-Einheit auf das Zielprotein übertragen. Dieser Vorgang 
erfordert sehr flexible Enzyme, die in diversem Umfeld Akzeptorstellen finden und mit 
Ub modifizieren. Die zweite Reaktion, die elongation, umfasst das schrittweise 
Anheften weiterer Ub-Moleküle an die erste Einheit. Im Gegensatz zum Priming, 
beruht die Bildung einheitlicher Ketten auf der wiederholten und robusten 
Konjugation von Ub-Molekülen in gleichbleibendem Milieu. Ub-Ligasen verwenden 
verschiedene Strategien, um die unterschiedlichen Herausforderungen dieser 
Reaktionen zu bewältigen. Während Doa10 je ein E2-Enzym pro Reaktion nutzt, 
kann Hrd1 ein einzelnes E2-Enzym durch linchpin allostery ausreichend stimulieren, 
um beide Prozesse durchzuführen, wie diese Arbeit zeigt. 
Darüber hinaus wird ein Ub-Ligase-Komplex des Zellkerns, der Asi-Komplex, 
untersucht. Diese Ligase umfasst zwei RING-finger-Proteine, die für die Poly-
Ubiquitinierung von Substraten benötigt werden. Unglücklicherweise konnte der 
Beitrag der jeweiligen Untereinheiten an der Substratmarkierung, aufgrund 
technischer Probleme, nicht im Detail bestimmt werden. 
Schlagwörter: PQC, ERAD, E3-vermittelte E2-Stimulation, linchpin allostery, 
priming, elongation 
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Contributions  VII 
Contributions 
Work in this thesis regarding the stimulation of Ubc6 and Ubc7 by their cognate E3 
ligases Hrd1 and Doa10 as well as experiments conducted to analyze the versatility 
of ERAD ligases in yeast cells (sections 2.1 and 2.2) are subject of a collaborative 
effort between the groups of Prof. Dr. Thomas Sommer and Prof. Dr. Rachel Klevit. 
This work was inspired by a hypothesis that myself and Dr. Annika Weber set forth to 
analyze. After I conducted the first preliminary experiments, we teamed up with Dr. 
Tobias Ritterhoff and Prof. Dr. Rachel Klevit who supported us with detailed 
investigations with respect to the mechanisms underlying E3-mediated stimulation of 
E2 enzymes. To this end, Dr. Tobias Ritterhoff performed the herein presented 
discharge assays and NMR measurements. I performed in vitro chain elongation and 
substrate ubiquitination experiments as well as degradation assays in yeast cells. 
Results presented in this work are currently prepared for publication. 
Lips, C et al. ―Diversity in E2/E3 pairing and activation mechanisms ensures 
functional flexibility.‖ 
 
The results presented in section 2.3 address the analysis of the Asi complex, a 
second project that was single-handedly designed and driven by my ideas. 
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1. Introduction 
Around 40 years ago, Aaron Ciechanover, Avram Hershko and Irwin Rose 
characterized a small polypeptide, later identified as ubiquitin (Ub)1, to be a post-
translational modifier involved in protein breakdown2–4. By now it has been 
established that ubiquitination of proteins controls virtually every process in 
eukaryotic cells. Accordingly, defects in the ubiquitination machinery have been 
associated with the onset of several malignancies, including neurodegenerative 
diseases, cancer and inflammation, to name a few5,6. Consequently, Ub-associated 
enzymes represent attractive targets for the treatment of these diseases and the 
detailed study of their function is a prerequisite for the development of therapeutic 
strategies. 
 
1.1 Ubiquitin and the ubiquitination cascade 
The 76 amino acid peptide ubiquitin is conserved in all eukaryotes. As a post-
translational modification Ub is conjugated to proteins and thereby changes the fate 
of the target regarding its stability, sub-cellular localization or activity. Next to its well-
established role in directing proteins to proteasomal breakdown, Ub is involved in 
non-proteolytic processes such as DNA repair, chromatin remodeling and membrane 
trafficking7. These different functions rely on highly specialized cellular pathways for 
the generation of individual Ub signals and their decoding. The versatility of this 
system is even further expanded by other small proteins, among those the ―Small 
ubiquitin-like modifier‖ (SUMO), ―Neural precursor cell expressed, developmentally 
down-regulated 8‖ (NEDD8), ―Interferon-stimulated gene product 15‖ (ISG15) and 
―Autophagy-related protein 8‖ (Atg8), which are conjugated to polypeptides via 
enzymatic machineries highly reminiscent of the ubiquitin system8. 
Ubiquitin is attached to target proteins via its carboxy-terminal glycine residue using a 
three-step enzymatic cascade (Fig. 1-1). First, the carboxy-terminus of Ub is 
adenylated upon hydrolysis of ATP by a ubiquitin activating E1 enzyme and 
covalently attached to a cysteine residue in the enzyme via a thioester bond. The 
yeast S. cerevisiae contains one of such enzymes whereas humans harbor two 
closely related variants9,10.  
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Next, Ub is transferred to a cysteine residue in the catalytic site of a ubiquitin 
conjugating E2 enzyme, by a transesterification reaction. While 12 of such E2 
enzymes have been identified in yeast, there are approximately 60 known in human 
cells. Of note, each E2 enzyme displays slightly distinct enzymatic properties, which 
contribute to the type of generated Ub signal. 
In the last step, Ub is covalently attached to an appropriate acceptor side, typically 
the ε-amino group of a lysine residue, within a target protein. This reaction involves 
ubiquitin ligases, also known as E3 enzymes, which determine the specificity of 
ubiquitination by binding to the substrates. Importantly, each E3 enzyme only works 
with an appointed set of E2 enzymes, which defines the layout of the Ub signal on its 
client proteins. Since essentially any protein can become a substrate of the Ub 
system and the Ub ligases must specifically interact with all these clients to promote 
ubiquitination, the E3 enzymes form the largest group within the Ub system. There 
are three major types of E3 ligases that differ in their reaction mechanism. 
Ub ligases of the ―Really Interesting New Gene‖ (RING)-type harbor a cysteine-rich 
region termed the RING-finger domain which attains its characteristic fold by 
complexing zinc ions. Via their RING-finger, these ligases bind E2 enzymes and 
bring them into spatial proximity to the target. At the same time, the association with 
the RING-finger stimulates the catalytic activity of the E2 enzymes for the direct 
transfer of Ub to client proteins. RING finger-related proteins like ―Ubiquitin-box‖ (U-
box), ―Plant homeodomain‖ (PHD) and ―Leukemia-associated protein‖ (LAP) ligases 
also contain an E2 binding region and display a similar reaction mechanism11. 
Around 95 % of all known E3s belong to the group of RING-finger and RING finger-
like proteins, with about 100 members in yeast and over 500 in humans9,10. 
Ligases of the ―Homologous to the E6AP Carboxyl Terminus‖ (HECT)-type contain a 
cysteine residue in their catalytic center. For this class of ligases, an E2 enzyme first 
transfers Ub to the cysteine in the HECT domain via transesterification and then the 
Ub moiety is conjugated to the bound substrate. Therefore, HECT ligases not only 
select the target for ubiquitination, but also determine the character of the generated 
Ub signal. Six HECT-type ligases have been identified in yeast and approximately 28 
are known in human cells9–11. 
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The third class of E3 enzymes is termed ―RING-in-between-RING‖ (RBR) ligases. 
Such enzymes contain three different domains: RING domain 1 binds and activates 
the E2 enzymes, the ―in-between-RING‖ (IBR) domain mediates protein-protein 
interactions and the catalytic RING domain 2 harbors an active site cysteine. RBR 
ligases employ a RING/HECT-hybrid mechanism, in which the charged E2 bound by 
RING1 transfers Ub to the catalytic cysteine residue in RING2. The Ub is then 
conjugated to the client. RBR ligases comprise the smallest class of E3 enzymes 
respresented by two species in yeast and around 14 in humans12–14. 
Ub can itself serve as acceptor for Ub modifications and thereby give rise to Ub 
chains. Depending on the catalytic properties of the involved E2 enzymes, the HECT 
and RBR ligases, substrates can be mono-ubiquitinated or decorated with poly-Ub 
molecules. This is referred to as the ubiquitin code, which will be explained in more 
detail in the following section. 
Figure 1-1: The ubiquitination cascade. Ubiquitination is achieved in the course of a three-step reaction 
cascade involving E1, E2, and E3 enzymes. As a result target molecules are decorated with distinct Ub signals. 
Ubiquitination is counteracted by the function of deubiquitinating enzymes (DUBs). Adopted from Smit & Sixma
15
. 
Ub modifications are dynamic and can be edited by proteases, called 
―deubiquitinating enzymes‖ (DUBs). Individual DUBs are highly specific for the Ub 
signals they act on. Some DUBs completely detach all Ub molecules from a protein, 
while others remove single Ub moieties from the tip of an appointed Ub chain or 
cleave inside a poly-Ub molecule and thereby dismount several Ub moieties at once. 
A well-characterized function of DUBs is associated with the activity of the 26S 
proteasome. Here, several DUBs cooperate to hydrolyze Ub chains from client 
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proteins, which allows their passage into the catalytic core of the proteasome and 
recycling of Ub. It is still a matter of intense studies how the relatively small number 
of DUBs, with 17 putative enzymes in yeast and around 100 in humans, can 
specifically modulate the highly diverse Ub signals in a cell16–18. 
 
1.2 The ubiquitin code 
Ubiquitination is a highly versatile modification that comes in many different flavors 
(Fig. 1-2). The simplest signal is the addition of a single Ub moiety to a target, also 
referred to as mono-ubiquitination. While ubiquitination preferentially occurs on lysine 
residues in the client (canonical ubiquitination), also serines, threonines, cysteines or 
amino-terminal methionines can serve as acceptor sites (atypical ubiquitination)19–22. 
Modification of several residues in a target results in a different signal, called multiple 
mono-ubiquitination. 
Ub itself harbors seven lysine residues and an amino-terminal methionine, which 
each can serve as acceptors for additional Ub moieties. The attachment of Ub to 
another Ub molecule that is already conjugated to a target causes the formation of a 
Ub chain. Depending on the acceptor site used within Ub, these chains comprise 
different linkage types. For example, poly-Ub molecules connected via lysine 48 in 
Ub are referred to as K48-linked Ub chains. In addition to homotypic chains, which 
exclusively contain entities attached to the same acceptor site, heterotypic or 
branched chains can be formed. Importantly, poly-Ub molecules connected via 
different linkages display distinct topological and structural properties, which are 
recognized by downstream acting factors. 
Ub itself was shown to be subjected to other post-translational modifications, such as 
phosphorylation, acetylation, or even SUMOylation. An important role for Ub 
phosphorylated on serine 65 has been found in PARKIN-mediated mitophagy23. 
Acetylation of Ub is readily detected in cells and was shown to inhibit the formation of 
Ub chains. Ub acetylation seems to contribute to the stabilization of mono-
ubiquitinated histone H2B, but the detailed role of this modification in this process still 
remains elusive24. Moreover, SUMOylated Ub species at lysine residues K6, K11, 
K27, K48 and K63 have been detected in cells, but again their biological function is 
unclear25. 
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Figure 1-2: The ubiquitin code. Various signals can be formed by ubiquitination of targets that in turn activate a 
great amount of distinct signaling pathways. Numbers in Ub spheres represent the modified lysine inside the Ub 
molecule. 
This large diversity of Ub modifications routes client proteins into very different 
cellular pathways. Table 1-1 summarizes our knowledge on how distinct Ub signals 
modulate specific cellular activities26–28. 
Proteins encompassing so-called ―ubiquitin binding domains‖ (UBDs) decode 
individual Ub signals. Each UBD can specifically interact with a defined Ub structure 
and route the attached client into a selected pathway. UBDs encompass domains of 
different folds which determine the specificity in signal recognition. Examples are zinc 
fingers, ―Ubiquitin-associated‖ (UBA) domains and ―Plekstrin Homology‖ (PH) folds29. 
Most mono-Ub binding UBDs directly bind the hydrophobic patch of Ub by a 
ubiquitin-interacting motif (UIM) or ubiquitin-binding zinc fingers (UBZ). Other UBD-
carrying proteins can detect Ub chains by displaying a distinct interaction motif for a 
specific Ub linkage type. The recognition of long and complex chains is often 
mediated by effector proteins harboring several UBDs that allow multivalent 
interactions with Ub. Thus, multifaceted Ub interactors have evolved that specifically 
decode the diverse signals displayed by this post-translational modification. 
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Table 1-1: Specific Ub modification activate distinct signaling pathways
26–28
 
Ub modification Signaling outcome 
  
Mono-Ub Regulation of protein-protein interactions, cellular 
localization, lysosomal degradation 
Multiple Mono-Ub Cellular localization, proteasomal degradation 
M1-linked (linear) chains Inflammation and immunity 
K6-linked chains DNA damage response, mitophagy 
K11-linked chains Implicated in non-canonical NF-κB signaling, T-cell 
activation and EGF receptor trafficking, yeast ERAD 
K27-linked chains Protein recruitment, DNA repair, autoimmunity 
K29-linked chains Proteasomal degradation, proteasome regulation, 
epigenetics 
K33-linked chains trans-Golgi network trafficking 
K48-linked chains Proteasomal degradation 
K63-linked chains DNA repair, innate immune response, mitophagy, 
protein sorting, protein translation, autophagy 
Mixed chains K29/K48-mixed chains  ubiquitin-fusion degradation 
pathway (UFD), DNA repair 
M1/K63-mixed chains  NF-κB signaling 
Branched chains K48/K11-branched chains  cell cycle control 
K48/K63-branched chains  NF-κB signaling 
SUMOylated Ub Indications in heat shock response and protein 
homestasis 
Phosphorylated Ub Ser65-phosphorylated Ub  mitophagy 
Acetylated Ub Possible stabilization of mono-ubiquitinated histone H2B 
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1.3 Ub in Endoplasmic reticulum-associated protein degradation 
Protein maturation is a complex process which is compromised by environmental 
stress or by mutations in the coding genes. Misfolded polypeptides that arise from 
unsuccessful folding attempts are typically dysfunctional and pose a threat for the 
maintenance of cellular homeostasis. Therefore, cells harbor potent quality control 
systems that detect unproductively folded protein species, facilitate their refolding 
and eliminate terminally misfolded molecules. Such quality control systems are found 
in every cellular compartment where they make an essential contribution for the 
function of the corresponding organelle. One of the main functions of the Ub system 
is the removal of defective proteins from the cell and Ub ligases constitute the central 
components of most quality control systems. The ligases label their clients with Ub 
signals that either target them for proteasomal hydrolysis or route them to 
autophagosomes for degradation. 
Proteins of the secretory pathway have to enter the endoplasmic reticulum (ER) in an 
unfolded state through a narrow pore, termed the translocon. In the ER, they attain 
their native structure before they are released to downstream acting compartments. 
Even though protein maturation is assisted and tightly regulated by folding enzymes, 
this process is error-prone and can eventually result in the formation of terminally 
malfolded polypeptides30. Such aberrant species may form proteotoxic aggregates, 
which have been linked to the onset of several neurodegenerative diseases and 
type II diabetes31. ―Endoplasmic reticulum-associated protein degradation‖ (ERAD) 
eliminates misfolded proteins by routing them into the cytoplasm where they are 
decorated with poly-Ub and degraded by proteasomes. Additionally, the ERAD 
pathway also regulates the amount of metabolic enzymes in the sterol biosynthesis 
pathway32. 
 
1.4 Ub ligases involved in ERAD 
The yeast S. cerevisiae harbors ERAD Ub ligases which each target a specific 
subset of client proteins33. Membrane-bound polypeptides with structural defects in 
their cytosolic parts are termed ERAD-C substrates and are processed by the Doa10 
ligase. Integral membrane proteins exposing lesions inside their transmembrane 
segments are classified as ERAD-M substrates and are degraded in a Hrd1-
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dependent manner. Finally, misfolded polypeptides residing inside the ER lumen 
belong to the ERAD-L class which is also targeted by the Hrd1 ligase. Importantly, 
ERAD-L substrates have to be first extracted from the ER before they can be 
assessed by the Ub system and the proteasome in the cytoplasm. 
The Hrd1 and Doa10 RING-finger proteins are the central components of large and 
highly conserved multi-subunit protein complexes (Fig. 1-3). The integral membrane 
protein Hrd1 contains a RING-finger in its cytoplasmic domain at the carboxy-
terminus and serves as a Ub ligase. Hrd1 tightly binds to Hrd3 which exposes several 
so-called ―Suppressor enhancer of Lin12-like‖ (SEL1L) repeats into the ER lumen. 
Together with the associated protein Yos9, a glycan-binding lectin in the ER lumen, 
Hrd3 is thought to constitute the substrate receptor of the Hrd1 Ub ligase complex34. 
In the ER membrane, Hrd1 is in close contact with the membrane proteins Usa1 and 
Der1. While Usa1 is a scaffolding protein that controls the assembly and 
oligomerization of the complex, Der1 was shown to participate in the dislocation of 
ERAD-L substrates from the ER lumen35,36. 
The modification of Hrd1 client proteins with K48-linked poly-Ub chains mainly 
involves the E2 enzyme Ubc7. Ubc7 is recruited to the ligase by binding to the 
membrane protein Cue137,38. In absence of Cue1, Ubc7 becomes short-lived, while 
the association with Cue1 causes a structural rearrangement in the E2, which 
stimulates its catalytic activity38–40. Moreover, Cue1 contains a UBD termed CUE 
domain which positions Ubc7 at K48-linked poly-Ub and thereby facilitates the 
elongation of Ub chains41,42. Hrd1 also binds to the membrane protein Ubx2 which 
recruits a cytoplasmic protein complex containing the ―ATPase associated with 
diverse cellular activities‖ (AAA-ATPase) Cdc48, Npl4 and Ufd1 to the ligase43. This 
Cdc48 complex is a Ub-dependent chaperone that binds poly-ubiquitinated proteins 
and possibly extracts them from the ER to allow their processing by 26S 
proteasomes44–46. 
The Doa10 Ub ligase is integrated into the membranes of the ER and the inner 
nucleus by 14 transmembrane segments47. This protein exposes a short soluble 
region at its amino-terminus into the cyto- and nucleoplasm that harbors the RING-
finger domain. For substrate processing, Doa10 teams up with the E2 enzymes 
Ubc6, which itself contains a membrane-spanning region, and the Ubc7/Cue1 
complex48. The Doa10 Ub ligase also encompasses Ubx2 and the Cdc48 complex33. 
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While the mechanisms of substrate selection at the Doa10 ligase are still elusive, the 
ubiquitination of client proteins by Ubc6 and Ubc7 was studied in more detail. Doa10 
employs Ubc6 for the initial conjugation of single Ub moieties on a protein that are 
then elongated to K48-linked Ub chains by Ubc720. Hence, in contrast to Hrd1, the 
processing of Doa10 clients requires separate E2 enzymes for the priming with Ub 
and the generation of a poly-Ub signal. Importantly, Ubc6 attaches Ub not only to 
lysines, but also to the non-canonical acceptor sites serine and threonine via an 
oxyester bond20. This unusual activity is thought to broaden the substrate range of 
the Doa10 quality control Ub ligase. 
Figure 1-3: Schematic presentation of the Doa10 and Hrd1 ligase complexes. The multi-subunit complexes 
recognize and modify substrates with Ub signals. Targets are then extracted by the AAA-ATPase Cdc48 and 
handed over for proteasomal disposal. 
 
1.5 Inner nuclear membrane-associated protein degradation 
A pathway recently described as ―Inner nuclear membrane-associated protein 
degradation‖ (INMAD) contributes to protein quality control in the inner nuclear 
membrane and the nucleus49. A membrane-bound ubiquitin ligase, termed the Asi 
complex, is the major player of INMAD. The components of the Asi complex were 
initially identified in a genetic screen for suppressors of mislocalized Stp1 and 
Stp250,51. Stp1 and Stp2 are transcription factors that control the expression of amino 
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acid permeases in response to external stimuli52,53. In the presence of amino acids, 
the precursor forms of Stp1 and Stp2, which reside in the cytoplasm, are cleaved by 
a subunit of the so-called SPS sensor. Processed Stp1 and Stp2 are then imported 
into the nucleus where they induce the expression of target genes54. Unprocessed 
Stp1 and Stp2, which eventually leak into the nucleus in absence of amino acids, are 
ubiquitinated by the Asi complex and degraded by proteasomes. This prevents 
unsolicited gene expression50,51,55. Intriguingly, the Asi complex also targets specific 
membrane-bound proteins involved in later steps of sterol biosynthesis similar to the 
ERAD ligases Hrd1 and Doa1056. 
The Asi complex contains two highly homologous membrane proteins, Asi1 and Asi3, 
which each expose a RING-finger domain at their carboxy-terminus into the 
nucleoplasm (Fig. 1-4). Both proteins constitute bona fide ubiquitin ligases. The Asi 
complex also harbors another membrane-embedded subunit termed Asi2, but the 
function of this protein is unknown. For ubiquitination of its client proteins, the Asi 
complex employs the E2 enzyme Ubc7. Two other Ub conjugating enzymes, Ubc4 
and Ubc6, were also associated with the function of the Asi complex. However, their 
role at this ligase is unclear56,57. 
Figure 1-4: Schematic presentation of the Asi complex. The Asi complex is composed of two RING-finger 
domain-containing ubiquitin ligases. Both act in conjunction with the bona fide accessory factor Asi2. The ubiquitin 
conjugating enzymes Ubc4, Ubc6 and Ubc7 are implicated to take part in Asi-dependent substrate processing. 
Extraction of substrates from the inner nuclear membrane is facilitated by the AAA-ATPase Cdc48. 
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1.6 Stimulation of E2 enzymes by RING-type E3 ubiquitin ligases 
The vast majority of all E3 enzymes are RING-type Ub ligases. This class of proteins 
is characterized by a RING-finger domain where a conserved cysteine motif 
coordinates two zinc ions in a cross-braced arrangement. The RING scaffold serves 
to bind E2 enzymes58. 
RING-type ligases adopt different topological architectures. Some are found to be 
monomeric including the CBL family of RING E3 ligases (c-CBL, CBL-B, CBL-C)59. 
Others function as homodimers as BIRC7 or several members of the TRIM 
family60,61. Then again, RING-type ligases are found to form heterodimers as the 
famous example of the BRCA1/BARD1 complex shows62. Moreover, RING domain-
containing proteins can assemble into large complexes mediated by a Cullin protein 
scaffold, so-called Cullin-type RING ligases (CRLs). The cell cycle-regulating CRLs 
SCF (Skp1-Cul1-F-box protein) and APC (anaphase promoting complex) are just two 
amongst many other examples63. 
E2 enzymes are characterized by their catalytic core domain, the ubiquitin-
conjugating (UBC) domain. This domain is formed by an α/β fold, typically with four 
α-helices and a four-stranded β-sheet64. It also harbors the catalytic cysteine which 
forms a transient thioester with Ub during the ubiquitination reaction. Different E2s 
encompass distinct catalytic behaviors ranging from the efficient mono-ubiquitination 
of targets to the processive formation of Ub chains of a specific linkage type. 
RING/E2 interactions are governed by a shallow groove which is formed by the zinc-
coordinating loops and the central α-helix of the RING domain (Fig. 1-5). The UBC 
domain of an E2 is bound on the backside rather than in close proximity to the 
catalytic center. Noteworthy, the interaction surface of the E2, which is bound to the 
RING, overlaps with the surface that is utilized for E1/E2 interaction. Thus, it was 
proposed that E2 enzymes need to dissociate from their cognate RING domains after 
Ub transfer in order to enter a new charging cycle65. An exception has been 
discussed in regard to the APC. Here, distinct interactions between RING and E2, 
remote from the previously defined surfaces, could allow recharging of the E3-bound 
E2 to support rapid Ub chain synthesis66. Generally, E2/E3 interactions are 
characterized by low affinities58. Accordingly, co-immunoprecipitation experiments of 
E2s and E3s are rarely successful causing the need for biophysical measurements 
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like NMR or X-ray crystallography to analyze physical interactions. In recent years, a 
powerful tool for the characterization of functional interactions between Ub ligases 
and their cognate ubiquitin conjugating enzymes was established. So-called 
discharge assays involving small molecules provide the means to analyze the 
inherent activities of E2 enzymes and their stimulation by E3 catalytic domains67. 
 
 
 
 
 
 
 
 
Figure 1-5: Exemplary interaction of a RING domain with an E2~Ub conjugate. Crystal structure of the 
RNF165 RING domain in complex with a UbcH5b~Ub conjugate. The figure is based on PDB file 5ULH. 
RING E3 ligases do not only bring substrate and E2 enzyme into close proximity to 
allow efficient transfer of Ub, they also stimulate the intrinsic activity of E2s. RING 
domains bind to a region remote from the active site of the E258. Thus, RING-
mediated stimulation of a cognate E2 enzyme must be facilitated by an allosteric 
mechanism. Conjugates formed by E2 enzymes and Ub assume a variety of different 
―open‖ and ―closed‖ states68. By now it has been established that E2~Ub conjugates 
need to adopt a closed conformation as a prerequisite for Ub transfer to client 
molecules. A recent study provided much needed inside in how a RING domain 
pushes an E2~Ub conjugate into such an arrangement by an allosteric mechanism 
(Fig. 1-6)69. This involves the residue at the so-called linchpin position of a RING 
domain which is situated directly downstream of the last zinc-coordinating cysteine 
pair. This linchpin allostery involves positively charged residues, like arginine or 
lysine that expose long side chains into the backbone of the E2 where they form a 
hydrogen bond. The conformational space of an E2~Ub conjugate (Fig. 1-6, green 
sphere) is therefore restricted upon interaction with a RING domain which exerts 
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linchpin allostery (Fig. 1-6, blue sphere). Thus, RING domains harboring conserved 
arginines or lysines at the linchpin position comprise the activity to directly stimulate 
the transfer of Ub from E2 enzymes enabling a spatiotemporal regulation of substrate 
ubiquitination. 
Figure 1-6: The conformational space of an E2~Ub conjugate can be restricted by interaction with a RING-
finger domain. The formation of a covalent hydrogen bond between the residue at the linchpin position of a 
RING-finger domain and the backbone of the E2 pushes the conjugate into a closed conformation. Spheres 
represent the conformational space that the E2~Ub conjugate can adopt. Modified from Pruneda et al.
69
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1.7 Aims of this study 
Protein quality control is important to protect cells from proteotoxic stress. It is 
unknown why there is more than one PQC ubiquitin ligase in cells. To understand the 
requirement for those multiple protein degradation pathways, their function needs to 
be elicited and their mechanisms of substrate processing need to be unraveled in 
molecular detail. Therefore, the requirements of different E3 ligases for distinct E2 
enzymes and the specific stimulation of E2s need to be investigated. 
To shed light on the differential requirements of the Hrd1 and Doa10 ligases 
regarding their cognate E2 enzymes, the E3-mediated stimulation of Ubc6 and Ubc7 
was to be analyzed in reconstituted in vitro systems. Special focus was set on the 
differential effects of RING domain-facilitated linchpin allostery during the sequential 
steps of substrate priming and Ub chain elongation. 
Simultaneously, distinct alterations abrogating priming and elongation in cells were to 
be introduced using yeast as a model system. This approach should elucidate how 
priming and Ub chain elongation are facilitated at the ERAD E3 ligases in the context 
of the ER membrane and which factors contribute to either process. 
Finally, the third ER membrane-bound yeast Ub ligase, the Asi complex, was to be 
analyzed. To this end, the involvement of single subunits in complex function was 
addressed with special regard to the distinct contribution of the Asi1 and Asi3 RING 
domains. Moreover, complex organization and the requirement for distinct E2 
enzymes at the complex were to be analyzed in molecular detail. Furthermore, an 
in vitro assay should be established to monitor Asi complex-mediated ubiquitination 
of client proteins in a reconstituted system. 
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2. Results 
 
2.1 Hrd1 and Doa10 RING domains stimulate Ubc6 and Ubc7 activity 
by different mechanisms 
 
2.1.1 Doa10 harbors a non-canonical residue at its linchpin position 
The Doa10 and Hrd1 ubiquitin ligases display different requirements regarding the 
E2 enzymes they cooperate with. While the degradation of Doa10 client proteins 
relies on the sequential action of Ubc6 and Ubc7, Ubc7 alone suffices for the 
processing of Hrd1 substrates. To explore such mechanistic differences of both E3 
ligases in the ubiquitinating reaction, a sequence alignment of their RING finger 
domains was conducted (Fig. 2-1). 
Figure 2-1: Sequence alignment of yeast E3 ligase RING domains. Sequence alignment was conducted with 
Clustal Omega. Conserved zinc-coordinating residues are highlighted in yellow. Residues at the linchpin-position 
are colored in red/green. Asterisks mark conserved residues. Colons mark chemically similar residues. 
Most canonical RING domains harbor an arginine or a lysine residue at their so-
called linchpin position which is located immediately downstream of the most 
carboxy-terminal zinc-coordinating pair of cysteines. These positively charged 
residues expose long side chains into the backbone of the interacting E2~Ub 
conjugate. The formation of a hydrogen bond restricts the conformational space of 
the conjugate and pushes it into a ―closed conformation‖. This is a prerequisite for the 
transfer of Ub to target proteins69. In contrast to the Hrd1 RING domain, which 
contains such an arginine at the linchpin position, Doa10 harbors a histidine at the 
corresponding site. While histidine can serve as a donor for hydrogen bond formation 
in an appropriate chemical environment, its side chain is much shorter and probably 
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does not extend far enough into the E2 backbone. Therefore, the non-canonical 
linchpin residue of Doa10 can be expected to be less efficient in E2 stimulation. 
 
2.1.2 E3 RING-finger ligases stimulate Ubc6 and Ubc7 activity by different 
mechanisms 
Detailed analyses of Doa10’s and Hrd1’s linchpin residues were conducted to 
evaluate differences in the interaction with their cognate E2 enzymes and resulting 
effects in E2 behavior. To this end, a series of Doa10 and Hrd1 RING domain 
variants were generated and studied in reconstituted in vitro ubiquitination assays 
containing purified components (Fig. 2-2). 
Figure 2-2: Purified components for in vitro ubiquitination assays. Coomassie-stained SDS-PAGE gels 
showing purified components heterologously expressed in E. coli. Architecture of depicted constructs is listed in 
table 4-2. Hrd1R or Doa10R correspond to constructs comprising the RING domains of each enzyme. Asterisk 
marks the respective signal for the E1 enzyme. 
The linchpin residue in each RING domain was substituted with the corresponding 
basic residue of the other RING domain, the polar residue alanine, or the acidic 
amino acid glutamate. The last two variants cannot form hydrogen bonds and thereby 
should not be able to stimulate the transfer of Ub from the interacting E2s via linchpin 
allostery. In order to reconstitute ubiquitination in vitro, other purified components of 
the Ub cascade were added, such as E1 enzyme, E2s, e.g. Ubc4, Ubc6 or Ubc7, the 
cytosolic part of the Ubc7 cofactor Cue1 and either monomeric Ub or preformed Ub 
chains of different lengths. With this toolset in hand, in vitro Ub chain formation was 
monitored in step-by-step reactions to determine the contribution of the involved 
enzymes. 
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2.1.3 Stimulation of Ubc7 activity relies on a particular linchpin residue 
The first step in forming a Ub chain is the transfer of a Ub moiety to a nucleophilic 
side chain of a target protein. This primes the substrate for the addition of further Ub 
moieties. In most cases, Ub is attached to the ε-amino group of lysine residues but 
some specialized E2s, like Ubc6, may also facilitate Ub transfer to hydroxyl groups of 
serines or threonines. This initial ubiquitination event can be studied in Ub discharge 
assays onto small molecules. Therefore, E2 enzymes were charged with Ub in a first 
reaction and subsequently incubated with appropriate acceptors for Ub attachment. 
To compare the reactivity of Ubc6 and Ubc7, discharge reactions were performed on 
ethanolamine (Fig. 2-3 A). Ethanolamine harbors a hydroxyl and an amino group and 
thereby meets possible preferences of Ubc6 and Ubc7 for lysines or hydroxylated 
amino acids as acceptor sites of Ub. Any decline in the amount of Ub-charged E2 
(Ubc7~Ub) over time was visualized on Coomassie-stained gels (Fig. 2-3 B, C) and 
quantified (Fig. 2-3 D, E). Single exponential fits of these data were used to calculate 
turnover rates (Fig. 2-3 F, G). 
All reactions contained the Ubc7-binding region (U7BR) of Cue1 which induces 
conformational changes and thereby activates Ubc740,70. Discharge assays with 
Doa10 RING variants were incubated at 37 °C while the Hrd1 reactions were 
conducted at room temperature due to general differences of the Doa10 and Hrd1 
constructs to stimulate this E2 enzyme. Assays without RING domains demonstrated 
an intrinsic propensity of Ubc7 to transfer Ub onto targets. Depending on the residue 
at the linchpin position, this reaction was accelerated at different rates upon addition 
of the Doa10 or Hrd1 RING domains. Hrd1 and Doa10 constructs containing an 
arginine at this site facilitated Ub transfer most efficiently. A Doa10 variant harboring 
the endogenous histidine stimulated catalysis of Ubc7~Ub nearly as good suggesting 
that in the context of the Doa10 RING, histidine can serve as a hydrogen bond donor 
for linchpin allostery. Conversely, Hrd1 featuring a histidine at the linchpin position 
was significantly impaired in supporting Ubc7~Ub discharge comparable to the effect 
of an alanine substitution. This implies that the Hrd1 RING does not provide the 
chemical environment needed for histidine-mediated linchpin allostery. Alanine-
substituted RINGs promoted moderate activation of Ubc7, which hints to another yet 
unknown linchpin-independent mechanism as discussed in section 2.1.2.3. RING 
variants harboring a glutamate at the linchpin position were completely inert for Ubc7 
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stimulation despite their ability to bind E2 enzymes, as seen later for Ubc6 (compare 
Fig. 2-4). 
Taken together, these results show that RING-mediated stimulation of the canonical 
E2 Ubc7 clearly depends on the nature of the position residue. 
Figure 2-3: Ubc7 is stimulated in a linchpin-dependent manner. (A) Scheme of discharge reactions modified 
from von Delbrück et al.
42
 (B, C) Representative Coomassie-stained SDS-PAGE gels showing the decrease in the 
Ubc7~Ub conjugate and the increase in free Ubc7 over time dependent on different (B) Doa10 and (C) Hrd1 
RING domain variants. Reactions with Doa10 and Hrd1 variants were incubated at 37 °C and room temperature, 
respectively. (D, E) Quantifcations of Ubc7~Ub conjugates as seen in (B) and (C). (F, G) Kinetic rate constants 
extracted from single exponential fits of the data in (D) and (E). Error bars represent the standard deviation of 
mean of at least three independent experiments. Assays were performed by Dr. Tobias Ritterhoff. 
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2.1.4 Ubc6 activity is stimulated by a linchpin-independent mechanism 
To compare the reactivity of Ubc6 and Ubc7, discharge assays containing Ubc6 were 
performed. These reactions were incubated at room temperature. In contrast to 
Ubc7, Ub transfer by Ubc6 was stimulated by the Doa10 and Hrd1 RING domains 
irrespective of the identity of the linchpin residue. Consequently, while Ubc7 
discharge assays gave a characteristic pattern depending on the introduced 
substitutions, reactions containing Ubc6 showed clustering of the recorded graphs 
(Fig. 2-4). 
Figure 2-4: Ubc6 is stimulated via a linchpin-independent mechanism. (A, B) Representative Coomassie-
stained SDS-PAGE gels showing the decrease in the Ubc6~Ub conjugate and the increase in free Ubc6 over time 
dependent on different (A) Doa10 and (A) Hrd1 RING domain variants. All reactions were performed at room 
temperature. (C, D) Quantifcations of Ubc6~Ub conjugates as seen in (A) and (B). (E, F) Kinetic rate constants 
extracted from single exponential fits of the data in (C) and (D). Error bars represent the standard deviation of 
mean of at least three independent experiments. Assays were performed by Dr. Tobias Ritterhoff. 
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Overall, Ub discharge from Ubc6 was substantially faster than that from Ubc7 
implying that this E2 enzyme transfers Ub more readily to targets. Addition of 
different RING domain variants led to an efficient stimulation of Ubc6’s inherent 
activity albeit the linchpin variants revealed no significant differences in reaction 
rates. It is noteworthy that Doa10 RING variants generally enhanced Ub discharge 
from Ubc6 to a greater extent than Hrd1 variants indicating a tight and probably more 
conserved functional interaction of this E2/E3 pair. Importantly, glutamate-substituted 
RINGs promoted Ubc6 activity to a similar degree as the other variants pointing out 
that they were still able to bind the E2 enzymes while they did not induce linchpin-
mediated conformational changes.  
The presented data indicate that Ubc6 activity is stimulated by a RING-dependent 
mechanism that does not involve the linchpin position. 
 
2.1.5 Ubc6 adopts a closed conformation more readily than Ubc7 
To gain a deeper understanding of the E2/E3 interactions and thereby the E3-
mediated stimulation of E2 enzyme activity, NMR titration experiments were 
performed. In the first setup, Ub was labeled with deuterium (2H) and heavy nitrogen 
isotopes (15N) and stably conjugated to the designated E2s via a disulfide bridge. For 
that purpose, a Ub variant with a C-terminal cysteine was used (UbG76C) and 
conjugated to the active site cysteine of the E2 enzymes. Chemical shift 
perturbations (CSPs) in comparison to free Ub were recorded and mapped over the 
amino acid sequence of the protein (Fig. 2-5). 
When an E2~Ub conjugate adopts the closed conformation, subtle structural 
changes can be observed in the hydrophobic patch of Ub. Indeed, prominent shifts at 
distinct sites within this region were detected when Ub was conjugated to the E2s. 
Presumably, Ubc6~Ub and Ubc7~Ub adopt closed conformations as a prerequisite 
for Ub transfer. Interestingly, the CSP pattern of Ubc6~Ub and Ubc7~Ub displayed 
different profiles. Overall, CSPs and especially changes in the hydrophobic patch of 
Ub were more pronounced in the Ubc6~Ub conjugate suggesting that it adopts a 
catalytic active conformation more readily than Ubc7. 
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Figure 2-5: The Ubc6~Ub conjugate is predisposed to form the closed conformation. Shown are chemical 
shift perturbations from HSQC-TROSY experiments of stably conjugated (
2
H/
15
N) Ub
G76S
 to either Ubc6 (top) or 
Ubc7 (bottom) in relation to free Ub mapped over its sequence. Unassignable residues are shown as off-scale. 
Residues of the hydrophobic patch (closed conformation interaction interface) are underlined in green. 
Measurements were performed by Dr. Tobias Ritterhoff. 
Canonical E2’s interact with three distinct regions within the RING domains of E3 
enzymes, the first and last Zinc binding CXXC motifs and a conserved α-helix of the 
RING fold64. To address the interaction of Ubc6/Ubc7 with the RINGs, NMR titration 
experiments employing 2H/15N-labeled Doa10 RING variants and unlabeled E2~Ub 
conjugates were conducted. Recorded specific intensity losses for each residue per 
equivalent of conjugate were mapped onto the sequence of the employed Doa10 
construct (Fig. 2-6). This calculated value was used since experiments in the slow 
exchange regime (e.g. E2/E3 titrations) usually give weak CSP signals that are 
difficult to detect. 
In these experiments, we noted significant differences at the Doa10 linchpin position 
(Fig. 2-6 A). Ubc7~Ub induced a prominent doubling of the peak that corresponds to 
histidine 94 indicative for a physical interaction with this residue. In contrast, this 
amino acid was unaffected upon titration of Ubc6~Ub. When mutated to an alanine, 
neither Ubc6~Ub nor Ubc7~Ub caused a shift at this site. This result supports the 
idea that histidine facilitates linchpin allostery in the context of the Doa10 RING 
domain. Moreover, it confirms the notion that the activation of Ubc7 by RING 
domains depends on the nature of the linchpin residue, while stimulation of Ubc6 
does not involve this site. 
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Figure 2-6: Canonical binding of E2~Ub to Doa10. (A) Representative spectra from HSQC-TROSY 
experiments showing peak doublings induced by titration of Ubc7~Ub (top) or Ubc6~Ub (bottom) on the linchpin 
position of the Doa10 RING domain containing either histidine (left) or alanine (right). Peak colors are as follows: 
gray: (
2
H/
15
N) Doa10, green: equimolar amount of E2~Ub, blue: 2 x E2~Ub, orange: 4x E2~Ub, red: 8x E2~Ub.  
(B) Specific intensity losses per equivalent of conjugate induced by Ubc6~Ub (top) or Ubc7~Ub (bottom) plotted 
over the sequence of the Doa10 RING construct. Regions where canonical E2 binding takes place are underlined 
in green. Presumed Ub contacts are underlined in red. Unassignable residues are shown as off-scale. 
Measurements were performed by Dr. Tobias Ritterhoff. 
Overall, titration of the E2~Ub conjugates induced specific intensity losses at the 
canonical residues involved in E2 binding (Fig. 2-6 B). Interestingly, titration of 
Ubc6~Ub generally resulted in less pronounced effects on the Doa10 RING than 
Ubc7~Ub, even though the binding affinities of the RING for either E2 as determined 
by NMR were comparable. Doa10/Ub contacts were relatively more pronounced in 
the Ubc6~Ub conjugate, suggesting that RING/Ub interaction plays a role in E2 
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stimulation. Upon titration of the Ubc7~Ub conjugate, clear shifts were visible at the 
E2 binding sites indicating a canonical interaction between Doa10 and Ubc7. Also 
with this conjugate, changes were detected at residues involved in Ub binding, 
supporting the recent idea that RING/Ub contacts are important for ubiquitination 
reactions71. 
Following these results, direct contacts of the E2-conjugated Ub to the RING 
domains were investigated. Again, (2H/15N)-labeled Ub was stably conjugated to 
either Ubc6 or Ubc7 and subsequently titrated with unlabeled Doa10H94 (Fig. 2-7) or 
Hrd1R400 (Fig. 2-8) RING domains. Observed intensity losses in comparison to the 
above presented conjugates (compare Fig. 2-5) were mapped onto the sequence of 
Ub. 
Figure 2-7: The Doa10 RING contacts Ub in E2~Ub conjugates. (A) Specific intensity losses of Ub residues 
per equivalent of Doa10 were plotted over the sequence Ub which was either conjugated to Ubc6 (top) or Ubc7 
(bottom). (B) Intensity losses were normalized in relation to the average intensity loss of residues 16-22 and 52-
63 of Ub. Residues of the hydrophobic patch are underlined in green. Presumed Doa10 contacts are underlined in 
red. Unassignable residues are shown as off-scale. Measurements were performed by Dr. Tobias Ritterhoff. 
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Figure 2-8: The Hrd1 RING contacts Ub in E2~Ub conjugates. (A) Specific intensity losses of Ub residues per 
equivalent of Hrd1 were plotted over the sequence Ub which was either conjugated to Ubc6 (top) or Ubc7 
(bottom). (B) Intensity losses were normalized in relation to the average intensity loss of residues 16-22 and 52-
63 of Ub. Residues of the hydrophobic patch are underlined in green. Presumed Hrd1 contacts are underlined in 
red. Unassignable residues are shown as off-scale. Measurements were performed by Dr. Tobias Ritterhoff. 
It is readily visible that the effects of the RING titrations on Ubc6~Ub are drastically 
less pronounced than on Ubc7~Ub, especially at the closed conformation interface 
(Fig. 2-7 A, Fig. 2-8 A). The strong responses that RINGs elicit on the Ubc7~Ub 
conjugate imply that, upon interaction, the conjugate is heavily pushed into a closed 
conformation thereby being activated. Those responses are likely due to linchpin-
mediated allostery, explaining the robust stimulation of Ubc7 in the discharge assays 
(Fig. 2-3). Ubc6, on the other hand, only shows minor responses to RING titrations. 
For means of visualization, the effects of the RING titrations were normalized in 
relation to the average intensity loss of ubiquitins residues 16-22 and 52-63 which 
are not involved in any reported interactions (Fig. 2-7 B, Fig. 2-8 B). The RING 
domains made clear contacts with Ub in the Ubc6~Ub conjugate without showing 
more pronounced shifts in the hydrophobic patch. 
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In summary, the results suggest that Ubc6 is inherently more biased towards a 
closed conformation than Ubc7. Contacts between RING domains and Ub are 
sufficient to stabilize this conformation and thereby allow a RING-dependent 
stimulation of the Ub transfer. At the same time, this means that Ubc6 is mostly 
independent of linchpin-mediated activation, while stimulation of Ubc7 heavily relies 
on this allostery. Contacts between RING domains and Ub in the Ubc7~Ub conjugate 
indicate that RING/Ub interaction is a general mechanism in stabilizing closed 
conformations and thereby enhances the ability of E2s to transfer Ub to targets. 
 
2.1.6 K48-linked Ub chain formation by Ubc7 only partially relies on stimulation 
by the RING domain 
Substrates labeled with poly-Ub linked via lysine 48 (K48) are in most cases 
degraded by the 26 S proteasome72. The E2 enzyme Ubc7 with its cofactor Cue1 is a 
very efficient K48-chain builder and can therefore generate such a degradation 
signal38. So far in this thesis, the effect of RING domains on the first step in Ub chain 
formation, the general transfer of Ub from E2 enzymes, was analyzed. This did not 
address the involvement of the RINGs in Ub chain formation. Accordingly, in vitro 
studies to monitor the detailed contribution of E2s and E3s in the individual steps 
during Ub chain formation were performed. To this end, the same constructs from the 
discharge and NMR assays were used, except for the addition of the complete 
cytosolic part of Cue1 instead of the U7BR domain (compare purification Fig. 2-2). 
To address the mechanism of chain elongation in molecular detail, an assay was 
adopted from von Delbrück et al.42 Monomeric or polymeric, C-terminally His6-tagged 
Ub species (Ub-His6, Ub2-His6, Ub3-His6) were added in high molecular excess and 
served as acceptors for additional Ub moieties during chain formation, thus 
resembling substrate-conjugated Ub. Conjugation of Alexa Fluor™ 488-labeled Ub 
(Ub488) to these molecules by Ubc7 in single turnover experiments was then followed 
over time in presence of different RING domain variants (Fig. 2-9 A). Fluorescent 
signals of the products were visualized (Fig. 2-9 B, D), quantified in relation to whole-
lane fluorescence and plotted over time (Fig. 2-9 C, E). Single exponential fits were 
then calculated to extract turnover rates (Fig. 2-9 F, G). 
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Figure 2-9: Chain elongation by Ubc7 is less dependent on RING stimulation. (A) Scheme of single turnover 
chain elongation reactions modified from von Delbrück et al.
42
 (B-E) Representative fluorescence scans of 
elongation reactions from (B) mono- to diubiquitin and (D) di- to triubiquitin. Asterisks mark free fluorescent dye 
which could not be completely removed after labeling. Fluorescence signal of the respective reaction products in 
relation to whole-lane fluorescence was quantified and plotted as a function of time (C, E). (F, G) Kinetic rate 
constants for (F) Hrd1-dependent and (G) Doa10-dependent elongation reactions in cooperation with Cue1
WT
 
(dark colored) or Cue1
RGA
 (light colored) were extracted from single exponential fits of resulting curves. Error bars 
represent the standard deviation of mean of at least three independent experiments. 
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In these experiments, not only the impact of the RING domains on Ub chain 
formation was investigated but also the contribution of the Ubc7 cofactor Cue1. Cue1 
is embedded in the ER membrane where it recruits Ubc7 to ER-resident E3 ligases37 
and promotes Ubc7-mediated K48-linked Ub chain formation. Binding of Cue1 
causes a steric activation of Ubc740,70. Moreover, the CUE domain of Cue1 aligns 
growing Ub chains with Ubc7 and thereby facilitates chain elongation41,42,73. It has 
been shown that Cue1 preferentially associates with the penultimate Ub moiety in a 
K48-linked poly-Ub chain and that a change of residues 76-78 (LAP  RGA) in the 
CUE domain abrogates binding and impairs chain elongation. With this variant in 
hand, the effects of the RING and CUE domains on Ub chain elongation were 
analyzed. 
Ubc7-mediated elongation of the priming Ub moiety (Ub-His6) was readily stimulated 
by the wild type Hrd1 RING domain independently of the Cue1 variant in the assay 
(Fig. 2-9 B, C). Addition of different Hrd1 or Doa10 RING domain constructs resulted 
in a similar reaction pattern as observed in the discharge experiments on 
ethanolamine (Fig. 2-9 F, G, blue bars). This demonstrates an enzymatic activation of 
Ubc7 by linchpin-mediated allostery. All tested RING domain variants displayed 
comparable reaction kinetics in presence of Cue1WT or Cue1RGA suggesting that the 
first step in chain elongation is not stimulated by the alignment of Ubc7 to the 
acceptor Ub via Cue1. 
When the elongation of chains containing two or three Ub molecules was followed, 
linchpin-substituted RING domains showed the same overall behavior as was 
observed in the discharge assays on smaller molecules (Fig. 2-9 F, G, red and green 
bars). However, in contrast to the elongation of the monomeric Ub, turnover of longer 
chains was significantly accelerated by Cue1WT, but not by the Ub binding-deficient 
Cue1RGA variant (Fig. 2-9 D, E). This result confirms published information that 
binding of Cue1 requires at least two Ub moieties42. While supplementation of RING 
domains led to an additive stimulation in the first 10 minutes of the reaction, the 
kinetic curves converged at later timepoints (Fig. 2-9 E). Importantly, wild type Cue1 
stimulated the intrinsic chain elongation capacity of Ubc7 stronger than the addition 
of a RING domain. The Ub binding deficient Cue1RGA variant accelerated Ub chain 
formation to a similar degree than the elongation of mono-Ub. 
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In general, early steps in Ub chain formation are stimulated by a mechanism 
involving the linchpin residue in the RING domain. The extension of longer chains is 
still accelerated by the RING domain, but the alignment of these substrates with 
Ubc7 via Cue1 now constitutes the dominant stimulating factor. This implies that 
during poly-Ub synthesis, the impact of the RING domain on the reaction decreases 
along with the length of the assembled Ub chain. The addition of Ub moieties is then 
primarily facilitated by the positioning of the Ubc7/Cue1 complex on the growing 
chain via the CUE domain. 
 
2.1.7 In vitro ubiquitination of proteins by Ubc7 is stimulated by Hrd1 
Ub discharge from E2 enzymes and Ubc7-mediated Ub chain elongation have been 
analyzed extensively in the previous sections. Still, it is unclear if the modification of 
protein substrates is affected by any of the reported interactions. To address this 
issue, an in vitro substrate ubiquitination assay based on an experimental setup by 
Bays et al.74 was established. The authors fused a peptide stretch termed ―S 
peptide‖, which is derived from bovine RNase A and is commonly used in protein 
purification procedures, to the Hrd1 RING domain. The S peptide epitope displays a 
high affinity for binding the remaining part of the RNase A termed ―S protein‖, with 
which it forms the so-called RNase S75 (Fig. 2-10 A). In the in vitro assay, the S 
peptide-RING fusions are recruited to the S protein which serves as an acceptor for 
ubiquitination. 
Ubc7 predominantly generates unanchored Ub chains in in vitro experiments41, and 
therefore any modifications on the S protein can only be visualized upon direct 
detection of the substrate. To increase the sensitivity of the assay, a technique for 
fluorescent labeling via the so-called Tub-tag labeling approach was implemented76. 
A construct comprising a short α-tubulin-derived recognition peptide fused to the C-
terminus of the S protein was purified and modified with 3-Azido-L-tyrosine by the 
addition of tubulin tyrosine ligase. This allowed for site-specific strain-promoted 
azide-alkyne cycloaddition77 (SPAAC) introducing dibenzocyclooctyne (DBCO)-
strained Alexa Fluor™ 488 into the substrate. In the first step, experiments performed 
by Bays et al.74 using the E2 enzyme Ubc4 were recapitulated and further extended 
by including appointed variants of the Hrd1 and Doa10 RING domains (Fig. 2-10 B). 
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Figure 2-10: In vitro ubiquitination of the S protein by Ubc4. (A) S peptide harbors a high affinity for the 
S protein, adopted from Bays et al.
74
 (B) Fluorescence scan of in vitro ubiquitination reactions involving Ubc4 and 
different untagged and S peptide-tagged RING domain variants. Asterisks mark unspecific signals. 
As described by Bays et al.74, Ubc4 decorated RNase S with up to two Ub moieties in 
such reactions. Considering the known catalytic properties of Ubc4, the observed 
modifications most likely represent mono-ubiquitination on multiple lysine residues78. 
Obviously, Ubc4-mediated ubiquitination was strictly dependent on the presence of 
the wild type Hrd1 RING domain. Even in presence of Hrd1 lacking the S peptide, a 
significant portion of the S protein was decorated with Ub (Fig. 2-10, lane 2). This 
activity probably results from random interactions of the proteins in solution. An 
S peptide-Hrd1R400 RING domain construct significantly increased ubiquitination on 
the S protein and caused a decrease of the unmodified form (Fig. 2-10, lane 3). S-
Hrd1R400H, which contains a histidine at the linchpin position, did not facilitate 
substrate ubiquitination implying that the activation of Ubc4 strictly depends on 
linchpin allostery (Fig. 2-10, lane 4). Remarkably, none of the S peptide-Doa10 RING 
constructs promoted ubiquitination of the S protein and hence this ligase seems 
unable to stimulate the activity of Ubc4 (Fig. 2-10, lanes 5-7). 
Next, Ubc7-mediated substrate modification was analyzed (Fig. 2-11). These 
experiments also contained Cue1WT to activate Ubc7 and to allow the synthesis of 
poly-Ub chains. 
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Figure 2-11: Ubc7-mediated in vitro substrate ubiquitination is Hrd1-dependent. Fluorescence scan of in 
vitro ubiquitination reactions involving Cue1
WT
/Ubc7 and different untagged and S peptide-tagged RING domain 
variants. Asterisks mark unspecific signals. 
Ubc7 weakly promoted chain formation on the S protein upon addition of the 
untagged Hrd1R400 RING domain (Fig. 2-11, lane 2), probably due to some unspecific 
association of the substrate with the RING construct and the E2. Specific recruitment 
of the RING domain via the S peptide increased the reactivity of Ubc7 towards the 
S protein (Fig. 2-11, lane 3). Substrate ubiquitination was largely dependent on the 
nature of the linchpin residue since the amount of ubiquitinated S protein was 
significantly lower in reactions containing S-Hrd1R400H (Fig. 2-11, lane 4). Again, there 
was no substrate modification observed in presence of Doa10 RING domain variants 
(Fig. 2-11, lanes 5-7).  
Taken together, in vitro ubiquitination of the S protein by Ubc7 required an arginine in 
the linchpin position of the Hrd1 RING domain. Given that Ub chain elongation is 
primarily accelerated by Cue1 (compare section 2.1.2.4), this indicates that the 
stimulation of Ubc7 by Hrd1 predominantly serves to facilitate the priming of 
substrates. Noteworthy, none of the Doa10 RING variants promoted ubiquitination by 
Ubc7. This result shows that the allosteric activation of Ubc7 by the linchpin residue 
relies on additional properties of the RING domain. 
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2.1.8 In vitro ubiquitination of proteins by Ubc6 does not require stimulation by 
a linchpin residue 
Ubc6 is stimulated in discharge assays by Hrd1 and Doa10 RING domain variants 
regardless of the residue at the linchpin position (compare section 2.1.2.2). Still, this 
does not exclude that the transfer of Ub onto a protein by Ubc6 depends on allosteric 
activation via the linchpin residue. Thus, ubiquitination of the S protein by Ubc6 was 
analyzed (Fig. 2-12). 
Figure 2-12: Ubc6-mediated in vitro substrate ubiquitination is linchpin-independent. Fluorescence scan of 
in vitro ubiquitination reactions involving Ubc6 and different untagged and S peptide-tagged RING domain 
variants. Asterisks mark unspecific signals. 
Ubc6 was shown to efficiently prime client proteins with Ub, but lacks the capacity to 
form Ub chains on these substrates20. Concordantly, Ubc6 readily attached single Ub 
moieties to the S protein in the in vitro assays. This process was equally efficient 
regardless of which RING domain variant was added. Obviously substrate 
modification by Ubc6 is not stimulated by linchpin allostery. Furthermore, the S 
peptide on the RING domain did not enhance substrate ubiquitination. These findings 
correlate with the inherent activity of Ubc6 to dispose Ub onto acceptor molecules 
even in the absence of a RING domain as observed in discharge assays. 
In summary, substrate ubiquitination by Ubc6 does not rely on the nature of the 
linchpin residue in a RING domain. Preliminary results suggest that this process does 
not require activation by a RING domain (data not shown). However, to draw more 
profound conclusions, the substrate ubiquitination assay needs to be further 
optimized to increase the client turnover rates and thereby improve the quality of the 
data. Moreover, an experiment lacking a RING domain construct should be 
performed to analyze any inherent activity of Ubc6 in substrate ubiquitination. 
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2.2 ERAD ligases exploit different strategies of priming and 
elongation to ensure efficient substrate degradation 
 
2.2.1 The linchpin residue in Hrd1 determines the degradation rate of client 
proteins 
After a thorough in vitro analysis, the effect of RING-mediated E2 stimulation was 
investigated in S. cerevisiae. The ERAD system was intensely studied in this model 
organism and specific substrates for the Doa10 and Hrd1 Ub ligase complexes have 
been identified. Of note, key players of the ERAD pathway are well-conserved in all 
eukaryotes79. 
To gain insight into the relevance of linchpin allostery on the function of Hrd1, the 
degradation of two model substrates showing different topology was analyzed. The 
soluble protein PrA* is derived from the vacuolar proteinase yscA (PrA), but lacks a 
short sequence encompassing the processing site and is therefore removed by Hrd1-
mediated ERAD from the ER lumen80. Conversely, HMG-CoA reductase (Hmg2) 
represents an integral enzyme of the ER membrane involved in sterol biosynthesis 
that is regulated by Hrd1-dependent proteolysis81. 
Pulse-chase assays were conducted to follow the degradation of these model 
substrates. To this end, PrA* and Hmg2 were fused to 3xHA and 6xMyc epitopes, 
respectively, to allow a specific enrichment during the procedure. PrA*-3xHA was 
expressed in yeast cells from plasmids, while the construct for Hmg2-6xMyc 
expression was stably integrated in the yeast genome and replaced the endogenous 
gene. Cells were provided with S35-radiolabeled amino acids which are incorporated 
into newly synthesized proteins. Subsequently, the cells were chased with unlabeled 
amino acids. Aliquots of the samples were removed at regular time points and cell 
lysates were prepared. HA- and Myc-tagged proteins were isolated by 
immunoprecipitation and the recovered material was visualized by autoradiography 
(Fig. 2-13 A, B). The amount of radiolabeled substrate was then quantified and 
plotted against the chase time (Fig. 2-13 C, D). The amount of recovered PrA*-3xHA 
rapidly decreased over time indicative for a fast turnover of this protein. In strains 
lacking Hrd1 (Δhrd1) substrate decay was heavily impaired and could be restored 
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with a plasmid expressing wild type Hrd1 (Hrd1R400). This demonstrates that PrA*-
3xHA is degraded via the Hrd1 Ub ligase. Similarly, Hmg2-6xMyc was degraded over 
time but this process was not exclusively dependent on Hrd1, since a significant loss 
of substrate could be observed even in cells lacking this ligase. 
Figure 2-13: Degradation at the HRD ligase is linchpin-dependent. Representative autoradiography scans 
following the degradation of (A) PrA*-3xHA and (B) Hmg2-6xMyc. The upper species in the PrA*-3xHA scan 
represents the full-length construct. The lower species most likely results from premature translation termination 
and represents a variant with less than three HA epitopes. (C, D) Radioactive signals were quantified and plotted 
over time. Error bars represent the standard deviation of mean of at least three independent experiments. 
Expression of appointed linchpin variants led to a gradual decrease in the turnover of 
both substrates. Remarkably, these results matched the effects observed in the 
Hrd1-stimulated Ubc7 discharge reactions (compare section 2.1.2.1). This implies 
that the nature of the linchpin residue affects protein degradation at the Hrd1 ligase 
irrespective of the topology of the substrate. Furthermore, these data suggest that 
Hrd1-mediated protein turnover mainly involves Ubc7. 
 
2.2.2 Turnover of Doa10 target proteins does not involve the linchpin position 
Doa10-mediated protein breakdown was analyzed by implementation of two Doa10 
model substrates. An engineered cytosolic protein composed of the Doa10 target 
region Deg1 and two copies of the enhanced green fluorescent protein (Deg1-
eGFP2)
82 was expressed from a plasmid in yeast cells. Deg1 constitutes a degron 
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derived from the yeast transcriptional repressor Matalpha2 which is partially down-
regulated by Doa10-mediated breakdown48,83. Therefore, fusion constructs 
containing Deg1 are degraded via the Doa10 pathway. In addition, an ER 
membrane-resident tail-anchored protein, which undergoes Doa10-dependent 
turnover, was studied. Sec61 β-subunit homologue 2 (Sbh2) is part of the trimeric 
Ssh1 (Sec61 homologue 1) translocon84. Unassembled Sbh2 subunits are rapidly 
removed via Doa10-mediated ubiquitination85. To increase the turnover of Sbh2, a 
FLAG epitope-marked version was expressed in yeast cells lacking its interaction 
partner Ssh1. 
Addition of cycloheximide (CHX) to the growth medium blocks the synthesis of new 
proteins. The fate of already translated proteins can be followed by analyzing their 
amount in samples taken at regular time points after CHX addition and subsequent 
immunoblotting with specific antibodies (Fig. 2-14 A, B). To facilitate quantitative 
analysis, fluorescently labeled secondary antibodies were used and the obtained 
data for proteins amounts were plotted as a function of time (Fig. 2-14 C, D) 
Figure 2-14: Degradation at the Doa10 ligase is linchpin-independent. Representative western blots following 
the decay of (A) Deg1-eGFP2 and (B) FLAG-Sbh2. In both cases, Cdc48 served as loading control. Assays 
involving FLAG-Sbh2 were performed in cells deleted for Ssh1 (Δssh1). (C, D) Signals detected via fluorescently-
labeled secondary antibodies were quantified and plotted over time. Error bars represent the standard deviation of 
mean of at least three independent experiments. 
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As seen in Figure 2-14, the amount of the Deg1-eGFP2 signal rapidly decreases over 
time, indicative of fast proteolysis of the protein. Deg1 degron-containing proteins are 
in part degraded by pathways other than the Doa10 ligase, because the deletion of 
the DOA10 gene (Δdoa10) did not fully abolish the turnover of Deg1-eGFP2. In 
contrast, FLAG-Sbh2 decay was completely blocked in cells lacking Doa10. 
Degradation of Deg1-eGFP2 and FLAG-Sbh2 was then investigated in yeast strains 
expressing Doa10 variants with different amino acids at the linchpin position from the 
endogenous chromosomal locus. Strikingly, none of the Doa10 constructs affected 
the turnover of these substrates indicating that the processing of Doa10 client 
proteins commences without the stimulation of E2 enzymes via linchpin allostery. 
 
2.2.3 The rate of Ub chain elongation does not restrict substrate degradation 
In section 2.1.2.4, Ubc7-mediated Ub chain elongation was analyzed in molecular 
detail. Since both the Hrd1 and the Doa10 ligase cooperate with this E2, the impact 
of chain elongation on target breakdown was monitored in yeast cells. To this end, 
strains were constructed that express Cue1RGA from the endogenous chromosomal 
locus or that completely lack Cue1 (Δcue1). In addition, different linchpin variants of 
Hrd1 or Doa10 were expressed in these cells. 
To determine the relevance of chain elongation at the Hrd1 ligase, the proteolytic 
breakdown of PrA*-3xHA and Hmg2-6xMyc was followed in pulse-chase experiments 
(Fig. 2-15). While cells deleted for CUE1 were unable to degrade these substrates 
(blue curves), cells expressing Cue1RGA (red curves) were not affected in this process 
compared to wild type cells (black curves). The Cue1RGA variant is impaired in Ub 
binding, but efficiently recruits Ubc7 to the Ub ligases in the ER membrane. 
Introduction of selected linchpin variants in these cells led to some variability during 
target turnover, but overall the decay of PrA*-3xHA and Hmg2-6xMyc followed the 
same pattern as observed in strains expressing the corresponding Hrd1 variants 
alone (compare Fig. 2-13). Since the CUE domain in Cue1 primarily serves to 
correctly align Ubc7 with growing Ub chains during poly-Ub synthesis, this indicates 
that the rate of chain elongation is not a limiting factor for the degradation of Hrd1 
client proteins. 
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Figure 2-15: Introduction of Cue1
RGA
 does not exacerbate the degradation defects of the Hrd1 linchpin 
variants. Representative autoradiography scans following the degradation of (A) PrA*-3xHA and (B) Hmg2-
6xMyc. The upper species in the PrA*-3xHA scan represents the full-length construct. The lower species most 
likely results from premature translation termination and represents a species with less than three HA epitopes. 
(C, D) Radioactive signals were quantified and plotted over time. Curves for Hrd1 linchpin variants (Hrd1
R400x
) 
correspond to experiments in a Cue1
RGA
 strain background. Error bars represent the standard deviation of mean 
of at least three independent experiments. 
The impact of Cue1RGA on the processing of Doa10 substrates was also analyzed 
(Fig. 2-16). Deletion of CUE1 only had a mild effect on Deg1-eGFP2 breakdown, 
probably because the turnover of this protein only partially commences via the Doa10 
ligase and the alternative degradation routes do not involve Cue1 function. In 
contrast, decay of FLAG-Sbh2 was completely abolished in absence of Cue1. 
Expression of the Cue1RGA variant did not affect the processing of either substrate. 
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Figure 2-16: Degradation of Doa10 client proteins does not depend on the CUE domain of Cue1. 
Representative western blots following the decay of (A) Deg1-eGFP2 and (B) FLAG-Sbh2. In both cases, Cdc48 
served as loading control. Assays involving FLAG-Sbh2 were performed in cells deleted for Ssh1 (Δssh1). (C, D) 
Signals detected via fluorescently-labeled secondary antibodies were quantified and plotted over time. Curves for 
Doa10 linchpin variants (Doa10
H94x
) correspond to experiments in Cue1
RGA
 strain background. Error bars 
represent the standard deviation of mean of at least three independent experiments. 
Also the expression of the Doa10 linchpin variants in the Cue1RGA cells did not cause 
significant changes in the turnover rates of Deg1-eGFP2 or FLAG-Sbh2. Thus, similar 
to the results obtained with the Hrd1 ligase, degradation of Doa10 client proteins is 
not restricted by the rate of poly-Ub synthesis on the targets. 
The impact of the Cue1RGA variant on substrate decay was negligible although the 
efficient formation of K48-linked Ub chains by Ubc7 is thought to constitute a 
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prerequisite for proteasomal degradation. Therefore, the activity of the Hrd1 and 
Doa10 ligases was examined in cells lacking Ubc7 (Fig. 2-17). 
Figure 2-17: Degradation of Hrd1 and Doa10 target proteins relies on Ubc7. Representative autoradiography 
scans following the degradation of (A) PrA*-3xHA and (B) Hmg2-6xMyc and representative western blots 
following the decay of (E) Deg1-eGFP2 and (F) FLAG-Sbh2. Experiments were performed in cells lacking Ubc7 
(Δubc7). Cdc48 served as loading control in CHX chase experiments. Assays involving FLAG-Sbh2 were 
performed in cells deleted for Ssh1 (Δssh1). Radioactive (C, D) as well as fluorescent (G, H) signals were 
quantified and plotted over time. Error bars represent the standard deviation of mean of at least three 
independent experiments. 
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As expected, the decay of almost all tested substrates was heavily impaired in cells 
deleted for UBC7 with the exception of Hmg2-6xMyc. In contrast to published data86, 
degradation of this protein was only marginally slower in absence of Ubc7. Yet, 
Hmg2-6Myc breakdown proceeded differently in cells expressing individual Hrd1 
RING linchpin variants indicating that also other E2 enzymes can initiate proteasomal 
degradation by synthesizing Ub chains onto this protein in a Hrd1-dependent 
manner. A promising candidate for this is Ubc4, since in vitro it could ubiquitinate a 
protein in a Hrd1-dependent manner and its activity in this assay was stimulated by 
linchpin allostery (compare Fig. 2-10). Degradation of the Hrd1 client protein, PrA*-
3xHA was completely abolished in cells lacking Ubc7. This suggests that Ub signals 
that may be generated by other E2 enzymes in absence of Ubc7 are not efficiently 
initializing proteasomal breakdown of Hrd1 target proteins. Most likely, the Hrd1 
ligase does not generally employ E2 enzymes other than Ubc7 to facilitate 
recognition of its substrates by the proteasome. The requirement of certain E2 
enzymes in substrate processing may also originate from the distinct topology of the 
targets. The cytosolically exposed parts of membrane-bound Hmg2 may be directly 
accessible to Ubc4, while ubiquitination of PrA* may predominantly occur on regions 
which are selectively exposed to Ubc7 during retrotranslocation. 
In summary, the rate of chain elongation seems to not constitute a limiting factor for 
the degradation of Hrd1 and Doa10 client proteins in vivo, even though the efficient 
synthesis of a K48-linked Ub signal on proteins is a prerequisite for proteasomal 
processing. 
 
2.2.4 Priming of proteins with Ub is a rate-limiting step for their degradation 
If chain elongation is not rate-limiting for substrate degradation, priming might be. 
Doa10 employs two E2 enzymes, Ubc6 and Ubc7, during substrate ubiquitination. 
Ubc6 first primes a target by attaching single Ub moieties which are then elongated 
to K48-linked poly-Ub chains by Ubc720,87. The impact of priming on substrate 
turnover at the Doa10 ligase was investigated in CHX decay assays (Fig. 2-18). 
In these experiments the deletion of UBC6 abolished the degradation of Deg1-eGFP2 
irrespective of the Doa10 RING variant supplied. This demonstrates that the priming 
of a Doa10 substrate with Ub moieties strictly relies on Ubc6. Even a Doa10 variant 
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exposing an arginine at the linchpin position, which significantly stimulated Ubc7 
activity in the in vitro discharge assays (compare section 2.1.2.1), did not bypass the 
requirement for Ubc6 in vivo. 
Degradation of FLAG-Sbh2 was not completely abolished in cells lacking Ubc6, 
indicating that this substrate can be primed by Ubc7 or other E2s. Still, degradation 
succeeded noticeably slower in Δubc6 than in wild type cells (compare Fig. 2-14). 
Expression of the Doa10 RING variants had no further impact on the turnover rate. 
Figure 2-18: Impaired substrate priming slows down degradation at the Doa10 ligase. Representative 
western blots following the decay of (A) Deg1-eGFP2 and (B) FLAG-Sbh2. Experiments were performed in cells 
lacking Ubc6 (Δubc6). Cdc48 served as loading control. Assays involving FLAG-Sbh2 were performed in cells 
deleted for Ssh1 (Δssh1). (C, D) Signals detected via fluorescently-labeled secondary antibodies were quantified 
and plotted over time. Error bars represent the standard deviation of mean of at least three independent 
experiments. 
In contrast to the Doa10 ligase, the exchange of the linchpin residue in the Hrd1 
RING affected substrate turnover. This most likely accounts for a reduced capability 
to stimulate the activity of Ubc7. Obviously, the activation of Ubc7 by a RING domain 
via linchpin allostery requires an arginine at the linchpin position. As revealed in the 
experiments employing the Cue1RGA mutant, the synthesis of K48-linked poly-Ub 
chains by Ubc7 seems to proceed fast enough to allow efficient substrate 
degradation even in the absence of an appropriate residue at the linchpin site. These 
results imply that the Hrd1 linchpin mutants should be less efficient to allow the 
Results  41 
priming of substrates with Ub by Ubc7. Therefore, the question arose whether target 
priming may be facilitated by another E2 apart from Ubc7 in cells harboring partially 
limited Hrd1 variants. Ubc6 is a priming enzyme which was stimulated by the Hrd1 
RING in vitro (compare Fig. 2-4) and was already implicated in the degradation of a 
Hrd1-dependent model substrate88. Accordingly, protein breakdown at the Hrd1 
ligase was analyzed in cells lacking Ubc6 (Fig. 2-19). 
Figure 2-19: Ubc6 facilitates priming at the HRD ligase when Ubc7 is incapable thereof. Representative 
autoradiography scans following the degradation of (A) PrA*-3xHA and (B) Hmg2-6xMyc. Experiments were 
performed in cells lacking Ubc6 (Δubc6). (C, D) Radioactive signals were quantified and plotted over time. Error 
bars represent the standard deviation of mean of at least three independent experiments. 
In cells lacking Hrd1, the deletion of UBC6 (Δubc6) did not delay substrate 
degradation further (blue curves, compare Fig. 2-13). Likewise, the turnover of the 
Hrd1 client proteins was not affected in wild type cells deleted for UBC6 alone (red 
curves). Remarkably, deletion of UBC6 in cells expressing the Hrd1 RING linchpin 
mutations substantially impaired the degradation of both model substrates. This 
implies that Ubc6 can decorate Hrd1 client proteins with Ub. In situations, where 
Hrd1 fully activates Ubc7 for the transfer of Ub directly onto target proteins, the Ubc6 
activity at Hrd1 does not significantly contribute to substrate turnover. However, once 
Hrd1 fails to stimulate Ubc7 activity, e.g. due to an exchange of the linchpin residue 
in the Hrd1 RING domain, Ubc6 activity promotes the degradation of at least a 
fraction of the Hrd1 client proteins. 
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Taken together, these results show that the attachment of the first Ub moiety to a 
protein, the so-called priming step, represents the rate-limiting event of the poly-
ubiquitination process. Subsequent elongation by the conjugation of additional Ub 
molecules is a prerequisite for proteasomal breakdown, but does not necessarily limit 
the rate of degradation. To meet different requirements for the priming and 
elongation reaction, ERAD ligases employ distinct mechanisms. Doa10 cooperates 
with specialized E2 enzymes for substrate priming (Ubc6) and for Ub chain 
elongation (Ubc7). In some instances, Ubc7 may also serve as a priming E2 at this 
ligase. The Hrd1 ligase utilizes a single E2, Ubc7, for priming and elongation. This 
ligase can activate Ubc7 via linchpin allostery to facilitate the conjugation of Ub 
directly to target proteins. Still, Ubc6 can also prime Hrd1 client proteins with Ub, 
although with significantly reduced efficiency. 
 
2.2.5 Hrd1 employs Ubc6 for non-canonical ubiquitination of client proteins 
In the early days of ERAD research, a mutant form of the vacuolar carboxypeptidase 
yscY (CPY) termed CPY* was established as a Hrd1 target80. A single point mutation 
(G255R) close to the catalytic center prevents the delivery of this protein to the 
vacuole and routes it to ERAD via Hrd1. More recently, a version of CPY* devoid of 
all lysine residues (CPY*_noK-HA) was also shown to be efficiently degraded via the 
Hrd1pathway89. 
In all experiments so far, Ubc7 fails to attach Ub to amino acid residues other than 
lysine. Therefore, priming of CPY*_noK-HA with Ub should involve the activity of 
another E2. Ubc6 was shown to ubiquitinate not only lysines, but also hydroxylated 
amino acids on client proteins20. Moreover, this E2 enzyme attaches Ub to Hrd1 
target proteins. Therefore, pulse chase assays were performed to investigate any 
involvement of Ubc6 in the turnover of CPY*_noK-HA (Fig. 2-20). 
Degradation of CPY*_noK-HA depended on Hrd1, because it was heavily impaired in 
Δhrd1 cells. Strikingly, Ubc6 was also strictly required for CPY*_noK-HA decay even 
in cells harboring wild type Hrd1 (Δubc6). Nonetheless, Doa10 was not involved in 
CPY*_noK-HA degradation. Cells deleted for DOA10 (Δdoa10) even displayed a 
slightly accelerated turnover rate compared to the wild type, maybe due to a lack of 
competition of Hrd1 and Doa10 for Ubc6 binding. Another experiment revealed that 
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the disposal of lysine-free CPY* is still dependent on Ubc7 (data not shown) 
suggesting that the degradation signal is built up by a cooperative effort of Ubc6 and 
Ubc7. Analogous to their activity at the Doa10 ligase, Ubc6 may prime the substrate 
with Ub before Ubc7 can form a chain on the first Ub moiety. 
 
 
 
 
 
 
 
Figure 2-20: Hrd1 employs Ubc6 for ubiquitination of a lysine-free substrate. (A) Representative 
autoradiography scan following the degradation of CPY*_noK-HA. (B) Radioactive signals were quantified and 
plotted over time. Error bars represent the standard deviation of mean of at least three independent experiments. 
In conclusion, Ubc6 and Ubc7 can initiate the degradation of Hrd1 target proteins by 
priming them with Ub. Still, most Hrd1 clients are not efficiently ubiquitinated by 
Ubc6. When the priming activity of Ubc7 is compromised or when substrates lack 
appropriate acceptor sites, the activity of Ubc6 suffices for the priming of at least a 
fraction of the Hrd1 substrates. This backup mechanism increases the flexibility of the 
ERAD system required to remove highly diverse misfolded proteins from cells and 
thereby prevent their cytotoxic accumulation. 
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2.3 Molecular analysis of the Asi complex at a glimpse 
 
2.3.1 Establishment of a novel Asi model substrate 
Up to this point, two different E3 ligases have been analyzed in molecular detail. 
Hrd1 harbors a canonical arginine at the linchpin position while Doa10 comprises an 
atypical histidine at this site. Recently, a third membrane-bound E3 ligase complex, 
termed the Asi complex, has been described in yeast. This ligase is involved in 
quality control at the inner nuclear membrane and the nucleus50,51,56,57. Two subunits 
of this complex expose nucleoplasmic domains containing a RING fold at their very 
C-terminus. Interestingly, the Asi1 RING harbors an arginine while the Asi3 RING 
holds an aspartate at the linchpin position. This unusual setup raised the question, 
how each of these different RING domains contributes to the ubiquitination reaction 
of the E3 ligase complex. 
To address this issue, a novel Asi-dependent model substrate was constructed. 
Amongst others, the Asi complex regulates the activity of transcription factors Stp1 
and Stp250,51. A region in Stp1 comprising amino acids 16-50 has been identified as 
an Asi-dependent degron55. To analyze the ability of this degron to direct proteins to 
the Asi complex, Stp116-50 was fused to a triple HA epitope tag attached to the stable 
―superfolder green fluorescent protein‖ (sfGFP-3xHA)90. Degradation of plasmid-
borne sfGFP-3xHA or the sfGFP construct containing the Stp1 degron (Stp1-sfGFP-
3xHA) was monitored in wild type yeast by CHX decay assays (Fig. 2-21). 
Noteworthy, the fusion of the Stp1 degron to sfGFP induced rapid removal of the 
otherwise stable protein from the cell. 
Figure 2-21: sfGFP is rapidly degraded after fusion to the Stp1 degron. (A) Representative western blot 
following the decay of two versions of sfGFP. Cdc48 served as a loading control. (B) Signals detected via 
fluorescently-labeled secondary antibodies were quantified and plotted over time. Error bars represent the 
standard deviation of mean of at least three independent experiments. 
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2.3.2 Each Asi subunit directly contributes to the function of the complex 
To test if the Asi complex is involved in the degradation of Stp1-sfGFP-3xHA, CHX 
decay assays were performed. In these experiments, the turnover of another Asi 
target that adopts a different cellular topology was also investigated. The amount of 
lanosterol 14-α-demethylase (Erg11), a membrane-bound enzyme of the inner 
nucleus involved in ergosterol biosynthesis91, has been shown to be subject to Asi-
mediated regulation56. A construct for the expression of Erg11 harboring a triple HA 
epitope tag was integrated into the genomic locus of the ERG11 gene to allow 
detection via immunoblotting. CHX chase assays in cells lacking single Asi subunits 
are shown below (Fig. 2-22). 
Figure 2-22: All Asi subunits contribute to the function of the complex. Representative western blots 
following the decay of (A) Stp1
16-50
-sfGFP-3xHA and (B) Erg11-3xHA. Cdc48 and GAPDH served as loading 
controls, respectively. (C, D) Signals detected via fluorescently-labeled secondary antibodies were quantified and 
plotted over time. Error bars represent the standard deviation of mean of at least three independent experiments. 
Stp1-sfGFP-3xHA and Erg11-3xHA were efficiently degraded in wild type yeast 
whereas cells lacking any component of the Asi complex displayed defects in their 
processing. This shows that both proteins constitute substrates of the Asi complex 
and that each Asi subunit contributes to their degradation. 
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2.3.3 The subunits of the Asi complex are tightly associated 
Removal of individual subunits may cause the dissociation of the Asi complex and 
thereby indirectly affect substrate processing. Thus, binding of the Asi proteins to the 
complex was analyzed. To this end, plasmids that encode epitope-tagged versions of 
each component of the Asi complex were generated. Because the Asi proteins are 
probably synthesized with an amino-terminal signal sequence that targets them to the 
inner nuclear membrane, constructs for 3xHA, 3xMyc, or 3xFLAG epitope tags were 
inserted 30 codons downstream of the start codons of the ASI genes. These 
plasmids were then transformed into yeast cells deleted for the endogenous copies of 
all ASI genes. Non-denaturing immunoprecipitation (IP) using antibody-conjugated 
magnetic beads then allowed the isolation of individual subunits of the Asi complex 
and the associated partner proteins (Fig. 2-23). 
IPs were performed for the purification of 3xHA-Asi1 (Fig. 2-23 A), 3xMyc-Asi2 (Fig. 
2-23 B) or 3xFLAG-Asi3 (Fig. 2-23 C) and the retrieved material was analyzed by 
immunoblotting. The relative amount of the epitope tagged Asi proteins slightly varied 
in the samples, probably due to aberrations of the plasmid copy numbers in these 
cells. None of the Asi proteins unspecifically bound to the beads (first lane of Fig. 2-
23 IP blots). Moreover, each Asi protein was co-purified with the other Asi subunits 
(last lane of each IP blot). In absence of the other subunits all Asi proteins were 
efficiently expressed and enriched in the pull-down experiments (lane 2 of Fig. 2-23 
IP blots). This suggests that the Asi proteins constitute stable proteins even when the 
formation of the ligase is impaired and that unassembled complex partners are not 
necessarily removed by a cellular protein quality control pathway as previously 
described92,93. Remarkably, all Asi proteins were co-purified with any other subunit in 
absence of the third component (lanes 3 and 4 of each IP blot). This implies that 
each subunit of the Asi complex individually forms tight interactions with the other two 
elements. 
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Figure 2-23: Tight binding of the subunits of the Asi complex. Representative blots of IP experiments 
enriched for (A) 3xHA-Asi1, (B) 3xMyc-Asi2 or (C) 3xFLAG-Asi3. Experiments were performed in cells deleted for 
all Asi complex proteins (Δasi1/Δasi2/Δasi3). 
Taken together, these data show that the defects in substrate breakdown observed in 
the deletion mutants (compare Fig. 2-22) are not caused by an overall inability to 
form a functional complex, but rather indicate the requirement of still elusive functions 
administered by every single subunit of the complex. 
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2.3.4 Binding of the Asi subunits involves their nucleoplasmic domains 
In the near future, in vitro ubiquitination assays need to be established to analyze the 
Asi complex in molecular detail. A prerequisite for a functional assay is the interaction 
of the soluble nucleoplasmic domains. If binding is primarily mediated by the 
transmembrane regions, the addition of dimerization domains needs to be considered 
during expression construct design94. Accordingly, the interaction interfaces of the 
complex proteins were mapped. To this end, truncation constructs of every subunit 
were created and analyzed for their interaction with the remaining complex subunits. 
First, IP experiments using various constructs of Asi1 consisting of either 
transmembrane or nucleoplasmic sections were conducted (Fig. 2-24). 
Asi1 truncation variants (Fig. 2-24 A) were expressed from plasmids along with 
epitope tagged full-length Asi2 and Asi3 in cells deleted for all ASI genes. The N-
terminal half of Asi1 encompasses several membrane-spanning regions while the C-
terminal part comprises a large soluble domain exposed to the nucleoplasm. While 
constructs spanning different parts of the transmembrane region should still localize 
to the inner nuclear membrane due to their inherent N-terminal signal sequence, 
constructs harboring fragments of the nucleoplasmic domain were fused to the 
nuclear localization sequence of the simian virus 40 large T antigen (SV40 NLS)95 to 
direct them to the compartment of interest. Unfortunately, nucleoplasmic constructs 
could neither be detected in the input nor after immunoprecipitation showing that 
expression of these was not successful in yeast (Fig. 2-24 B). Nevertheless, 
constructs covering the Asi1 transmembrane region were stably expressed and 
efficiently enriched during the IP procedure. While full-length Asi1 efficiently co-
immunoprecipitated Asi2 and Asi3, the fragments comprising the N-terminal 99 or 
199 amino acids of Asi1 displayed no detectable interaction with the remaining 
complex partners. Solely, the construct spanning the first 299 amino acids of the 
protein maintained a weak affinity for Asi2 suggesting that part of the interaction 
interface between Asi1 and Asi2 is located in the C-terminal fraction of the Asi1 
transmembrane region. However, the amount of precipitated Asi2 was diminished in 
comparison to full-length Asi1 and Asi3 was not enriched at all using any of the 
transmembrane fragments. This indicates that binding of the other complex subunits 
to Asi1 is mainly facilitated by its nucleoplasmic portion. 
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Figure 2-24: Asi1 shows only weak interactions with other complex partners through its transmembrane 
region. (A) Schematic presentations of the domain structure of full-length Asi1 and the created truncation 
constructs. Domain assignment was conducted using the UniProt
96
 Asi1 entry (#P54074) (B) Shown are 
representative blots of IP experiments enriched for 3xHA-tagged Asi1 constructs of varying length. Experiments 
were performed in cells deleted for all Asi complex proteins (Δasi1/Δasi2/Δasi3). 
Next, 3xMyc-tagged Asi2 truncation variants were created and analyzed for their 
ability to pull down the remaining complex partners. Experiments were performed as 
before for Asi1 in cells deleted for all Asi subunits and rescued with plasmids 
expressing different variants of Asi2 in addition to full-length Asi1 and Asi3 proteins 
(Fig. 2-25). 
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Figure 2-25: Interactions between Asi2 and other subunits are governed by its C-terminal region.             
(A) Schematic presentations of the domain structure of full-length Asi2 and the created truncation constructs. 
Domain assignment was conducted using the UniProt
96
 Asi2 entry (#P53895) (B) Shown are representative blots 
of IP experiments enriched for 3xMyc-tagged Asi2 constructs of varying length. Experiments were performed in 
cells deleted for all Asi complex proteins (Δasi1/Δasi2/Δasi3). 
Although the expression of the transformed Asi2 constructs could not be detected on 
input blots, luckily the full-length protein and some truncated variants were enriched 
after IPs directed against the 3xMyc epitope. Asi1 and Asi3 could only be co-
immunoprecipitated using full-length Asi2 and constructs harboring its C-terminal part 
made up of the last transmembrane helix and a short nucleoplasmic tail. Interestingly, 
precipitated amounts of Asi1 and Asi3 using those fragments were increased 
compared to full-length Asi2, suggestive of a tight interaction in this region. 
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Thirdly, IP experiments using 3xFLAG epitope-marked Asi3 truncation variants were 
performed just as before for Asi1 and Asi2 to map specific interactions to 
corresponding regions of the Asi3 subunit (Fig. 2-26). 
Figure 2-26: Asi3 mainly interacts with other complex partners through its nucleoplasmic portion.          
(A) Schematic presentations of the domain structure of full-length Asi3 and the created truncation constructs. 
Domain assignment was conducted using the UniProt
96
 Asi3 entry (#P53983) (B) Shown are representative blots 
of IP experiments enriched for 3xFLAG-tagged Asi3 constructs of varying length. Experiments were performed in 
cells deleted for all Asi complex proteins (Δasi1/Δasi2/Δasi3). 
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In contrast to Asi1, expression of the transmembrane constructs failed while the 
soluble fragments were produced as seen on the input blot (Fig. 2-26 B). Pull-downs 
of Asi1 and Asi2 were readily visualized, even though immunoprecipitated Asi3 
constructs were only partially detected. Observed interactions between the utilized 
constructs and the remaining Asi complex partners were clearly mapped to the 
nucleoplasmic region of Asi3. A fragment spanning the C-terminal 176 amino acids 
co-immunoprecipitated the whole complex, while further truncation resulted in 
reduced interaction, suggesting that the minimal interaction motif comprises the last 
76 up to 176 amino acids. 
All in all, the observed intermolecular interactions building up the Asi complex were 
mainly mapped to the nucleoplasmic regions of the Asi subunits. This is strongly 
supported by the incapability of Asi1 transmembrane constructs to bind partner 
proteins and by the strong enrichment of Asi complex subunits when soluble Asi3 
fragments were used. Since it is rather unlikely to observe tight interactions between 
soluble and transmembrane domains, the detected interactions between the C-
terminal part of Asi2 and its interaction partners might be mediated by the short 
nucleoplasmic tail of Asi2 rather than the two transmembrane helices. This 
interaction mapping experiment provides first insights into Asi complex architecture 
and may be used in future experiments to design constructs suitable for in vitro 
ubiquitination studies involving the Asi complex. 
 
2.3.5 The Asi complex employs Ubc4 and Ubc7 for ubiquitination 
Another prerequisite for the establishment of in vitro ubiquitination assays is the 
knowledge on the E2 enzymes that cooperate with an E3 ligase. Previous studies 
indicated a physical and functional interaction of the Asi complex with the E2s Ubc4, 
Ubc6 and Ubc756,57. In this thesis, this was re-evaluated by studying the degradation 
of the model substrates Erg11-3xHA and Stp1-sfGFP-3xHA. CHX chase assays in 
cells lacking Ubc4 (Δubc4), Ubc6 (Δubc6), Ubc7 (Δubc7) or appointed combinations 
thereof were performed (Fig. 2-27). 
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Figure 2-27: The Asi complex mainly cooperates with Ubc4 and Ubc7. Representative western blots following 
the decay of (A) Stp1
16-50
-sfGFP-3xHA and (B) Erg11-3xHA. Cdc48 and GAPDH served as loading controls, 
respectively. (C, D) Signals detected via fluorescently-labeled secondary antibodies were quantified and plotted 
over time. Error bars represent the standard deviation of mean of at least three independent experiments. 
In these experiments, Ubc4 and Ubc7 were strictly required for the turnover of Stp1-
sfGFP-3xHA. The combined deletion of both genes did not cause additive effects 
suggesting that Ubc4 and Ubc7 operate in the same pathway for Stp1-sfGFP-3xHA 
ubiquitination. Noteworthy, Ubc6 did not contribute to the removal of the soluble Asi 
target. Degradation of Erg11-3xHA was only moderately affected by single E2 
deletions. Simultaneous knockouts of Ubc6 and Ubc7 did not impair the target 
turnover beyond the level observed in the single mutants. The yeast strain deleted for 
UBC4 and UBC7 displayed the most pronounced defect in client removal. However, 
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in contrast to Stp1-sfGFP-3xHA, an additive effect compared to single knockouts was 
detected for the turnover of the membrane-bound Erg11-3xHA protein. This indicates 
that Ubc4 and Ubc7 act in separate pathways to degrade Erg11. A similar 
observation was made by Foresti et al.56, even though they found Erg11 to be 
completely stable in cells lacking Ubc4 and Ubc7. 
In summary, the presented data show a functional requirement of Ubc4 and Ubc7 for 
the removal of Asi complex client proteins, while Ubc6 seems to be mostly 
dispensable for this process. 
 
2.3.6 Degradation of Asi client proteins involves both RING domains and a 
correctly situated linchpin residue 
The contribution of the Asi1 and Asi3 RING domains to ligase function was analyzed 
by studying substrate degradation in cells expressing mutated versions of these 
proteins. Asi1 variants were expressed from plasmids in cells deleted for the ASI1 
gene (Δasi1) and the turnover of Stp1-sfGFP-3xHA or Erg11-3xHA was determined 
in CHX decay assays (Fig. 2-28). Plasmid-encoded Asi1WT at least partially rescued 
degradation of Stp1-sfGFP-3xHA and Erg11-3xHA in ASI1-deleted cells (compare 
Fig. 2-22). 
Following this, two mutated versions of Asi1 were assayed for their ability to 
complement the ASI1 deletion. Asi1CC583/585SS harbors serine residues at the position 
of two cysteines, which contribute to the coordination of Zinc within the RING domain, 
and hence this protein should be inactive for E3 ligase function. Concordantly, 
expression of this variant did not promote the degradation of Stp1-sfGFP-3xHA and 
Erg11-3xHA in the Δasi1 strain background. In Asi1R608D, the arginine in the linchpin 
position of the Asi1 RING domain was substituted with the aspartate which is found in 
the corresponding site in Asi3. This single amino acid exchange also fully impaired 
the activity of the Asi complex demonstrating a function of the Asi1 linchpin residue in 
substrate processing. 
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Figure 2-28: Substrate processing by the complex involves an activating residue at the linchpin position 
of the Asi1 RING domain. Representative western blots following the decay of (A) Stp1
16-50
-sfGFP-3xHA and (B) 
Erg11-3xHA. Cdc48 and GAPDH served as loading controls, respectively. Experiments were performed in cells 
deleted for Asi1 (Δasi1). (C, D) Signals detected via fluorescently-labeled secondary antibodies were quantified 
and plotted over time. Error bars represent the standard deviation of mean of at least three independent 
experiments. 
Analogous RING domain variants of the Asi3 protein were expressed in cells lacking 
endogenous Asi3 and the degradation of client proteins was monitored in CHX chase 
assays (Fig. 2-29). While plasmid-encoded wild type Asi3 efficiently restored Erg11-
3xHA degradation in Δasi3 cell, the amount of Stp1-sfGFP-3xHA apparently did not 
decrease over time in these cells. However, the steady state level of Stp1-sfGFP-
3xHA was substantially reduced upon expression of Asi3 compared to cells lacking 
this complex subunit (see inset in Fig. 2-29 C for quantification) indicating that this 
Asi3 construct was at least partly functional. Turnover of both substrates was 
impaired in cells expressing an Asi3 variant harboring replacements of cysteine 
residues in the RING domain (Asi3CC624/627SS). Interestingly, the substitution of the 
aspartate residue at the Asi3 linchpin position with an arginine (Asi3D664R) fully 
complemented the degradation defect of the ASI3-deleted yeast strain. This indicates 
that substrate processing by the Asi complex does not depend on the nature of the 
amino acid in the Asi3 RING linchpin position. Therefore it can be concluded that this 
RING domain does not stimulate the activity of an E2 enzyme via linchpin allostery. 
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Figure 2-29: The function of the Asi complex does not depend on an activating amino acid in the linchpin 
position of the Asi3 RING domain. Representative western blots following the decay of (A) Stp1
16-50
-sfGFP-
3xHA and (B) Erg11-3xHA. Cdc48 and GAPDH served as loading controls, respectively. Experiments were 
performed in cells deleted for Asi3 (Δasi3). (C, D) Signals detected via fluorescently-labeled secondary antibodies 
were quantified and plotted over time. Error bars represent the standard deviation of mean of at least three 
independent experiments. 
Next, it was tested if the introduction of a potent linchpin in the Asi3 RING domain 
could rescue the defect observed for an Asi1 variant incapable of providing linchpin 
allostery (Fig. 2-30). The expression of wild type Asi1 and Asi3 constructs rescued 
the deletion of both genes as determined by comparing steady state levels and 
degradation kinetics of Stp1-sfGFP-3xHA and Erg11-3xHA. Notably, an Asi1 variant 
harboring an aspartate in the linchpin position in combination with a version of Asi3 
containing an arginine at the corresponding site rendered the complex inactive 
towards substrate degradation. Thus, the allosteric activation of an E2 enzyme by 
Asi1 probably relies on additional properties of the RING domain aside from the 
appropriate amino acid in the linchpin position. 
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Figure 2-30: Linchpin allostery needs to be conferred by the Asi1 RING domain. Representative western 
blots following the decay of (A) Stp1
16-50
-sfGFP-3xHA and (B) Erg11-3xHA. Cdc48 and GAPDH served as loading 
controls, respectively. Experiments were performed in cells deleted for Asi1 and Asi3 (Δasi1/Δasi3). (C, D) 
Signals detected via fluorescently-labeled secondary antibodies were quantified and plotted over time. Error bars 
represent the standard deviation of mean of at least three independent experiments. 
In summary, it has been shown that Asi complex client removal strictly requires two 
functionally folded RINGs. Furthermore, linchpin allostery is a prerequisite for efficient 
target turnover. Interestingly, the location of the linchpin is of utter importance since it 
was observed that only a linchpin-harboring Asi1 RING induces substrate 
degradation while the Asi3 RING is not able to provide linchpin allostery. A possible 
model accommodating the presented findings could be one where in a fully functional 
Asi complex Asi3 recruits cooperating E2 enzymes via its RING domain which are 
then passed over to the Asi1 RING domain for stimulation of their inherent activity. 
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3. Discussion 
In all eukaryotic cells a quality control process termed ―endoplasmic reticulum-
associated protein degradation‖ (ERAD) removes misfolded polypeptides from the 
secretory pathway and thereby ensures maintenance of protein homeostasis. Central 
to ERAD are the Hrd1 and Doa10 Ub ligases. Although Hrd1 and Doa10 target 
different sets of clients, they both employ the Ub conjugating enzymes Ubc6 and 
Ubc7. Strikingly though, Doa10 and Hrd1 display fundamental differences in how 
they cooperate with these E2 enzymes33,48,88,97. At the Doa10 ligase, ubiquitination of 
most substrates requires the initial attachment of single Ub moieties by Ubc6 which 
are then elongated to lysine 48-linked poly-Ub chains by Ubc720. Contrarily, Ubc7 
alone suffices for the efficient processing of the majority of Hrd1 client proteins. 
Recently, another membrane-embedded Ub ligase, termed the Asi complex, was 
shown to be involved in maintaining protein homeostasis at the inner nuclear 
membrane and in the nucleus50,51. Aside from Ubc7, this ligase also seems to 
cooperate with Ubc4 and Ubc656,57. Remarkably, the Asi complex harbors two closely 
related, yet different, RING-finger proteins but their contribution to substrate 
processing is unclear. 
The aim of this study was to investigate how the ERAD RING-finger ligases Hrd1 and 
Doa10 stimulate the activity of their cognate E2 enzymes Ubc6 and Ubc7. Of 
particular interest were the impact of linchpin allostery and other interactions of the 
RING-finger domain with Ub on this process. Via these contacts the RING drives an 
E2~Ub conjugate into a closed conformation thereby facilitating the transfer of Ub 
onto a client. The RING-finger domains of Hrd1 and Doa10 harbor different amino 
acid residues at their linchpin positions and this work shows that both enzymes 
appear to stimulate their cognate E2 enzymes in a slightly diverse manner. 
Consequently, the Doa10 and Hrd1 ligases follow different approaches to mediate 
efficient poly-ubiquitination of client proteins.  Doa10 employs distinct E2 enzymes for 
the priming and elongation steps during poly-Ub formation while Hrd1 is capable of 
stimulating Ubc7 activity via linchpin allostery for both reactions. Moreover, this work 
revealed that both RING-finger proteins in the Asi complex are required for substrate 
processing and that each of them also appears to activate E2 enzymes in different 
ways. 
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In summary, this thesis demonstrates that individual RING-finger ligases stimulate 
their cognate E2 enzymes via different mechanisms. This most likely accounts for 
divergent strategies to meet the distinct requirements of individual steps during the 
poly-ubiquitination reaction or of particular biological processes. 
 
3.1 Differential stimulation of Ubc6 and Ubc7 by the Hrd1 and Doa10 
RING-finger domains 
 
3.1.1 Different stimulation of Ubc6 and Ubc7 activity by linchpin allostery 
In absence of a RING-finger domain, Ubc7 was rather inactive for the transfer Ub to 
targets in the in vitro discharge assays. The addition of such a stimulating cofactor 
significantly increased the activity of the E2 enzyme. However, this stimulatory effect 
strictly relied on an appropriate amino acid in the linchpin position of the RING 
domains. While an arginine residue at this site in the Hrd1 RING-finger was 
absolutely mandatory for full activation, the Doa10 RING domain proved to be more 
flexible. Here, an arginine or histidine at the linchpin position displayed similar 
stimulatory effects on Ubc7. This suggests that the activation of an E2 enzyme by the 
Hrd1 RING mainly occurs via linchpin allostery while an additional mechanism 
supports the stimulation of E2 enzymes by the Doa10 RING-finger. 
The deployment of a non-canonical histidine residue at the linchpin position of the 
Doa10 RING domain may be related to its tight functional interplay with Ubc6. This 
E2 enzyme was already quite reactive in reactions lacking a RING-finger domain and 
the stimulation of its activity by a RING did not involve the linchpin residue. 
Interestingly, the human Doa10 homologue MARCH6 harbors a lysine residue at its 
linchpin site. This suggests that linchpin allostery is involved in the activation of its 
cognate E2 enzyme UBE2J2, a homologue of Ubc698. Although Ubc6 and UBE2J2 
share similar catalytic properties20, we lack detailed knowledge on how the human E2 
enzyme is stimulated by its Ub ligase. The activation of UBE2J2 might rely on 
linchpin allostery, which explains why the MARCH6 RING domain harbors a 
canonical lysine residue at this site. Still, further studies are required to analyze the 
functional interplay of UBE2J2 and MARCH6 in more detail. 
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Several other yeast E3 RING-finger ligases expose non-canonical amino acids at 
their linchpin sites. These enzymes are often associated with processes that do not 
involve the formation of a Ub chain. Hence, the inability of certain RING-finger Ub 
ligases to stimulate the activity of their E2 enzymes via linchpin allostery may prevent 
the formation of Ub chains and facilitate the generation of mono-Ub signals on their 
client proteins. Mono-ubiquitination of histone H2B involves the Rad6 ubiquitin 
conjugating enzyme and the Bre1 RING-finger ligase. This Ub signal specifically 
initiates the methylation of histone H3 which in turn is associated with active 
chromatin99,100. When associated with the E3 enzyme Rad18, Rad6 facilitates the 
mono-ubiquitination of PCNA101. Interestingly, Bre1 and Rad18 harbor non-canonical 
asparagine and leucine residues at their corresponding linchpin positions. Importantly 
though, Rad6 is proficient to catalyze the formation of poly-Ub when associated with 
other E3 enzymes102. 
Recycling of the cargo receptor Pex5 after peroxisomal import is triggered by mono-
ubiquitination103. This is facilitated by the E2 enzyme Pex4 in concert with the RING-
finger ligase Pex12. Pex12 harbors an alanine at its linchpin position, which may 
again represent an adaptation to avoid the poly-ubiquitination of the Pex5 protein. 
In another context, the stimulation of E2 activity via linchpin allostery may also be 
counterproductive for the function of a ubiquitinating enzyme. Structural work 
revealed that RBR-type Ub ligases actively force their cognate E2 enzymes into an 
open state to favor the transfer of Ub onto the cysteine of the catalytic active RING2 
domain and prevent direct ubiquitination of substrates104. In line with this, the RING-
finger domains in RBR enzymes do not contain appropriate amino acids at their 
linchpin positions that are capable of facilitating stimulation of E2 enzymes by 
linchpin allostery. 
The Doa10 RING-finger ligase does not contain a canonical linchpin residue for the 
activation of E2 enzymes. This ligase employs the specialized E2 enzyme Ubc6 in 
the priming step. This E2 does not require activation via linchpin allostery for its 
function. However, the activity of Ubc6 apparently must be regulated because a 
Doa10 RING-finger variant harboring a stimulating canonical arginine at its linchpin 
site affects the processing of client proteins. 
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3.1.2 RING/Ub contacts contribute to E2 stimulation 
The stimulation of the catalytic activity of Ubc6, independent of linchpin allostery, 
indicated a second, so far unknown mechanism for the activation of this enzyme by a 
RING-finger protein. This work unraveled that binding of the RING to the Ub moiety in 
the Ubc6~Ub conjugate contributes to stimulate the transfer of Ub. Those contacts 
seemed to stabilize a closed conformation of the E2 enzyme and to enhance its 
inherent activity. The contact sites map to a non-conserved loop region in the Doa10 
RING-finger. This suggests that Doa10 stimulates the activity via a novel and so far 
uncharacterized mechanism (Fig. 3-1). 
 
 
 
 
 
 
 
 
 
Figure 3-1: A non-conserved, yet dedicated loop in Doa10 mediates interaction with Ub. Shown is a rigid 
body model of Doa10 RING/Ubc6~Ub complex primed for catalysis. The model is based on PDB: 4AP4. Putative 
contacts between Doa10 and Ub are colored in cyan. The figure was adopted from Dr. Tobias Ritterhoff. 
Contacts of the RING-finger domain with Ub were particularly prominent in the NMR 
samples containing Doa10 and the Ubc6~Ub conjugate, but also in the other 
experimental setups such interactions were readily observed. Previous work reports 
on other contacts of RING-finger domains with Ub in E2~Ub conjugates, indicating 
that such interactions are generally involved in the stimulation of ubiquitin conjugating 
enzymes60,71,105. Still, some RING-finger domains do not expose apparent Ub-
interacting elements58. 
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Additional work will reveal the detailed mechanisms of how the contacts of a RING-
finger domain to Ub in the E2~Ub conjugates accelerates the ubiquitination reaction. 
This requires the thorough investigation of appropriate RING variants that are 
specifically impaired in the establishment of such interactions. 
 
3.1.3 Stimulation of E2 enzymes by the RING-finger is mainly required for early 
steps in Ub chain synthesis 
The analysis of Ubc7 function during the formation of K48-linked poly-Ub allowed a 
detailed look on the requirements for the individual steps in this reaction. The first 
attachment of Ub on another Ub molecule, which gives rise to a di-Ub species, 
clearly required stimulation of Ubc7 by a RING-finger domain. The subsequent steps 
in this process were also accelerated by the RING, however to a lesser degree. 
Consequently, the impact of the RING domain on the elongation reaction declines 
and the binding of Ubc7 to the poly-Ub chain via Cue1 becomes the more important 
factor. Thus, the catalytic stimulation of E2 enzymes by E3 ligases seems to primarily 
support the priming of client proteins and early events during the Ub chain 
elongation, but does not necessarily contribute to the formation of longer poly-Ub 
molecules. Those results are in line with previous studies describing the Cue1/Ubc7 
chain elongation system as a self-accelerating machinery which requires di-ubiquitin 
as a minimal substrate for the binding to Cue141,42. Cue1 positions Ubc7 on poly-Ub 
and thereby facilitates the addition of more Ub molecules. The CUE domain of Cue1 
only weakly binds to the Ub chains, which allows a dynamic sliding of the Cue1/Ubc7 
complex along a growing poly-Ub molecule. A slightly higher binding affinity for the 
penultimate Ub moiety in a chain suffices to place Ubc7 preferentially at the tip of the 
chain and thereby substantially increases the chance for the attachment of another 
Ub moiety. A more recent study demonstrated the structural flexibility of K48-linked 
poly-Ub73. Cue1 appears to actively select for open conformations within these 
molecules that allow a perfect positioning of Ubc7. 
The results from the discharge and chain elongation assays were directly confirmed 
in a reconstituted in vitro ubiquitination assay. Again, the formation of a poly-Ub 
signal on a reporter protein by Ubc7 was strongly enhanced when the Hrd1 RING-
finger construct contained a canonical arginine at its linchpin position. Neither a Hrd1 
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RING construct harboring a histidine at this site nor any of the tested Doa10 RING-
finger variants facilitated poly-ubiquitination of the substrate. This implies that the 
transfer of Ub from Ubc7 to a client protein is substantially stimulated by linchpin 
allostery via the Hrd1 RING-finger domain. Although Doa10 can activate Ubc7 via the 
linchpin residue, this does not suffice to allow the priming of a substrate with Ub. 
 
3.1.4 A refined model describing RING-mediated E2 stimulation 
The results of this work allow a refinement of our current ideas on RING-finger-
mediated stimulation of E2 activity (Fig. 3-2). This new ―four-point-interaction model‖ 
describes, how distinct contacts of a RING-finger domain to an E2~Ub conjugate 
stabilize closed conformations of the intermediate and thereby trigger the transfer of 
Ub. 
In Ubc7~Ub conjugates, the position of the Ub moiety is highly flexible. Binding of this 
intermediate by a RING-finger allows the interaction with an appropriate amino acid 
in the linchpin position, which restricts the movement of Ub and drives the Ubc7~Ub 
conjugate into a more closed conformation. Contacts of Ub with the E2 and the RING 
domain then further stabilize this compact configuration and thereby support the 
transfer of Ub to client proteins. 
In contrast, the Ubc6~Ub conjugate inherently adopts a more closed conformation. 
The interaction of the RING-finger domain with Ub in the intermediate induces only 
minor changes, which slightly increases the stability of the reactive conformation. 
Linchpin allostery is not necessary for the stabilization of the Ubc6~Ub intermediate. 
In consequence, the association with a RING-finger domain only weakly stimulates 
the catalytic activity of Ubc6. 
This model serves as a general draft of how RING-finger Ub ligases stimulate the 
catalytic activity of associated E2 enzymes. Other pairs of E2 enzymes and RING-
finger proteins may employ only some aspects of the presented model to obtain a 
closed conformation of the E2~Ub intermediate. Under certain circumstances, the 
excessive stimulation of an E2 enzyme may counteract its cellular function. Thus, 
individual RING-finger ligases most likely have adapted their mode of E2 activation to 
the general requirements of the biological process they are involved in. 
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Figure 3-2: Four-point-interaction model for RING-mediated E2 stimulation. E2/RING binding, linchpin 
allostery, Ub/E2 interaction and Ub/RING contacts contribute to the stabilization of closed E2~Ub conjugate 
conformations that actively promote Ub transfer. The figure was adopted from Dr. Tobias Ritterhoff. 
 
3.2 ERAD ligases employ different strategies in the priming and 
elongation reactions 
 
3.2.1 ERAD ligases display different requirements regarding linchpin allostery 
Processing of Hrd1 client proteins relies on particular amino acids in the linchpin 
position of the RING-finger domain, whereas the nature of the linchpin residue is not 
important for the degradation of Doa10 targets. This difference is correlated with 
diverging strategies for the priming of substrates with Ub. Still, both E3 ligase 
complexes employ Ubc7 for Ub chain formation. Unexpectedly, changes in the CUE 
domain of Cue1, which specifically impaired the elongation of Ub chains in vitro, did 
not generally affect the turnover of ERAD substrates in vivo. 
However, this may not apply to all ERAD substrates. In yeast cells, Ubc6 is 
constitutively degraded via a Doa10-dependent pathway. Proteolysis of this particular 
ERAD substrate is affected by changes in the CUE domain of Cue1 that impair the 
association with poly-Ub42. However, the turnover of Ubc6 is unorthodox in some 
respects. Ubc6 auto-ubiquitinates itself and a large fraction of the protein modified 
with mono-Ub can be readily detected in cell extracts20. Therefore, degradation 
kinetics of this specific target may not be limited by its priming with mono-Ub, but 
rather by the rate of poly-Ub chain synthesis. 
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A puzzling observation was encountered during the analysis of Hmg2-6xMyc 
degradation. Processing of this protein was not completely abrogated in absence of 
Hrd1 or Ubc7. It is therefore feasible to speculate that cytosolic PQC pathways 
contribute in part to the turnover of this target. A recent study in human cells 
demonstrated the degradation of an ERAD-M substrate by a cytosolic protein quality 
control pathway106. Processing of INSIG1-GFP is mediated by the ER membrane-
bound E3 ligase AMFR, but also required the activity of a cytosolic E2 enzyme and 
Ub ligase. 
 
3.2.2 Backup mechanisms ensure efficient substrate removal 
The Hrd1 and Doa10 ERAD ligases display clear preferences on how they prime 
their client proteins with Ub. Remarkably data in this thesis imply that both ligases 
can employ alternative priming mechanisms to handle specific subsets of substrates. 
Degradation of unassembled Sbh2 via Doa10 does not entirely rely on Ubc6 function. 
Obviously, also Ubc7 is able to prime this target with Ub in the context of the Doa10 
RING-finger enzyme. However, the over-stimulation of Ubc7 activity by placing a 
canonical arginine into the linchpin position of the Doa10 RING-finger domain did not 
restore Sbh2 turnover in cells lacking Ubc6. This suggests that priming of Doa10 
substrates by Ubc7 is not facilitated by linchpin allostery, but depends on other 
properties of the RING domain. 
The degradation of Hrd1 client proteins was gradually impaired in mutants of the 
RING-finger domain that did not support full stimulation of Ubc7. Importantly, the 
turnover of these proteins was further delayed in absence of Ubc6. This 
demonstrates that Ubc6 is able to attach Ub onto Hrd1 substrates. In wild type cells, 
the priming activity of Ubc7 at the Hrd1 Ub ligase outperforms that of Ubc6. Once the 
stimulation of Ubc7 via linchpin allostery is compromised, the residual Ubc6 priming 
activity suffices to allow the degradation of at least a fraction of the Hrd1 substrates. 
Importantly, the processing of particular Hrd1 clients, like a variant of CPY* devoid of 
all lysine residues, may completely depend on priming by Ubc6. This shows that also 
the Hrd1 Ub ligase can employ a specialized E2 enzyme for the priming of certain 
target proteins with Ub, which most likely contributes to broaden the flexibility of this 
ERAD enzyme in the disposal of defective polypeptides. 
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In human cells, the Hrd1 homologue, SYVN1, cooperates with the homologues of 
Cue1 and Ubc7, AUP1 and UBE2G2, respectively106,107. In addition, several studies 
show a physical and functional interaction of SYVN1 and the Ubc6 homologue 
UBE2J1106,108,109. Obviously, the interplay of Hrd1 with a specialized priming E2 
enzyme is conserved from yeast to human. Interestingly, human cells harbor two 
homologues of Ubc6. Each of those is functionally connected with either human Hrd1 
or the homologue of Doa10. Human cells might therefore equip each of those ERAD 
Ub ligases separately with a highly flexible and versatile Ub priming enzyme to 
facilitate the ubiquitination of their client proteins.  
In conclusion, the poly-ubiquitination of ERAD substrates is largely delimited by the 
priming reaction. To this end, two distinct strategies have evolved to ensure the 
efficient attachment of the initial Ub moieties (Fig. 3-3). The Doa10 ligase employs a 
specialized E2 enzyme for priming and utilizes another one for the formation of Ub 
chains. Accordingly, the Doa10 RING-finger domain binds both enzymes equally 
well. It accommodates a non-canonical amino acid residue at its linchpin position and 
thus does not stimulate the activity of the priming enzyme via linchpin allostery. 
Nevertheless, it is capable to support poly-Ub formation by Ubc7. 
Hrd1 primarily cooperates with Ubc7 in the priming and elongation reactions. 
Nevertheless, Ubc6 can be utilized for the initial ubiquitination of appointed client 
proteins. Thus, these ERAD Ub ligases employ two fundamentally different strategies 
to promote the efficient degradation of their targets, but maintain a high degree of 
versatility to target unorthodox client proteins. 
Figure 3-3: Interaction model of ERAD ligases and their cognate E2 enzymes during substrate priming 
and chain elongation. Distinct interactions between E3’s and E2’s serve the purpose of high processivity while 
backup mechanisms provide vast versatility. 
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3.3 Molecular analysis of the Asi complex at a glimpse 
A novel Asi model substrate was established based on the very stable superfolder 
GFP90. Fusion of sfGFP to an Asi-regulated degron robustly recruited the engineered 
protein towards Asi-mediated quality control in yeast cells. With this tool in hand, 
several published and so far uninvestigated contributions to Asi complex function 
were dissected. 
Foresti et al.56 proved a strong interaction between Asi1 and Asi3 in absence of Asi2 
and argued for the existence of different subcomplexes. Work in this thesis reveals 
that any two of the Asi subunits robustly interact with each other independent of the 
third complex partner. This still opens the possibility for the presence of distinctly 
active subcomplexes. However, the strict requirement for every single subunit of the 
complex regarding substrate degradation suggests that active Asi complexes 
comprise all three interaction partners. 
In line with results from Foresti et al.56, ubiquitination of Asi clients was facilitated by 
Ubc4 and Ubc7. Deletion of Ubc6 had only minor effects. While Khmelinskii et al.57 
provided data that show a physical interaction between Ubc6 and the Asi1 and Asi3 
RING-finger domains, a clear indication for a functional partnership is missing. Thus, 
this physical interaction might solely result from close proximity since Ubc6, together 
with Doa10, also localizes to the inner nuclear membrane to regulate Asi2 protein 
levels92,110. 
In the final part of this thesis, the distinct contributions of the Asi1 and Asi3 RING-
finger domains to target breakdown were analyzed. This study reveals that both 
RING domains are required for efficient substrate processing at the Asi complex. 
Furthermore, it proves that spatially regulated linchpin allostery is necessary for 
modification of client proteins.  
An intriguing model accommodating the presented results is based on the 
consecutive action of the Asi1 and Asi3 RING domains. Cooperating E2 enzymes 
could be recruited to the complex by the Asi3 RING domain. Then, E2s would be 
passed over to the Asi1 RING domain for stimulation and Ub transfer to client 
molecules. To validate this hypothesis, a ―RING-swapping‖ experiment could be 
conducted. To this end, fusion proteins consisting of Asi1 and Asi3 proteins harboring 
the corresponding RING domain of the other subunit could be used. If E2 recruitment 
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and stimulation is solely facilitated by the RING domains, the complex should still be 
functional. Additionally, the residues at the linchpin positions could be substituted by 
the corresponding one in the other RING domain to investigate if the observed effects 
are due to spatial issues or if other features of the RINGs are important. Spatial 
regulation may also be connected to substrate recruitment to the Asi complex, which 
unfortunately, has not yet been studied in detail. Even though, all Asi subunits have 
been shown to efficiently precipitate substrate molecules56, they might only come in 
close proximity to E2 enzymes at the Asi1 RING. 
Another model explaining the necessity of two correctly folded RING domains 
emerges from the heterodimeric BRCA1/BARD1 Ub ligase complex. The 
BRCA1/BARD1 ligase harbors two RING-carrying subunits. NMR studies proved that 
interaction between the complex and E2 enzymes is exclusively promoted by the 
BRCA1 RING, but not the BARD1 RING111. Nevertheless, interaction of the RINGs is 
strictly required for complex function. The authors claimed that the BARD1 RING 
stabilizes active BRCA1 conformations in the context of the active ligase complex. 
This could also apply to the Asi complex. To test this hypothesis, the effect of single 
point mutations in conserved residues, which are important for RING 
heterodimerization could be analyzed. 
Another, albeit doubtful model features Asi1 as the only active subunit needed for 
substrate turnover. In this case, Asi2 and Asi3 would only partially contribute to 
substrate recruitment to the complex. Lack of those should then be covered by Asi1 
overexpression. A similar mechanism was proposed for the Hrd1 ligase where it has 
been shown that overexpression of Hrd1 suppresses the need of other subunits of 
the Hrd1 ligase complex112. Experiments implementing overexpression of single Asi 
subunits in different deletion backgrounds could be performed to examine this idea. 
Future work is needed to deepen the understanding of the Asi complex. 
Unfortunately, due to technical difficulties, the establishment an in vitro assay to 
monitor Asi-dependent E2 stimulation was not successful, so far. The newly 
established model substrate Stp1-sfGFP-3xHA may help in this regard by providing 
the means to directly follow substrate modification in solution. 
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3.4 Mechanisms of priming and elongation during Ub chain 
formation 
Substrate priming with Ub and elongation of chains on previously attached Ub 
moieties display two fundamentally different processes. During priming, E2 enzymes 
are faced with the challenge to detect and modify accessible residues in a highly 
varying substrate pool. Targets of different topology are probably presented to the Ub 
conjugating enzymes in a many different ways leading to a manifold of different 
environments surrounding the amino acid side chains that will be modified. During 
elongation, E2 enzymes are repeatedly encountered with virtually the same interface 
on the client Ub. This is often achieved by distinct Ub binding domains aligning the 
Ub chain with the catalytic center of the E2 allowing for efficient Ub transfer. 
To overcome these different challenges, versatile systems have been identified that 
uncouple substrate priming from chain elongation. With the Doa10 ligase to begin 
with, two different E2 enzymes are employed for either process20. This is particularly 
important in protein quality control since involved E3 ligases are challenged with a 
highly heterogeneous substrate pool113. 
A comparable mechanism is found at the anaphase-promoting complex (APC). The 
APC controls cell cycle progression to ensure equal distribution of sister chromatids 
to the daughter cells during mitosis. This in turn contributes to the maintenance of a 
healthy genome. Therefore, rapid removal of cell cycle inhibitors, like securin and 
cyclin B1, at a given time point must be guaranteed. To achieve this, the APC teams 
up with Ubc4 and Ubc1 for target priming and elongation of K48-linked chains78. 
Another example is found in the NF-κB pathway, in which modification of IκBα by the 
SCFβTrCP2 complex is facilitated by sequential polyubiquitination114. The SCF ligase 
cooperates with the human Ubc4 homologue UbcH5c to prime IκBα with Ub, which is 
then elongated by Cdc34 to induce proteasomal degradation. 
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3.5 Concluding remarks 
Mechanisms of priming and elongation are widely spread in nature and come to play 
whenever substrates need to be rapidly and efficiently removed to induce signaling 
pathways or prevent cells from proteotoxic stress. Therefore, the detailed 
mechanisms of priming and elongation in various Ub-related systems need to be 
investigated in molecular detail to understand target modification with Ub. 
This study provides insight into the different strategies that E3 ligases employ to 
overcome the challenges of priming and elongation and proposes a refined model of 
E3-mediated E2 stimulation. This is not only limited to ERAD ligases, but can be 
extended to other systems. By analyzing the interactions between distinct E2/E3 
pairs, we may be able to predict how they fulfill their functions in their given cellular 
context. 
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4. Material and methods 
 
4.1 Material 
 
4.1.1 Chemicals 
All chemicals and reagents used in this study were purchased from Sigma, VWR or 
Roth, unless otherwise noted. Restriction enzymes were acquired from New England 
Biolabs (NEB). All buffer solutions were prepared using deionized H20 which has 
been passed through a Milli-DI ® system (Millipore). 
 
4.1.2 Bacterial strains 
XL1-Blue (Agilent Technologies) 
E. coli recA1 endA1 gyrA96 thi-1 hsdR17(rK
- mK
+) supE44 relA1 lac [F´ proAB 
lacIqZΔM15 Tn10 (Tetr)] 
BL21-Gold(DE3) (Agilent Technologies) 
E. coli B Fˉ ompT hsdS(rB
- mB
-) dcm+ Tet´gal λ(DE3) endA Hte [pLysS Camr] 
 
4.1.3 Yeast strains 
All strains used in this study are haploid descendants of the diploid S. cerevisiae 
strain DF5115. Haploid YWO1 and YWO2 strains serve as wild type standards. 
Deviations from their genotypes for strains used in this study are listed below. Strains 
termed ―YAWxxx‖ were constructed by Dr. Annika Weber as a contribution to this 
study, unless otherwise noted. 
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Table 4-1: Relevant yeast strains used in this thesis 
Strain Genotype Reference 
   
YWO1 trp1-1 (am), his-Δ200, ura3-52, lys2-801, leu2-3, -112, MATα Seufert et al.
116
 
YWO2 trp1-1 (am), his-Δ200, ura3-52, lys2-801, leu2-3, -112, MATa Seufert et al.
116
 
YWO13 Δubc4::HIS3, MATα Seufert et al.
116
 
YBM74 Δdoa10::kanMX6, MATα Birgit Meusser 
YBM77 Δdoa10::kanMX6, Δubc7::LEU2, MATα Birgit Meusser 
YJU3 Δubc7::LEU2, MATα Jörg Urban 
YJU4 Δubc4::HIS3, Δubc7::LEU2, MATα Jörg Urban 
YTX115 Δcue1::LEU2, MATα Laboratory of Prof. Sommer 
YTX190 Δubc7::LEU2, MATα Laboratory of Prof. Sommer 
YTX996 Δubc6::HIS3, MATα Weber et al.
20
 
YTX997 Δubc6::HIS3, Δubc7::LEU2, MATα Katrin Bagola 
YAW018 Δdoa10::kanMX6, Δubc6::HIS3, MATα Annika Weber 
YAW032 Δdoa10::kanMX6, Δssh1::HIS3, MATa Weber et al.
20
 
YAW068 Δdoa10::kanMX6, Δssh1::HIS3, Δubc6::LEU2, MATa Annika Weber 
YAW102 Doa10 H94E, MATα This study 
YAW109 Doa10 H94E, Δubc6::HIS3, MATα This study 
YAW110 Doa10 H94E, Δubc7::LEU2, MATα This study 
YAW111 Doa10 H94E, Δssh1::HIS3, Δubc7::LEU2, MATα This study 
YAW112 Doa10 H94E, Δssh1::HIS3, MATa This study 
YAW116 Doa10 H94E, Δssh1::HIS3, Δubc6::HIS3, MATα This study 
YCL005 Erg11-3xHA::TRP1, MATα This study 
YCL006 Erg11-3xHA::TRP1, MATa This study 
YCL007 Δasi1::kanMX6, MATa This study 
YCL010 Δasi2::URA3, MATa This study 
YCL013 Δasi3::HIS3, MATa This study 
YCL014 Erg11-3xHA::TRP1, Δubc7::LEU2, MATα This study 
YCL015 Erg11-3xHA::TRP1, Δubc6::HIS3, MATα This study 
YCL016 Erg11-3xHA::TRP1, Δubc6::HIS3, Δubc7::LEU2, MATa This study 
YCL018 Erg11-3xHA::TRP1, Δasi1::kanMX6, MATa This study 
YCL020 Erg11-3xHA::TRP1, Δasi2::URA3, MATa This study 
YCL022 Erg11-3xHA::TRP1, Δasi3::HIS3, MATa This study 
YCL036 Erg11-3xHA::TRP1, Δubc4::HIS3, MATα This study 
YCL057 Δasi1::kanMX6, Δasi3::HIS3, MATα This study 
YCL062 Erg11-3xHA::TRP1, Δasi1::kanMX6, Δasi3::HIS3, MATa This study 
YCL065 Δasi1::kanMX6, Δasi2::URA3, Δasi3::HIS3, MATa This study 
YCL070 Erg11-3xHA::TRP1, Δubc4::HIS3, Δubc7::LEU2, MATα This study 
YCL111 Δhrd1::TRP1, Δubc6::HIS3, MATa This study 
YCL114 Δhrd1::TRP1, MATα This study 
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YCL123 Δhrd1::TRP1, Δubc7::LEU2, MATa This study 
YCL137 Δhrd1::TRP1, Δubc6::HIS3, 6xMyc-Hmg2::URA3, MATa This study 
YCL138 Δhrd1::TRP1, Δubc7::LEU2, 6xMyc-Hmg2::URA3, MATa This study 
YCL153 Δssh1::HIS3, Δubc6::HIS3, MATα This study 
YCL155 Δdoa10::kanMX6, Δssh1::HIS3, Δubc7::LEU2, MATa This study 
YCL156 Δssh1::HIS3, Δubc7::LEU2, MATa This study 
YCL157 Δssh1::HIS3, MATa This study 
YCL169 Δhrd1::TRP1, Δcue1::LEU2, MATα This study 
YCL178 Δssh1::HIS3, Cue1 LAP(76-78)RGA, MATa This study 
YCL180 Δssh1::HIS3, Δcue1::LEU2, MATa This study 
YCL183 Δhrd1::TRP1, Cue1 LAP(76-78)RGA, MATa This study 
YCL185 Cue1 LAP(76-78)RGA, MATα This study 
YCL201 Δhrd1::TRP1, 6xMyc-Hmg2::URA3, MATα This study 
YCL202 Δhrd1::TRP1, Cue1 LAP(76-78)RGA, 6xMyc-Hmg2::URA3, MATα This study 
YCL207 Doa10 H94E, Δssh1::HIS3, Cue1 LAP(76-78)RGA, MATa This study 
YCL210 Doa10 H94E, Cue1 LAP(76-78)RGA, MATa This study 
YCL250 Doa10 H94R, MATα This study 
YCL252 Doa10 H94A, MATα This study 
YCL253 Doa10 H94R, Δssh1::HIS3, MATα This study 
YCL255 Doa10 H94A, Δssh1::HIS3, MATα This study 
YCL256 Doa10 H94R, Δssh1::HIS3, Δubc6::HIS3, MATα This study 
YCL258 Doa10 H94A, Δssh1::HIS3, Δubc6::HIS3, MATa This study 
YCL259 Doa10 H94R, Δubc6::HIS3, MATα This study 
YCL260 Doa10 H94A, Δubc6::HIS3, MATα This study 
YCL261 Doa10 H94R, Δubc7::LEU2, MATα This study 
YCL263 Doa10 H94A, Δubc7::LEU2, MATα This study 
YCL264 Doa10 H94R, Δssh1::HIS3, Δubc7::LEU2, MATα This study 
YCL266 Doa10 H94A, Δssh1::HIS3, Δubc7::LEU2, MATa This study 
YCL274 Doa10 H94R, Cue1 LAP(76-78)RGA, MATα This study 
YCL276 Doa10 H94R, Δssh1::HIS3, Cue1 LAP(76-78)RGA, MATα This study 
YCL277 Doa10 H94A, Cue1 LAP(76-78)RGA, MATα This study 
YCL279 Doa10 H94A, Δssh1::HIS3, Cue1 LAP(76-78)RGA, MATα This study 
 
4.1.4 Plasmids 
Plasmids used in this study are listed in table 4-2. Yeast expression plasmids encode 
for the endogenous promoter of the respective gene, unless otherwise noticed. pToR 
plasmids were constructed and provided by Dr. Tobias Ritterhoff from Rachel Klevit’s 
laboratory as a contribution to this study. pAW plasmids were constructed by Dr. 
Annika Weber as a contribution to this study, unless otherwise noted. 
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Table 4-2: Relevant plasmids used in this thesis 
Plasmid Insert Backbone Reference 
    
Bacterial Expression Plasmids 
pAW039 GST-HRV3C-Ubc6 (2-230) pGEX-6p1 Weber et al.
20
 
pLP016 GST-HRV3C-Ubc4 K91R pGEX-6p1 Lukas Pluska 
pMD10 hUb pETM60 Rogov et al.
117
 
pMD11 hUb-His6 pETM60 von Delbrück et al.
42
 
pMD12 hUb S20C pETM60 von Delbrück et al.
42
 
pMD26 GST-HRV3C-Cdc34 pGEX-6p1 von Delbrück et al.
42
 
pTX249 GST-HRV3C-Ubc7 (2-165) pGEX-6p1 Bagola et al.
41
 
pTX410 GST-HRV3C-Cue1-His6 (24-203) pGEX-6p1 Bagola et al.
41
 
pTX411 GST-HRV3C-Cue1 LAP(76-78)RGA-His6 (24-203) pGEX-6p1 Bagola et al.
41
 
pTX481 Uba1-His6 pET32 Berndsen & Wolberger
118
 
pToR1 His6-SUMO3-Hrd1 (325-412) pET28 This study 
pToR3 GST-HRV3C-Doa10 (19-102) pGEX-6p1 This study 
pToR4 GST-HRV3C-Doa10 H94R (19-102) pGEX-6p1 This study 
pToR5 GST-HRV3C-Doa10 H94A (19-102) pGEX-6p1 This study 
pToR6 GST-HRV3C-Doa10 H94E (19-102) pGEX-6p1 This study 
pCL151 His6-SUMO3-Hrd1 R400E (325-412) pET28 This study 
pCL153 His6-SUMO3-Hrd1 R400A (325-412) pET28 This study 
pCL160 His6-SUMO3-Hrd1 R400H (325-412) pET28 This study 
pCL166 His6-SUMO3-S-Hrd1 (325-412) pET28 This study 
pCL167 GST-HRV3C-S-Doa10 (19-102) pGEX-6p1 This study 
pCL172 GST-HRV3C-RNase A-TUB (42-150) pGEX-6p1 This study 
pCL173 His6-SUMO3-S-Hrd1 R400H (325-412) pET28 This study 
pCL176 GST-HRV3C-S-Doa10 H94R (19-102) pGEX-6p1 This study 
Yeast Expression Plasmids 
pRB256 CPY*_noK-HA pRS315 Baldridge & Rapoport
89
 
pTR1646 FLAG-Sbh2 pRS414 Weber et al.
20
 
pUL038 Deg1-eGFP2 pRS414 Lenk & Sommer
82
 
pAW183 Hrd1 R400H pRS416 This study 
pCL023 Asi1 pRS415 This study 
pCL026 Asi1 CC583/585SS pRS415 This study 
pCL030 3xHA-Asi1 pRS415 This study 
pCL068 3xMyc-Asi2 pRS317 This study 
pCL069 3xFLAG-Asi3 pRS414 This study 
pCL075 3xMYC Asi2 (1-159) pRS317 This study 
pCL076 3xFLAG-Asi3 (1-299) pRS414 This study 
pCL077 3xHA-Asi1 (1-299) pRS415 This study 
pCL080 SV40 NLS-3xHA-Asi1 (300-624) pRS415 This study 
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pCL081 SV40 NLS-3xMyc-Asi2 (160-289) pRS317 This study 
pCL082 SV40 NLS-3xFLAG-Asi3 (300-676) pRS414 This study 
pCL083 Hrd1 pRS416 this study 
pCL084 Hrd1 R400A pRS416 this study 
pCL087 3xHA-Asi1 (1-199) pRS415 This study 
pCL088 3xHA-Asi1 (1-99) pRS415 This study 
pCL089 3xMyc-Asi2 (1-119) pRS317 This study 
pCL090 3xMyc-Asi2 (1-79) pRS317 This study 
pCL091 3xFLAG-Asi3 (1-199) pRS414 This study 
pCL092 3xFLAG-Asi3 (1-99) pRS414 This study 
pCL099 SV40 NLS-3xHA-Asi1 (400-624) pRS415 This study 
pCL100 SV40 NLS-3xHA-Asi1 (500-624) pRS415 This study 
pCL101 SV40 NLS-3xMyc-Asi2 (200-289) pRS317 This study 
pCL102 SV40 NLS-3xMyc-Asi2 (240-289) pRS317 This study 
pCL103 SV40 NLS-3xFLAG-Asi3 (400-676) pRS414 This study 
pCL104 SV40 NLS-3xFLAG-Asi3 (500-676) pRS414 This study 
pCL105 SV40 NLS-3xFLAG-Asi3 (600-676) pRS414 This study 
pCL138 Stp1
16-50
-sfGFP-3xHA pRS424 This study 
pCL139 sfGFP-3xHA pRS424 This study 
pCL142 Hrd1 pRS317 This study 
pCL143 Hrd1 R400A pRS317 This study 
pCL149 PrA*-3xHA pRS317 This study 
pCL152 Hrd1 R400E pRS317 This study 
pCL157 Hrd1 R400E pRS416 This study 
pCL161 Hrd1 R400H pRS317 This study 
pCL165 Asi3 pRS416 This study 
pCL168 Asi1 R608D pRS415 This study 
pCL169 Asi3 CC624/627SS pRS416 This study 
pCL171 Asi3 D664R pRS416 This study 
 
4.1.5 Oligonucleotides 
Oligonucleotides used in this study are listed in table 4-3. All oligonucleotides were 
supplied by BioTeZ Berlin-Buch GmbH. Forward and reverse primers are indicated 
as ―fwd‖ and ―rev‖, respectively. Primers for amplification of promoter and terminator 
regions upstream and downstream of genes are indicated as ―up‖ and ―down‖ 
respectively. Primers AWxxx were designed by Annika Weber as a contribution to 
this study. RF corresponds to primers used for Restriction-Free cloning119. 
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Table 4-3: Relevant oligonucleotides used in this thesis 
Oligonucleotide Sequence 5’  3’ Target gene Description 
    
AW278 GGA TGT TAA ATG TGA CAT CTG TCG CTA 
TCC CAT TCA ATT C 
Doa10 Doa10 H94R fwd 
AW279 GAA TTG AAT GGG ATA GCG ACA GAT GTC 
ACA TTT AAC ATC C 
Doa10 Doa10 H94R rev 
AW280 CTC AGA CTT GTC CTA TTT GTG CAT TGC 
CTG TCT TTG ATG 
Hrd1 Hrd1 R400A fwd 
AW281 CAT CAA AGA CAG GCA ATG CAC AAA TAG 
GAC AAG TCT GAG 
Hrd1 Hrd1 R400A rev 
AW350 CTC AGA CTT GTC CTA TTT GTC ACT TGC 
CTG TCT TTG ATG 
Hrd1 Hrd1 R400H fwd 
AW351 CAT CAA AGA CAG GCA AGT GAC AAA TAG 
GAC AAG TCT GAG 
Hrd1 Hrd1 R400H rev 
AW352 GGA TGT TAA ATG TGA CAT CTG TGC TTA 
TCC CAT TCA ATT C 
Doa10 Doa10 H94A fwd 
AW353 GAA TTG AAT GGG ATA AGC ACA GAT GTC 
ACA TTT AAC ATC C 
Doa10 Doa10 H94A rev 
AW356 GGA TGT TAA ATG TGA CAT CTG TGA GTA 
TCC CAT TCA ATT C 
Doa10 Doa10 H94E fwd 
AW357 GAA TTG AAT GGG ATA CTC ACA GAT GTC 
ACA TTT AAC ATC C 
Doa10 Doa10 H94E rev 
AW363 CTC AGA CTT GTC CTA TTT GTG AAT TGC 
CTG TCT TTG ATG 
Hrd1 Hrd1 R400E fwd 
AW364 CAT CAA AGA CAG GCA ATT CAC AAA TAG 
GAC AAG TCT GAG 
Hrd1 Hrd1 R400E rev 
CL131 CTT TTT GTC GAC CAC AAT TAC GAA AAC 
TAT ATT GTT TTG 
Asi1 SalI_+200bp up_Asi1 
fwd 
CL132 GAA AAA CTG CAG CTC CCA AAC GAA AAA 
CCT C 
Asi1 Asi1_+50 bp down_PstI 
rev 
CL133 CTT TTT GTC GAC CAT TGC TGT GCA GTT 
AAT CTT C 
Asi2 SalI_+200bp up_Asi2 
fwd 
CL134 GAA AAA CTG CAG CGA CCA CAT GCG AAA 
G 
Asi2 Asi2_+50 bp down_PstI 
rev 
CL135 CTT TTT AAG CTT ATG TCT ACA AAT ATA 
TTG CAA CAT GTT AAG 
Asi3 HindIII_Asi3 fwd 
CL136 GAA AAA CTG CAG CAG ACT TGA GGT TGA 
ACA TAT CC 
Asi3 Asi3_+50 bp down_PstI 
rev 
CL149 ATA CAG TAT TAT GGC CCA GCC GAA GTT 
TTG CCA TTT GCG AG 
Asi1 Asi1 CC583/585SS fwd 
CL150 CTC GCA AAT GGC AAA ACT TCG GCT GGG 
CCA TAA TAC TGT AT 
Asi1 Asi1 CC583/585SS rev 
CL151 GTG GAG GAA ATG GAT CTC TCC AGC CTA 
ATC AGC AAA GTT AAT AAA AGA AAT AT 
Asi3 Asi3 CC624/627SS fwd 
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CL152 ATA TTT CTT TTA TTA ACT TTG CTG ATT 
AGG CTG GAG AGA TCC ATT TCC TCC AC 
Asi3 Asi3 CC624/627SS rev 
CL155 ATG ATT ATC TGT TTC AGC GAT TTC TAG 
AAG AAT CGG AAC AAA AGT TGA TTT CTG 
AAG AAG 
Asi2 RF 3xMyc-Asi2 fwd 
CL156 GAA GGC TCT CTA CTA TGC CTC GTT TCG 
TTC AAG TCT TCT TCT GAG ATT AAT 
Asi2 RF 3xMyc-Asi2 rev 
CL165 ACA AGC CGT AAT CTC AGG TAA CTC CTA 
CCC ATA CGA TGT TCC TGA CT 
Asi1 RF 3xHA-Asi1 fwd 
CL166 AGT CTA TAA GGA AAG TTG ATA ACA TTT 
GCG AAA GTA GCG TAA TCT GGA ACG TCA 
T 
Asi1 RF 3xHA-Asi1 rev 
CL207 TTA GCT TTT TTC ACA ACA AGA CTG GAA 
ATC TTA ATG ACT ACA AGG ACC ACG ACG 
GTG ACT ACA AGG ACC ACG ACA TCG ACT 
ACA AGG ACG ACG ACG ACA AGT ACC TAG 
ATA ACA CAA CTC AGA AAC CGG 
Asi3 RF 3xFLAG-Asi3 fwd 
CL208 CCG GTT TCT GAG TTG TGT TAT CTA GGT 
ACT TGT CGT CGT CGT CCT TGT AGT CGA 
TGT CGT GGT CCT TGT AGT CAC CGT CGT 
GGT CCT TGT AGT CAT TAA GAT TTC CAG 
TCT TGT TGT GAA AAA AGC TAA 
Asi3 RF 3xFLAG-Asi3 rev 
CL222 CAT GCG TCA GCT GTC GTA GTG AGG TGA 
AGG G 
Asi3 Asi3 D664R fwd 
CL223 CCC TTC ACC TCA CTA CGA CAG CTG ACG 
CAT G 
Asi3 Asi3 D664R rev 
CL267 CTT TTT CTC GAG CAC AAT TAC GAA AAC 
TAT ATT GTT TTG AAC AG 
Asi1 XhoI _Asi1-promoter fwd 
CL268 CGT ATG GGT AGA CCT TTC TTT TCT TTT 
TTG GCA TGT CGA CAT TCT TAG CAT AGT 
TTC TTT GTA AAA AGA AG 
Asi1 Asi1-promoter-SV40 
NLS-3xHA rev 
CL269 GTC GAC ATG CCA AAA AAG AAA AGA AAG 
GTC TAC CCA TAC GAT GTT CCT GAC 
Asi1 SV40 NLS-3xHA fwd 
CL270 ACT GTA AAA GTT CGC AAG AAT TAC GTG 
ATT TTC CAT GCA TAG CGT AAT CTG GAA 
CGT CA 
Asi1 3xHA_NsiI_Asi1 (300-
624) rev 
CL271 TGA CGT TCC AGA TTA CGC TAT GCA TGG 
AAA ATC ACG TAA TTC TTG CG 
Asi1 3xHA_NsiI_Asi1 (300-
624) fwd 
CL272 CTT TTT GGG CCC CAT TGC TGT GCA GTT 
AAT CTT CAT 
Asi2 ApaI_Asi2-promoter fwd 
CL273 ACT TTT GTT CGA CCT TTC TTT TCT TTT 
TTG GCA TGA ATT CTT TTT CTC ACT AAA 
TGC TTG TGA GG 
Asi2 Asi2-promoter-SV40 
NLS-3xMyc rev 
CL274 GAA TTC ATG CCA AAA AAG AAA AGA AAG 
GTC GAA CAA AAG TTG ATT TCT GAA GAA 
GAT TTG 
Asi2 SV40 NLS-3xMyc fwd 
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CL275 ATA TCT TGG CAA ATT TCC AGT ATC CCA 
CGA TAT GCA TGT TCA AGT CTT CTT CTG 
AGA TTA ATT TTT GTT C 
Asi2 3xMyc_NsiI_Asi2 (160-
289) rev 
CL276 GAA GAC TTG AAC ATG CAT ATC GTG GGA 
TAC TGG AAA TTT G 
Asi3 3xMyc_NsiI_Asi2 (160-
289) fwd 
CL277 CCT TGT AGT CGA CCT TTC TTT TCT TTT 
TTG GCA TAA GCT TAT TCT TAG CAT AGT 
TTC TTT GTA AAA AGA AG 
Asi3 Asi1-promoter-SV40 
NLS-3xFLAG rev 
CL278 AAG CTT ATG CCA AAA AAG AAA AGA AAG 
GTC GAC TAC AAG GAC CAC GAC GG 
Asi3 SV40 NLS-3xFLAG fwd 
CL279 TAT ATC TTG AAT ATA ATG ATC GGA ACG 
GAT TAC TAT GCA TCT TGT CGT CGT CGT 
CC 
Asi3 3xFLAG_NsiI_Asi3 (300-
676) rev 
CL280 ACG ACA AGA TGC ATA GTA ATC CGT TCC 
GAT CAT TAT ATT C 
Asi3 3xFLAG_NsiI_Asi3 (300-
676) fwd 
CL281 GCT TAA TTA GAT GGG ATC CAT TTT GAA 
AAT CAC GTA ATT CTT GCG AA 
Asi1 Asi1 299_STOP fwd 
CL282 TTC GCA AGA ATT ACG TGA TTT TCA AAA 
TGG ATC CCA TCT AAT TAA GC 
Asi1 Asi1 299_STOP rev 
CL283 AAT ATC TTG GCA AAT TTC CAG TAT CCC 
ACT CAT TCG ATT ATA AAA TCA TTC TCT 
GAA AAG G 
Asi2 Asi2 159_STOP fwd 
CL284 CCT TTT CAG AGA ATG ATT TTA TAA TCG 
AAT GAG TGG GAT ACT GGA AAT TTG CCA 
AGA TAT T 
Asi2 Asi2 159_STOP rev 
CL285 CCT GAA GGC TTT GTT CAC CTG AAA TCC 
GTT CCG ATC ATT AT 
Asi3 Asi3 299_STOP fwd 
CL286 ATA ATG ATC GGA ACG GAT TTC AGG TGA 
ACA AAG CCT TCA GG 
Asi3 Asi3 299_STOP rev 
CL287 GAA AAA AAG CTT TCA AAG AAA AGG TTT 
AAT AGA CGA TAA ATT TCC 
Hrd1 HindIII_+300bp up_Hrd1 
fwd 
CL288 CTT TTT GGA TCC CAG TAG TTT TTT TCT 
TTA AAA AAA ACT ATG TAT AAT ATA AAA C 
Hrd1 Hrd1_+50 bp 
down_BamHI rev 
CL294 GAA AAA ATG CAT CAA AGA TTT TTT TTA 
ATG TTT CCA AAA TCT ATA ATA TG 
Asi1 NsiI_Asi1 (400-624) fwd 
CL295 GAA AAA ATG CAT AAC GAA ACT CGG GAT 
GCC 
Asi1 NsiI_Asi1 (500-624) fwd 
CL296 GAA AAA ATG CAT TCT TCA CCT GTG ATA 
AAA CAT ATT ATG AAA AG 
Asi2 NsiI_Asi2 (200-289) fwd 
CL297 GAA AAA ATG CAT ATC TAT TTA GCT TAT 
GGC GTA AGT G 
Asi2 NsiI_Asi2 (240-289) fwd 
CL298 GAA AAA ATG CAT ACA TAT TTA GGC CTT 
TTT GAA TTA GTA AGA AC 
Asi3 NsiI_Asi3 (400-676) fwd 
CL299 GAA AAA ATG CAT TCA GAT GAA GAG TTT 
GAT AGT GAT ATG G 
Asi3 NsiI_Asi3 (500-676) fwd 
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CL300 GAA AAA ATG CAT GAT GAC AAA TTA GAG 
TTC AAG TTT GAT TTT G 
Asi3 NsiI_Asi3 (600-676) fwd 
CL301 TCA TTG TTT GAA CTT TCG ATT CAG TTT 
TAT ACA ATG ACT AAT TAG AAT ACT AAA 
TTT TTA GAT TCT CC 
Asi1 Asi1 199_STOP fwd 
CL302 GGA GAA TCT AAA AAT TTA GTA TTC TAA 
TTA GTC ATT GTA TAA AAC TGA ATC GAA 
AGT TCA AAC AAT GA 
Asi1 Asi1 199_STOP rev 
CL303 GAA CCG GTT CGT TGT ATT TTA CTG AGT 
CCT TAA CAA CGG TTC CAG AC 
Asi1 Asi1 99_STOP fwd 
CL304 GTC TGG AAC CGT TGT TAA GGA CTC AGT 
AAA ATA CAA CGA ACC GGT TC 
Asi1 Asi1 99_STOP rev 
CL305 CAG AGC CCT CTC AGA ACT TTT CTT TGA 
AAT TTA TTC ATT TTA GAT TAC TT 
Asi2 Asi2 119_STOP fwd 
CL306 AAG TAA TCT AAA ATG AAT AAA TTT CAA 
AGA AAA GTT CTG AGA GGG CTC TG 
Asi2 Asi2 119_STOP rev 
CL307 TTC TAC TTC AAA TAT AAA TAG AGC AGC 
TAA TTA GGA TGC AAC CAC AAA CGG 
Asi2 Asi2 79_STOP fwd 
CL308 CCG TTT GTG GTT GCA TCC TAA TTA GCT 
GCT CTA TTT ATA TTT GAA GTA GAA 
Asi2 Asi2 79_STOP rev 
CL309 TTT TCC ATA TGG GGT TTA TCA TTG AAT 
CTT TAG ATC ATA TCC AAA ATG CC 
Asi3 Asi3 199_STOP fwd 
CL310 GGC ATT TTG GAT ATG ATC TAA AGA TTC 
AAT GAT AAA CCC CAT ATG GAA AA 
Asi3 Asi3 199_STOP rev 
CL311 TAT GTT TTA GTA CCG CCA TTA TTT TGT 
AAA GGT TGA CTG TAA TGT CTT CAT TG 
Asi3 Asi3 99_STOP fwd 
CL312 CAA TGA AGA CAT TAC AGT CAA CCT TTA 
CAA AAT AAT GGC GGT ACT AAA ACA TA 
Asi3 Asi3 99_STOP rev 
CL393 GAA AAA GTC GAC TTT ATA ATC AAA TTT 
TAG TGG TCT TTT CTA TTT TTA TTT G 
Pra1 SalI_+200bp up_Pra1 
CL394 GAA GTT TTG AGG TGG AGT ACC CAA AGT 
AAT GTC AGT GTA ATA CTT TTG GCC TAA 
ATG AGC TAA ATG 
Pra1 Pra1 Y54 rev 
CL395 TCA CTT TCG AGC AAC ATT TAG CTC ATT 
TAG GCC AAA AGT ATT ACA CTG ACA TTA 
CTT TGG GTA CTC 
Pra1 Pra1 Y92 fwd 
CL396 CTT TTT CTG CAG TCA AGC GTA ATC TGG 
AAC GTC ATA TGG ATA GGA TCC TGC ATA 
GTC CGG GAC GTC ATA GGG ATA GCC CGC 
ATA GTC AGG AAC ATC GTA TGG GTA AAT 
TGC TTT GGC CAA ACC AAC 
Pra1 Pra1-3xHA_STOP_PstI 
rev 
CL399 GAA AAA GGG CCC GCA TGC AAC TTC TTT 
TCT TTT TTT TTC 
sfGFP ApaI_ADH1 fwd 
CL400 CTT TTT CTC GAG AGT TGA TTG TAT GCT 
TGG TAT AGC 
sfGFP ADH1_XhoI rev 
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CL401 GAA AAA GTC GAC ATG ATT CCA GGC AAG 
ATA TAC GCG TTC TTC AGA GAG CTC GTC 
AGC GGA GTT ATT ATA TCC AAG CCA GAT 
CTA AGT CAT CAT TAT TCT TGT GAA AAT 
GCG ACA AAG GAG CGT AAA GGC GAA GAG 
CTG 
sfGFP SalI_Stp1
16-50
-sfGFP fwd 
CL402 CTT TTT GAA TTC TCA AGC GTA ATC TGG 
AAC GTC ATA TGG ATA GGA TCC TGC ATA 
GTC CGG GAC GTC ATA GGG ATA GCC CGC 
ATA GTC AGG AAC ATC GTA TGG GTA TTT 
GTA CAG TTC ATC CAT ACC ATG C 
sfGFP sfGFP-3xHA_EcoRI rev 
CL403 GAA AAA GTC GAC ATG CGT AAA GGC GAA 
GAG CTG 
sfGFP SalI_sfGFP fwd 
CL445 CAG CAC TTG CGT ATG TTG TGA TAG TAA 
AGT TCA TGG GTA C 
Asi1 Asi1 R608D fwd 
CL446 GTA CCC ATG AAC TTT ACT ATC ACA ACA 
TAC GCA AGT GCT G 
Asi1 Asi1 R608D rev 
CL447 GTT CCA GCA GCA GAC GGG AGG TAA GGA 
AAC TGC AGC AGC CAA GTT TGA GCG GC 
Hrd1 RF S-Tag-Hrd1 (325-
412) fwd 
CL448 TCG TCG AGC TGT TTC GGA TCC ATG GAG 
TCC ATG TGC TGC CGC TCA AAC TTG GCT 
Hrd1 RF S-Tag-Hrd1 (325-
412) rev 
CL449 GGA AGT TCT GTT CCA GGG GCC CAA GGA 
AAC TGC AGC AGC CAA GTT TGA GCG GC 
Doa10 RF S Tag-Doa10 (19-
102) fwd 
CL450 CCT CGT TTG CCA CGG ATC CCA GGG AGT 
CCA TGT GCT GCC GCT CAA ACT TGG CT 
Doa10 RF S Tag-Doa10 (19-
102) rev 
CL452 GAA AAA GTC GAC TTA TTC TTC GCC TTC 
TTC TTC GCC TTC GCC TTC CAC GCT ATC 
CAC CAC TGA AGC ATC AAA GTG GAC 
RNase A RNase A (42-150)-TUB 
tag_SalI rev 
CL455 GAA AAA GGA TCC AGC ACT TCC GCT GCC RNase A BamHI_RNase A (42-
150) fwd 
 
4.1.6 Antibodies 
Antibody solutions were prepared in TBT buffer (50 mM Tris-HCl pH 7.5, 
150 mM NaCl, 0.1 % (v/v) Tween®-20) supplemented with 0.05 % (w/v) NaN3 and 
5 % (w/v) skim milk powder or BSA. Species from which the antibodies were derived 
are mouse (m), rabbit (rb), goat (g) and donkey (d). All antibodies used in this study 
are listed in table 4-4. 
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Table 4-4: Relevant antibodies used in this thesis 
Antibody Dilution Reference 
   
Primary antibodies 
Monoclonal α-FLAG (m) 1:2.000 Sigma-Aldrich F3165 
Monoclonal α-GAPDH (m) 1:1.000 Sigma-Aldrich G8795 
Monoclonal α-HA (m) 1:5.000 Sigma-Aldrich H9658 
Monoclonal α-HA (rb) 1:1.000 Cell Signaling Technology C29F4 
Monoclonal α-Myc (m) 1:2.000 Sigma-Aldrich M5546 
Polyclonal α-Cdc48 (rb) 1:10.000 Neuber et al.
43
 
Polyclonal α-FLAG (rb) 1:1.000 Cell Signaling Technology 2368S 
Polyclonal α-GFP (rb) 1:1.000 Thermo Fisher Scientific A-11122 
Polyclonal α-Myc (rb) 1:1.000 MBL International 562 
Secondary antibodies 
IRDye
®
 680RD α-m IgG (g) 1:10.000 LI-COR 926-68070 
IRDye
®
 800CW α-m IgG (d) 1:10.000 LI-COR 926-32212 
IRDye
®
 800CW α-rb IgG (g) 1:10.000 LI-COR 926-32211 
Polyclonal HRP-conjugated α-m IgG (rb) 1:10.000 Sigma-Aldrich A9044 
Polyclonal HRP-conjugated α-rb IgG (g) 1:10.000 Sigma-Aldrich A0545 
 
4.2 Methods 
 
4.2.1 Polymerase chain reaction (PCR) 
PCR reactions were performed using the Phusion® High-Fidelity DNA Polymerase 
system (NEB). 150 ng of plasmid DNA or yeast genomic DNA were supplemented 
with 0.2 µM of forward and reverse oligonucleotides, 200 µM of dNTP’s, 10 µl 
5x Phusion® HF buffer, 1 µl of Phusion® DNA Polymerase (2U) and ddH2O ad 50 µl. 
At first, DNA strands were denaturated for at 98 °C for 2 min. Subsequently, DNA 
was amplified in 30 cycles of denaturation at 98 °C for 30 s, oligonucleotide 
annealing at 53 °C for 1 min and DNA strand elongation at 72 °C for 1 min/kB. In a 
final elongation step at 72 °C for 5 min, immature strand ends were filled. 
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4.2.2 Site-directed mutagenesis 
Point mutations were introduced using the QuikChange Site-Directed Mutagenesis 
Kit (Agilent Technologies) according to the manufacturer’s instructions. 
Epitope tags were introduced by Restriction-Free (RF) cloning119. 
 
4.2.3 Cloning, DNA purification and ligation 
Amplified DNA fragments and target vectors were digested using restriction enzymes 
and appropriate buffers from NEB according to the manufacturer’s protocol. Digested 
DNA was supplemented with Purple Gel Loading Dye (6x concentrate, NEB) and 
separated on agarose gels (1 - 2 % (w/v) agarose in TAE buffer (40 mM Tris-HCl, 
pH 8.2, 0.14 % (v/v) acetic acid, 1 mM EDTA)). For subsequent UV-mediated 
detection, the DNA-intercalating fluorophore RedSafe™ (iNtRON Biotechnology) was 
added during agarose gel preparation. Separated DNA fragments and linearized 
vectors were purified from gels using the Wizard® SV Gel and PCR Clean-Up 
System (Promega) followed by ligation involving T4 DNA ligase (NEB) at 37 °C for 
1 h. 
 
4.2.4 Escherichia coli (E. coli) cell culture 
E. coli cells were grown in LB (lysogeny broth) medium (1 % (w/v) Bacto™ Tryptone, 
0.5 % (w/v) Bacto™ yeast extract, 1 % (w/v) NaCl) containing appropriate antibiotics 
(50 µg/ml ampicillin or 25 µg/ml kanamycin) or on solid LB medium plates (LB 
medium supplemented with 2 % (w/v) agar) for cloning and plasmid amplification 
purposes. For heterologous expression of target genes, E. coli cells were grown in 
TB (terrific broth) medium (1.2 % (w/v) Bacto™ Tryptone, 2.4 % (w/v) Bacto™ yeast 
extract, 0.4 % (v/v) glycerol, 17 mM KH2PO4, 72 mM K2HPO4) containing appropriate 
antibiotics. The production of perdeuterated proteins for NMR studies was performed 
in minimal M9/D2O medium (42,3 mM Na2HPO4, 22 mM KH2PO4, 17 mM NaCl, 1 mM 
MgSO4, 100 µM CaCl2, 7.5 µM thiamin, 37 µM FeCl3, 0.4 % (w/v) glucose, 18.4 mM 
15NH4Cl solved in 99.9 % D2O) containing appropriate antibiotics. 
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4.2.5 E. coli transformation 
Plasmid DNA was transformed into competent E. coli cells by electroporation. 
Therefore, 50 µl of cells were thawed on ice, supplemented with DNA and transferred 
to a precooled electroporation cuvette. After a short pulse at 2.5 MV, 25 µF and 
200 Ω, cells were taken up in 200 µl of SOC medium (2 % (w/v) Bacto™ Tryptone, 
0.5 % (w/v) Bacto™ yeast extract, 10 mM NaCl, 2.5 mM KCl, 10 mM MgCl2, 0.2 % 
(w/v) glucose) and incubated at 37 °C for 30 min (ampicillin resistance) or 2 h 
(kanamycin resistance). Afterwards, cells were plated on solid LB medium containing 
antibiotics for the selection of the desired plamids and incubated at 37 °C overnight. 
XL1-blue cells were transformed for plasmid amplification. For heterologous 
expression of target genes BL21-Gold (DE3) cells were used. 
 
4.2.6 Plasmid preparation and sequencing 
Single colonies of transformed XL1-blue cells were picked from LB selection plates 
and inoculated in 3 ml LB medium at 37 °C and 200 rpm overnight. Plasmids were 
extracted from 2 ml per culture using the Jetstar™ 2.0 Plasmid Purification Kits 
(GENOMED GmbH) according to the manufacturer’s instructions. Plasmid DNA was 
dissolved in 50 µl of ddH2O and the concentration was measured at a micro-volume 
spectrophotometer (NanoDrop™ 2000, Thermo Fisher Scientific). For sequencing, 
the concentration was adjusted according to the recommended sample requirements 
prior to sample delivery to LGC Genomics GmbH. 
 
4.2.7 Heterologous protein expression in E. coli 
Transformed BL21-Gold (DE3) cells were grown in 50 ml LB medium at 37 °C and 
200 rpm overnight. Overnight cultures were used to inoculate M9 or TB medium 
(typically, 2 l, starting OD600 of 0.1) which were then shaken at 37 °C and 90 rpm until 
an OD600 of 0.6 - 0.8 or 1 - 1.5, respectively was reached. Subsequently, cells were 
cooled to 16 °C for 30 min prior to induction of protein expression by addition of 
1 mM IPTG. After 16 - 18 h, cells were harvested by centrifugation (6,000 x g, 
30 min, 4 °C), washed with ddH2O, transferred to 50 ml Falcon tubes and frozen in 
liquid nitrogen. Pellets were stored at -80 °C until further use. 
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4.2.8 Saccharomyces cerevisiae cell culture 
Yeast cells were grown in YPD (yeast peptone dextrose) medium (2 % (w/v) Bacto™ 
Peptone, 1 % (w/v) Bacto™ yeast extract, 2 % (w/v) glucose, pH adjusted to 5.5 with 
HCl ± 250 µg/ml geneticin (G418)) or minimal SD (synthetic defined) medium (0.67 % 
(w/v) yeast nitrogen base without amino acids, 2 % (w/v) glucose, 20 mg/l adenine 
sulfate, 30 mg/l L-leucine, 30 mg/l L-lysine, 20 mg/l L-histidine, 20 mg/l L-tryptophan, 
20 mg/l uracil). To prepare solid medium plates, above mentioned media were 
supplemented with 2 % (w/v) agar. For auxotrophic selection of plasmids or gene 
deletions, designated amino acids were left out when preparing SD medium. 
 
4.2.9 Yeast transformation 
For plasmid transformation, 1 OD600 of logarithmic growing yeast cells were 
harvested by centrifugation (2,000 x g, 3 min). The pellet was resuspended in 100 µl 
of transformation buffer A (10 mM Tris-HCl, pH 7.4, 1 mM EDTA, 100 mM LiOAc). 
1 µg of plasmid DNA and denatured herring sperm DNA at a final concentration of 
0.2 µg/µl were added. The solution was supplemented with 500 µl of transformation 
buffer B (10 mM Tris-HCl, pH 7.4, 1 mM EDTA, 100 mM LiOAc, 40 % (v/v) 
PEG 3350) and incubated at 30 °C for 30 min. After a heat shock at 42 °C for 15 min, 
cells were pelleted (2,000 x g, 3 min), resuspended in 100 µl of ddH2O and plated on 
SD selection medium. 
For genomic integration of amplified PCR fragments, the protocol was slightly 
changed. 25 OD600 of logarithmic growing cells were harvested and washed in 1 ml of 
transformation buffer A. The cell pellet was resuspended in 200 µl of buffer A and 
supplemented with denatured herring sperm DNA. PCR-amplified DNA was 
precipitated by addition of 400 mM NaOAc and 2.5 volumes of ethanol and 
centrifugation (20,000 x g, 15 min, 4 °C). The DNA pellet was resuspended in 15 µl of 
ddH2O and added to the transformation solution. The solution was supplemented 
with 800 µl of transformation buffer B and incubated at 30 °C for 30 min. After heat 
shocking at 42 °C for 15 min, cells were either incubated for another 2 h at 30 °C to 
develop a resistance against G418 or for 30 min at 30 °C if auxotrophic marker 
cassettes were used. Following this regeneration step, 200 µl of the suspension were 
plated on YPD-G418 or SD selection medium, respectively. 
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4.2.10 Preparation of genomic yeast DNA 
Yeast cells were inoculated in 3 ml YPD medium at 30 °C and 200 rpm overnight. 
Genomic DNA was extracted from 2 ml per culture (5 - 10 OD600). Cells were 
harvested by centrifugation (2,000 x g, 3 min) and washed with 1 ml of ddH2O. The 
cell pellet was resuspended in 200 µl of DNA extraction buffer (10 mM Tris-HCl, 
pH 8.0, 100 mM NaCl, 1 mM EDTA, 1 % (w/v) SDS, 2 % (v/v) Triton X-100). The 
suspension was supplemented with a mixture of phenol:chloroform:isoamyl alcohol 
(25:24:1). Glass beads were added and mechanical lysis was performed by vigorous 
shaking on a Vibrax VXR basic for 5 min. The lysate was diluted with 200 µl of TE 
buffer (10 mM Tris-HCl, pH 7.4, 1 mM EDTA) and centrifuged (20,000 x g, 5 min) for 
phase separation. The upper aqueous was transferred to a fresh tube containing 1 ml 
of cold ethanol and centrifuged (20,000 x g, 15 min, 4 °C) to precipitate nucleic acids. 
The resulting pellet was resuspended in 400 µl of TE buffer. To digest precipitated 
RNA, 30 µg of RNase A (Roth) were added and the solution was incubated at 37 °C 
for 5 min. DNA was precipitated by addition of ammonium acetate (final concentration 
100 mM) and 1 ml of cold ethanol followed by centrifugation (20,000 x g, 15 min, 
4 °C). The pellet was dried at room temperature and resuspended in 100 µl of 
ddH2O. 
 
4.2.11 Yeast strain crossing 
Haploid yeast strains of different mating types (MATa or MATα) were inoculated in 
3 ml YPD medium overnight. 500 µl of each culture were mixed in a tube bearing a 
small hole in its lid for oxygen supply. The cell suspension was incubated under 
constant stirring at room temperature for 4 - 5 h. Sedimented (diploid) cells were 
plated on SD plates selecting for auxotrophy markers from both initial haploid strains 
allowing only diploid cells to grow. After two days of incubation at 30 °C, diploid yeast 
cells were inoculated in 3 ml YPD medium overnight. 200 µl of this culture were 
supplemented with 3 ml of nutrient-rich pre-sporulation medium (0.3 % (w/v) Bacto™ 
Peptone, 0.8 % (w/v) Bacto™ yeast extract, 10 % (w/v) glucose) and incubated for at 
30 °C and 200 rpm for 4 h. To initiate sporulation, 2 ml of this culture were harvested 
by centrifugation (2,000 x g, 3 min), washed twice with ddH2O, resuspended in 3 ml 
of nutrient-poor sporulation medium (0.1 % (w/v) Bacto™ yeast extract, 0.05 % (w/v) 
glucose, 1 % (w/v) KOAc) and incubated for up to 4 days at 30 °C and 200 rpm. 
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Sporulation efficiency was checked using an optical microscope (Zeiss). For tetrad 
dissection, 1 ml of the sporulation reaction was harvested (2,000 x g, 3 min) and 
resuspended in 1ml of SED medium (18.2 % (w/v) sorbitol, 25 mM EDTA). 200 µl of 
this suspension were supplemented with 50 mM DTT and 200 µg zymolyase (MP 
Biomedicals) and incubated at room temperature for 20 min to digest the ascus wall. 
Subsequently, a small amount of this suspension was spread on a YPD plate using 
an inoculation loop. Individual spores of a tetrade were dissected at a 
micromanipulator (Singer Instruments). After 2 days of incubation at 30 °C, spores 
were analyzed regarding their genotype by replica plating on appropriate selection 
plates. 
 
4.2.12 SDS-PAGE 
Complex protein samples were analyzed using sodium dodecyl sulfate-
polyacrylamide gel electrophoresis (SDS-PAGE)120. According to their molecular 
weight, proteins were separated in an electric field using gel electrophoresis systems 
(Hoefer Inc.) filled with Laemmli running buffer (LRB) (25 mM Tris, 192 mM glycine, 
0.1 % (w/v) SDS). Therefore, proteins were focused in a 3 % stacking gel (125 mM 
Tris-HCl, pH 6.8, 3 % (v/v) acrylamide, 0.15 % (v/v) bisacrylamide, 0.1 % (w/v) SDS, 
0.25 % (v/v) TEMED, 2.5 % (w/v) APS) at 80 V for 30 min. Subsequently, proteins 
were separated in 12 % or 18 % separating gels (500 mM Tris-HCl, pH 8.8, 12 % or 
18 % (v/v) acrylamide, 0.006 or 0.009 % (v/v) bisacrylamide, 0.1 % (w/v) SDS, 
0.25 % (v/v) TEMED, 2.5 % (w/v) APS) at 120 V until the buffer front reached the end 
of the gel. For protein detection, gels were subjected to Coomassie staining, 
fluorescence scanning, autoradiography or western blotting. To determine the 
molecular weight of detected proteins, a protein marker (Color Prestained Protein 
Standard, Broad Range (11 - 245 kDa), NEB) was applied to gels before 
electrophoresis. 
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4.2.13 Coomassie staining 
To detect all proteins in complex protein mixtures, gels were incubated with 
Coomassie staining solution (10 % (v/v) acetic acid, 40 % (v/v) methanol, 0.25 % 
(w/v) Coomassie Brilliant Blue R-250) at room temperature for 30 min. Destaining 
was achieved either in ddH2O, overnight or in destaining solution (10 % (v/v) acetic 
acid, 40 % (v/v) methanol) for several hours until stained proteins were clearly visible. 
The detection limit of Coomassie Brilliant Blue R-250 ranges around 0.2 - 0.5 µg of 
protein. 
 
4.2.14 Fluorescence scanning 
Alexa Fluor 488-labeled proteins were detected directly from SDS-PAGE gels. 
Therefore, the fluorophore was excited at 473 nm and emission was detected at 
510 nm with a LPB filter (510LP) using a Typhoon FLA 9500 laser scanner (GE 
Healthcare). Fluorescent signals were quantified in ImageQuant TL 7.01 (GE 
Healthcare). 
 
4.2.15 Autoradiography 
Radioisotope-labeled substrates were visualized by autoradiography. Therefore, 
samples were fixed by incubating SDS-PAGE gels in 10 % (v/v) acetic acid. Gels 
were washed with ddH2O and dried in a Model 583 gel dryer (Bio-Rad Laboratories, 
Inc.). Signals were transferred to BAS Storage Phosphor Screens (GE Healthcare) 
and detected using a Typhoon FLA 9500 laser scanner. Radioactive signals were 
quantified in ImageQuant TL 7.01. 
 
4.2.16 Western Blotting/Immunoblotting 
For the detection of selected proteins in complex samples separated proteins from 
SDS-PAGE gels were transferred to PVDF membranes (pore size 0.45 µm, Roth). To 
this ends, gels were placed on methanol-activated membranes and embedded in 
Whatman-paper. This assembly was placed in a TE22 Mighty Small Transfer Tank 
(Hoefer Inc.) filled with transfer buffer (25 mM Tris, 192 mM glycine, 15 % (v/v) 
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isopropanol). Transfer onto membranes was achieved by applying an electric current 
of 250 mA for 90 min. After the blotting procedure, unspecific binding sites were 
blocked by incubating the membranes at room temperature for 30 min in blocking 
solution (5 % (w/v) skim milk powder or BSA in TBT (50 mM Tris-HCl, pH 7.5, 
150 mM NaCl, 0.1 % (v/v) Tween®-20). Primary antibody solutions were prepared as 
described (4.1.6) and applied to membranes prior to incubation at 4 °C overnight. 
Membranes were washed three times with 20 ml TBT and three times with 20 ml 
PBS (137 mM NaCl, 2.7 mM KCl, 10.1 mM Na2HPO4, 1.8 mM KH2PO4) for 10 min, 
each. Secondary antibody solutions were prepared as before and applied to 
membranes at room temperature for 1 h. After another washing procedure as 
described above, signals were detected either by application of Western Lightning® 
Plus-ECL, Enhanced Chemiluminescence Substrate (PerkinElmer, Inc.) for HRP-
conjugated secondary antibodies or by instant scanning for fluorophore-conjugated 
IRDye® secondary antibodies (LI-COR Biosciences), both using an Odysee® Fc 
imaging system (LI-COR Biosciences). Fluorescent signals were quantified in Image 
Studio Lite 5.0 (LI-COR Biosciences). 
 
4.2.17 E. coli cell lysis 
Frozen cell pellets were thawed on ice and resuspended in 30 ml lysis buffer (50 mM 
Tris-HCl, pH 7.5, 150 mM NaCl, 1mM PMSF, 0.4 mg/ml lysozyme, 5 µg/ml DNase, 
10 µg/ml RNase). Lysis was done by high pressure homogenization, passing the cell 
suspension three times through an EmulsiFlex-C5 homogenizer (AVESTIN Europe, 
GmbH) (4 °C, 1500 bar). The lysate was cleared by centrifugation (20,000 x g, 
30 min, 4 °C). 
 
4.2.18 Purifcation of GST-tagged proteins 
Genes coding for Glutathione S-transferase (GST)-tagged proteins harbored a 
Human Rhinovirus (HRV) 3C protease cleavage site between the epitope and the 
target protein. All of the following steps were performed on ice or at 4 °C. Lysates of 
GST-tagged fusion proteins were supplemented with Glutathione Sepharose® 4 Fast 
Flow (GE Healthcare) (typically 2 ml slurry per liter of TB medium used for 
expression) and incubated for 4 h under constant shaking. Sepharose was washed 5 
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times with 15 ml of protease inhibitor-free lysis buffer. To elute bound proteins from 
the resin, self-made GST-tagged HRV 3C protease was added prior to overnight 
incubation. On the following day, the supernatant was collected and incubated with 
fresh sepharose for another hour to remove excess protease. After removing the 
resin, the protein solution was concentrated to 500 µl in centrifugal filters (Amicon® 
Ultra, Merck Millipore, MWCO corresponding to about 1/3 of the predicted MW of the 
target protein) and further purified by size exclusion chromatography (Superdex™ 75 
Increase 10/300 GL, GE Healthcare) in SEC buffer (50 mM Tris-HCl, pH 7.5, 150 mM 
NaCl) using an ÄKTA™ pure chromatography system (GE Healthcare). Fractions 
containing the target protein, as judged by absorbance at 280 nm as well as SDS-
PAGE and Coomassie staining, were pooled, concentrated, frozen in liquid nitrogen 
and stored at -80 °C until further use. 
 
4.2.19 Purification of His6-tagged proteins 
Most hexa histidine (His6)-tagged proteins were fused to SUMO3 (human small 
ubiquitin-related modifier 3) to increase solubility and expression. All of the following 
steps were performed on ice or at 4 °C. Lysates of those fusion proteins were 
supplemented with Ni-NTA Agarose (Qiagen) and incubated for 4 h under constant 
shaking. Agarose was washed 5 times with 15 ml of wash buffer (50 mM Tris-HCl, 
pH 7.5, 150 mM NaCl, 20 mM imidazole). To elute bound proteins from the resin, 
self-made His6-tagged Ulp1 (yeast protease cleaving SUMO3 from target proteins) 
was added prior to overnight incubation. From here on, the supernatant was treated 
as described before (4.2.2.7). 
The E1 enzyme (Uba1-His6) was purified with a slightly changed protocol. During the 
whole procedure, the cell pellet and lysate were kept in 2 x PBS (274 mM NaCl, 
5.4 mM KCl, 20.2 mM Na2HPO4, 3.6 mM KH2PO4). The lysate was applied to a 
HisTrap™ Fast Flow Crude column (GE Healthcare) using an ÄKTA™ pure. The 
column was washed with 10 column volumes of 2 x PBS including 20 mM Imidazol. 
Bound proteins were eluted by application of 2 x PBS containing 300 mM Imidazol. 
Size exclusion chromatography was performed on a HiLoad™ 16/60 Superdex™ 200 
prep grade. 
The purification of Ub-His6 is described in section 4.2.2.9. 
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4.2.20 Purification of ubiquitin monomers. 
Untagged ubiquitin monomers were purified by acidic precipitation. The stable fold of 
ubiquitin protected it from precipitation while other E. coli proteins aggregated. 300 µl 
of 70 % (v/v) perchloric acid were titrated to 30 ml of cleared cell lysates under 
vigorous stirring on ice. The precipitate was removed by centrifugation (20,000 x g, 
20 min, 4 °C). The pH of the supernatant was adjusted to neutral range by addition of 
10 M NaOH. The supernatant was concentrated to 2 ml and applied to a HiLoad™ 
26/60 Superdex™ 75 prep grade size exclusion column in SEC buffer. Fractions 
were collected as described in 4.2.2.7. 
Ub-His6 was purified using HisTrap™ Fast Flow Crude columns equilibrated in lysis 
buffer. Columns were washed with lysis buffer containing 20 mM Imidazol. Proteins 
were eluted in lysis buffer containing 300 mM Imidazol. SEC was performed as 
described above. 
The UbS20C variant was purified as before except for using 1 x PBS buffer during 
SEC. 
 
4.2.21 Lowry protein assay 
Protein concentration was determined based on the method established by Lowry121. 
Therefore, the DC™ Protein Assay (Bio-Rad Laboratories, Inc.) was used. A BSA 
concentration gradient served as standard curve to determine concentrations by 
measuring absorbance at 750 nm. 
 
4.2.22 Synthesis and purification of K48-linked ubiquitin chains 
Ubiquitin chains linked through lysine48 were enzymatically assembled on C-
terminally blocked Ub-His6. In vitro reactions included 1 µM E1, 20 µM Cdc34, 
900 µM Ub, 600 µM Ub-His6 in chain synthesis buffer (50 mM Tris-HCl, pH 8.0, 9 mM 
MgCl2, 0.9 mM DTT, 20 mM ATP) and were performed by incubation at 37 °C 
overnight. His6-tagged chains were enriched using Ni-NTA Agarose, concentrated to 
2 ml and further purified by SEC (HiLoad™ 26/60 Superdex™ 75 prep grade) in SEC 
buffer. Chains of specific length were collected as described before (4.2.2.7). 
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4.2.23 Fluorescent labeling of UbS20C 
Since Ub does not harbor any endogenous thiol groups, introduction of a cysteine at 
amino acid position 20 allowed for site-specific labeling of Ub with Alexa Fluor™ 488 
C5 Maleimide (Thermo Fisher Scientific). In a first step, the thiol group of Ub was 
reduced by addition of three-fold molar excess of TCEP in 1 x PBS at room 
temperature for 10 min. Subsequently, four-fold molar excess of fluorescent dye was 
added and the labeling reaction was performed at room temperature for 90 min in the 
dark. The reaction was quenched by addition of 10 mM β-mercaptoethanol and the 
labeling mix was desalted in two steps using NAP™-5 columns equilibrated in 50 mM 
Tris-HCl, pH 8.0 to remove excess reducing agent and dye. The eluate was 
concentrated to 300 µl. Labeling efficiency was determined by the ratio of dye 
concentration (absorbance at 493 nm) and protein concentration (4.2.2.10). Labeled 
Ub488 was stored at -80 °C until further use. 
 
4.2.24 Fluorescent labeling of S protein 
The S protein was modified with 3-Azido-L-tyrosine (Iris Biotech GmbH) by use of the 
previously reported TUB-tag labeling approach76. Therefore, 75 µM of the S protein 
were mixed with 1.8 mM of 3-Azido-L-tyrosine, 5 µM of tubulin tyrosine ligase (TTL), 
2.5 mM ATP and 5 mM GSH in TTL buffer (20 mM MES, pH 7.0, 100 mM KCl, 
10 mM MgCl2) and incubated for two hours at 37 °C. Unconjugated 3-Azido-L-
tyrosine was removed by SEC on a HiTrap™ Desalting column (GE Healthcare). 
Protein-carrying fractions were pooled, concentrated to 300 µl and protein 
concentration was determined as before (4.2.2.10). Subsequently, strain-promoted 
azide-alkyne cycloaddition77 (SPAAC) was initiated by addition of dibenzocyclooctyne 
(DBCO)-strained Alexa Fluor™ 488 (Jena Bioscience) in 30-fold molar excess and 
incubation at 30 °C for four hours. After another desalting step, labeled S protein488 
was treated as described before for Ub488 (4.2.2.12). 
 
 
 
94  Material and methods 
4.2.25 Reconstituted ubiquitination reactions involving purified components 
Discharge assays were performed in two subsequent steps. Charging reactions 
included 33 µM of the designated E2 (Ubc6 or U7BR/Ubc7), 132 µM Ub (UbWT for 
Ubc6 or UbK48R for U7BR/Ubc7), 3.3 µM or 0.55 µM E1 (for Ubc6 or U7BR/Ubc7, 
respectively), 5 mM ATP and 5 mM MgCl2 in PBS. Reactions were incubated at 
37 °C (3 min for Ubc6 or 2.5 min for U7BR/Ubc7), quenched by addition of 50 mM 
EDTA and discharge was started by dilution into ethanolamine (in PBS, final 
concentration of 100 mM) in absence or presence of E3 RING domains (final 
concentration 30 µM Doa10 variants for either enzyme, 45 µM Hrd1 variants for Ubc6 
and 10 µM Hrd1 variants for U7BR/Ubc7). Discharge reactions were incubated at 
room temperature or 37 °C (for U7BR/Ubc7 and Doa10). Samples were collected 
after 0, 1, 2.5, 6 and 15.5 min in non-denaturing sample buffer (125 mM Tris-HCl, 
8 % (w/v) SDS, 25 % (v/v) glycerol, 0.05 % (w/v) bromophenol blue) and analyzed by 
SDS-PAGE and Coomassie staining. 
Single-turnover chain elongation reactions included 0.15 µM E1, 2 µM Cue1 
(WT/RGA), 2 µM Ubc7, 2 µM RING domain variants (Hrd1/Doa10), 14.8 µM acceptor 
Ub (His6-blocked mono-Ub/Ub chains) and 0.2 µM donor Ub (fluorescent Ub
488) in in 
vitro reaction buffer (50 mM Tris-HCl, pH 8.0, 4 mM MgCl2, 0.5 mM DTT). Reactions 
were started by addition of 4 mM ATP and incubated at 30 °C. 15 µl samples were 
collected after 0, 1, 2, 3, 4, 5, 10, 30 and 60 min. Reactions were stopped with urea 
sample buffer (4 x concentrate: 200 mM Tris-HCl, pH 6.8, 8 M urea, 5 % (w/v) SDS, 
0.1 mM EDTA, 1.5 % (w/v) DTT, 0.03 % (w/v) bromophenol blue) at the indicated 
time points. Samples were analyzed by SDS-PAGE and fluorescence scanning. 
Ubiquitination reactions on the S protein included 0.3 µM E1, 5 µM E2 (Ubc4, Ubc6 
or Cue1/Ubc7), 5 µM RING variants (Hrd1/Doa10, S peptide-tagged or untagged), 
5 µM S protein488 and 50 µM UbWT in in vitro reaction buffer. Reactions were started 
by addition of 4 mM ATP and incubated at 30 °C for 30 min. Reactions were stopped 
with urea sample buffer and analyzed by SDS-PAGE and fluorescence scanning. 
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4.2.26 NMR titration experiments 
E2~Ub conjugates were prepared prior to NMR measurements. Therefore, UbG76C 
was activated by supplementation with a 5-fold molar excess of DTNB and incubated 
on ice for 5 min. Subsequently, the reaction was desalted by SEC. Conjugates were 
formed by addition of a 2-fold molar excess of UbG76C-TNB to the designated E2 
enzymes and incubation for 30 min at room temperature. Conjugates were purified by 
SEC (Superdex™ 75 Increase 10/300 GL, GE Healthcare) in NMR buffer (25 mM 
Na2HPO4, pH 7.0, 150 mM NaCl, 10 % D2O). 
Heteronuclear single quantum coherence-transverse relaxation-optimized 
spectroscopy (HSQC-TROSY) measurements were conducted with 200 µM labeled 
proteins at 295 K. Data was collected on a 500 MHz Bruker Avance II (University of 
Washington), processed using NMR-Pipe and visualized with NMRView. 
 
4.2.27 Pulse-chase assay 
Degradation of Hrd1-dependent model substrates PrA*-3xHA and Hmg2-6xMyc was 
observed in yeast cells by pulse-chase analysis. Therefore, 15 OD600 (5 OD600 per 
time point) of logarithmic growing cells were harvested (2,000 x g, 3 min) and 
resuspended in 1 ml SD selective medium. Newly synthesized proteins were labeled 
with radioisotopes by addition of 3 MBq EasyTag™ EXPRESS35S Protein Labeling 
Mix (PerkinElmer, Inc.) and incubation at 30 °C for 8 min. Cells were pelleted 
(8.000 x g, 30 s), resuspended in 3.5 ml of label-free chase mix (SD medium, 3.3 mM 
(NH4)2SO4, 0.013 % (w/v) L-methionine, 0.01 % (w/v) L-cysteine) and incubated at 
30 °C. At designated time points (0, 45, 90 min for PrA*-3xHA and 0, 90, 180 min for 
Hmg2-6xMyc) 1 ml samples were collected and degradation was stopped by addition 
of 10 mM NaN3. Cells were harvested (8,000 x g, 30 s) and resuspended in 100 µl 
lysis buffer (50 mM Tris-HCl, pH 7.5, 1 % (w/v) SDS, 1 mM PMSF). Glass beads 
were added and mechanical lysis was performed by vigorous shaking. The lysates 
were supplemented with 1 ml IP dilution buffer (50 mM Tris-HCl, pH 7.5, 165 mM 
NaCl, 5.5 mM EDTA, 1.1 % (v/v) Triton X-100) and incubated on ice for 30 min. After 
removing cell debris and glass beads by centrifugation (15,000 x g, 10 min, 4 °C), the 
supernatants were transferred to fresh tubes. To enrich for desired substrate 
proteins, 15 µl magnetic beads were added (Pierce™ Anti-HA Magnetic Beads for 
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PrA*-3xHA or Pierce™ Anti-c-Myc Magnetic Beads for Hmg2-6xMyc, Thermo Fisher 
Scientific) prior to overnight incubation at 4 °C under constant shaking. The next day, 
beads were washed three times with 1 ml IP buffer (50 mM Tris-HCl, pH 7.5, 150 mM 
NaCl, 5 mM EDTA, 0.1 % (w/v) SDS, 1 % (v/v) Triton X-100). Anti-HA beads were 
additionally treated with 10 µl deglycosylation mix (IP buffer, 1 % (v/v) β-
mercaptoethanol, 0.4 U PNGase F (Roche)) for 1 h at 37 °C. Beads were 
supplemented with 20 µl SDS sample buffer (2x concentrate: 125 mM Tris/HCl, pH 
6.8, 4 % (w/v) SDS, 20 % (v/v) glycerol, 0.1 % (w/v) bromophenol blue, 100 mM 
DTT), incubated for 15 min at 65 °C and analyzed by SDS-PAGE and 
autoradiography. 
4.2.28 Cycloheximide decay assay 
Degradation of Doa10-dependent model substrates FLAG-Sbh2 and Deg1-eGFP2 
was observed in yeast cells by cycloheximide decay assays. Therefore, 20 OD600 of 
logarithmic growing cells were harvested (2,000 x g, 3 min), resuspended in 4.5 ml 
SD selective medium and incubated at 30 °C. Protein translation was inhibited by 
addition of 0.33 mg/ml cycloheximide. At designated time points (0, 10, 20, 40 min for 
FLAG-Sbh2 and 0, 30, 60, 120 min for Deg1-eGFP2) 1 ml samples were collected 
and degradation was stopped by addition of 10 mM NaN3. Cells were harvested 
(20,000 x g, 2 min) and resuspended in 100 µl lysis buffer (50 mM Tris-HCl, pH 7.5, 
1 % (w/v) SDS, 1 mM PMSF). Glass beads were added and mechanical lysis was 
performed by vigorous shaking. The lysates were supplemented with 80 µl SDS 
sample buffer (4x concentrate: 250 mM Tris-HCl, pH 6.8, 8 % (w/v) SDS, 40 % (v/v) 
glycerol, 0.2 % (w/v) bromophenol blue, 100 mM DTT) and incubated for 15 min at 
65 °C. Cell debris and glass beads were removed by centrifugation (1,000 x g, 5 min) 
and the supernatants were transferred to fresh tubes. Samples were analyzed by 
SDS-PAGE and western blotting. 
 
 
 
 
 
Material and methods  97 
4.2.29 Non-denaturing immunoprecipitation 
Yeast cells were grown to an OD600 of 1 - 1.5 in SD selective medium. 100 OD600 of 
cells were harvested (2,000 x g, 3 min), washed with 10 ml of cold ddH2O (containing 
1 mM PMSF) and resuspended in 1 ml IP15 buffer (50 mM Tris-HCl, pH 7.5, 480 mM 
KOAc, 1 mM EDTA, 10 % (v/v) glycerol). The suspension was transferred to a 2 ml 
tube, pelleted (2,000 x g, 3 min) and resuspended in 400 µl IP15 buffer. Glass beads 
were added and mechanical lysis was performed by vigorous shaking. The lysates 
were supplemented with 1 ml IP15 buffer and cell debris was removed (1,000 x g, 
5 min). The supernatant was transferred to a 1 ml tube and membranes were 
pelleted (20,000 x g, 20 min). The membrane pellet was gently solubilized in IP15 
buffer containing 1 % (w/v) LMNG and incubated for 1 h at 4 °C. The lysate was 
cleared (20,000 x g, 10 min) and the supernatant was transferred to a new 1 ml tube. 
45 µl of lysate were removed and supplemented with 15 µl SDS sample buffer (4x 
concentrate: 250 mM Tris-HCl, pH 6.8, 8 % (w/v) SDS, 40 % (v/v) glycerol, 0.2 % 
(w/v) bromophenol blue, 100 mM DTT) as a loading control sample. The remaining 
lysate was diluted with an equal amount of IP15 buffer and supplemented with 30 µl 
of magnetic beads conjugated with antibodies directed against the desired epitope 
tags (HA/Myc/FLAG for 3xHA-Asi, 3xMyc-Asi2 and 3xFLAG-Asi3) prior to incubation 
overnight at 4 °C. The next day, beads were washed three times with 1 ml IP15 
buffer. Beads were supplemented with 50 µl SDS sample buffer (1x concentrate: 
62.5 mM Tris/HCl, pH 6.8, 2 % (w/v) SDS, 10 % (v/v) glycerol, 0.05 % (w/v) 
bromophenol blue, 100 mM DTT), incubated for 15 min at 65 °C and analyzed by 
SDS-PAGE and western blotting. 
 
 
 
 
 
 
 
98  Material and methods 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Appendix  99 
5. Appendix 
 
5.1 Bibliography 
1.  Schlesinger DH, Goldstein G, Niall HD. Complete amino acid sequence of ubiquitin, an 
adenylate cyclase stimulating polypeptide probably universal in living cells. Biochemistry. 
1975;14(10):2214-2218. doi:10.1021/bi00681a026 
2.  Hershko A, Ciechanover A, Rose IA. Resolution of the ATP-dependent proteolytic system from 
reticulocytes: a component that interacts with ATP. Proc Natl Acad Sci. 1979;76(7):3107-3110. 
doi:10.1073/pnas.76.7.3107 
3.  Hershko A, Ciechanover A, Heller H, Haas AL, Rose IA. Proposed role of ATP in protein 
breakdown: conjugation of protein with multiple chains of the polypeptide of ATP-dependent 
proteolysis. Proc Natl Acad Sci. 1980;77(4):1783-1786. doi:10.1073/pnas.77.4.1783 
4.  Hershko A, Ciechanover A, Rose IA. Identification of the active amino acid residue of the 
polypeptide of ATP-dependent protein breakdown. J Biol Chem. 1981;256(4):1525-1528. 
http://www.ncbi.nlm.nih.gov/pubmed/6257674. 
5.  Hetz C. The unfolded protein response: controlling cell fate decisions under ER stress and 
beyond. Nat Rev Mol Cell Biol. 2012;13(2):89-102. doi:10.1038/nrm3270 
6.  Thibaudeau TA, Smith DM. A Practical Review of Proteasome Pharmacology. Ma Q, ed. 
Pharmacol Rev. 2019;71(2):170-197. doi:10.1124/pr.117.015370 
7.  Finley D, Ulrich HD, Sommer T, Kaiser P. The Ubiquitin–Proteasome System of 
Saccharomyces cerevisiae. Genetics. 2012;192(2):319-360. doi:10.1534/genetics.112.140467 
8.  Kerscher O, Felberbaum R, Hochstrasser M. Modification of Proteins by Ubiquitin and 
Ubiquitin-Like Proteins. Annu Rev Cell Dev Biol. 2006;22(1):159-180. 
doi:10.1146/annurev.cellbio.22.010605.093503 
9.  Kostova Z, Tsai YC, Weissman AM. Ubiquitin ligases, critical mediators of endoplasmic 
reticulum-associated degradation. Semin Cell Dev Biol. 2007;18(6):770-779. 
doi:10.1016/j.semcdb.2007.09.002 
10.  O’Connor HF, Lyon N, Leung JW, et al. Ubiquitin-Activated Interaction Traps (UBAITs) identify 
E3 ligase binding partners. EMBO Rep. 2015;16(12):1699-1712. 
doi:10.15252/embr.201540620 
11.  Metzger MB, Hristova VA, Weissman AM. HECT and RING finger families of E3 ubiquitin 
ligases at a glance. J Cell Sci. 2012;125(3):531-537. doi:10.1242/jcs.091777 
12.  Wenzel DM, Klevit RE. Following Ariadne’s thread: a new perspective on RBR ubiquitin 
ligases. BMC Biol. 2012;10(1):24. doi:10.1186/1741-7007-10-24 
13.  Dove KK, Stieglitz B, Duncan ED, Rittinger K, Klevit RE. Molecular insights into RBR E3 ligase 
ubiquitin transfer mechanisms. EMBO Rep. 2016;17(8):1221-1235. 
doi:10.15252/embr.201642641 
14.  Dove KK, Klevit RE. RING-Between-RING E3 Ligases: Emerging Themes amid the Variations. 
J Mol Biol. 2017;429(22):3363-3375. doi:10.1016/j.jmb.2017.08.008 
15.  Smit JJ, Sixma TK. RBR E3-ligases at work. EMBO Rep. 2014;15(2):142-154. 
doi:10.1002/embr.201338166 
16.  Amerik AY, Li S-J, Hochstrasser M. Analysis of the Deubiquitinating Enzymes of the Yeast 
Saccharomyces cerevisiae. Biol Chem. 2000;381(9-10). doi:10.1515/BC.2000.121 
100  Appendix 
17.  Mansour W, Nakasone MA, von Delbrück M, et al. Disassembly of Lys 11 and Mixed Linkage 
Polyubiquitin Conjugates Provides Insights into Function of Proteasomal Deubiquitinases 
Rpn11 and Ubp6. J Biol Chem. 2015;290(8):4688-4704. doi:10.1074/jbc.M114.568295 
18.  Leznicki P, Kulathu Y. Mechanisms of regulation and diversification of deubiquitylating enzyme 
function. J Cell Sci. 2017;130(12):1997-2006. doi:10.1242/jcs.201855 
19.  Tokarev AA, Munguia J, Guatelli JC. Serine-Threonine Ubiquitination Mediates Downregulation 
of BST-2/Tetherin and Relief of Restricted Virion Release by HIV-1 Vpu. J Virol. 2011;85(1):51-
63. doi:10.1128/JVI.01795-10 
20.  Weber A, Cohen I, Popp O, et al. Sequential Poly-ubiquitylation by Specialized Conjugating 
Enzymes Expands the Versatility of a Quality Control Ubiquitin Ligase. Mol Cell. 
2016;63(5):827-839. doi:10.1016/j.molcel.2016.07.020 
21.  Breitschopf K, Bengal E, Ziv T, Admon A, Ciechanover A. A novel site for ubiquitination: the N-
terminal residue, and not internal lysines of MyoD, is essential for conjugation and degradation 
of the protein. EMBO J. 1998;17(20):5964-5973. doi:10.1093/emboj/17.20.5964 
22.  Carvalho AF, Pinto MP, Grou CP, et al. Ubiquitination of Mammalian Pex5p, the Peroxisomal 
Import Receptor. J Biol Chem. 2007;282(43):31267-31272. doi:10.1074/jbc.M706325200 
23.  Wauer T, Simicek M, Schubert A, Komander D. Mechanism of phospho-ubiquitin-induced 
PARKIN activation. Nature. 2015;524(7565):370-374. doi:10.1038/nature14879 
24.  Ohtake F, Saeki Y, Sakamoto K, et al. Ubiquitin acetylation inhibits polyubiquitin chain 
elongation. EMBO Rep. 2015;16(2):192-201. doi:10.15252/embr.201439152 
25.  Hendriks IA, D’Souza RCJ, Yang B, Verlaan-de Vries M, Mann M, Vertegaal ACO. Uncovering 
global SUMOylation signaling networks in a site-specific manner. Nat Struct Mol Biol. 
2014;21(10):927-936. doi:10.1038/nsmb.2890 
26.  Komander D, Rape M. The Ubiquitin Code. Annu Rev Biochem. 2012;81(1):203-229. 
doi:10.1146/annurev-biochem-060310-170328 
27.  Swatek KN, Komander D. Ubiquitin modifications. Cell Res. 2016;26(4):399-422. 
doi:10.1038/cr.2016.39 
28.  Yau R, Rape M. The increasing complexity of the ubiquitin code. Nat Cell Biol. 2016;18(6):579-
586. doi:10.1038/ncb3358 
29.  Dikic I, Wakatsuki S, Walters KJ. Ubiquitin-binding domains — from structures to functions. Nat 
Rev Mol Cell Biol. 2009;10(10):659-671. doi:10.1038/nrm2767 
30.  Balchin D, Hayer-Hartl M, Hartl FU. In vivo aspects of protein folding and quality control. 
Science (80- ). 2016;353(6294):aac4354. doi:10.1126/science.aac4354 
31.  Chiti F, Dobson CM. Protein Misfolding, Amyloid Formation, and Human Disease: A Summary 
of Progress Over the Last Decade. Annu Rev Biochem. 2017;86(1):27-68. 
doi:10.1146/annurev-biochem-061516-045115 
32.  Stevenson J, Huang EY, Olzmann JA. Endoplasmic Reticulum–Associated Degradation and 
Lipid Homeostasis. Annu Rev Nutr. 2016;36(1):511-542. doi:10.1146/annurev-nutr-071715-
051030 
33.  Ruggiano A, Foresti O, Carvalho P. ER-associated degradation: Protein quality control and 
beyond. J Cell Biol. 2014;204(6):869-879. doi:10.1083/jcb.201312042 
34.  Gauss R, Jarosch E, Sommer T, Hirsch C. A complex of Yos9p and the HRD ligase integrates 
endoplasmic reticulum quality control into the degradation machinery. Nat Cell Biol. 
2006;8(8):849-854. doi:10.1038/ncb1445 
35.  Horn SC, Hanna J, Hirsch C, et al. Usa1 Functions as a Scaffold of the HRD-Ubiquitin Ligase. 
Mol Cell. 2009;36(5):782-793. doi:10.1016/j.molcel.2009.10.015 
Appendix  101 
36.  Mehnert M, Sommer T, Jarosch E. Der1 promotes movement of misfolded proteins through the 
endoplasmic reticulum membrane. Nat Cell Biol. 2014;16(1):77-86. doi:10.1038/ncb2882 
37.  Biederer T, Volkwein C, Sommer T. Role of Cue1p in ubiquitination and degradation at the ER 
surface. Science (80- ). 1997;278(5344):1806-1809. doi:10.1126/science.278.5344.1806 
38.  Bazirgan OA, Hampton RY. Cue1p Is an Activator of Ubc7p E2 Activity in Vitro and in Vivo. J 
Biol Chem. 2008;283(19):12797-12810. doi:10.1074/jbc.M801122200 
39.  Ravid T, Hochstrasser M. Autoregulation of an E2 enzyme by ubiquitin-chain assembly on its 
catalytic residue. Nat Cell Biol. 2007;9(4):422-427. doi:10.1038/ncb1558 
40.  Metzger MB, Liang YH, Das R, et al. A Structurally Unique E2-Binding Domain Activates 
Ubiquitination by the ERAD E2, Ubc7p, through Multiple Mechanisms. Mol Cell. 
2013;50(4):516-527. doi:10.1016/j.molcel.2013.04.004 
41.  Bagola K, vonDelbrück M, Dittmar G, et al. Ubiquitin Binding by a CUE Domain Regulates 
Ubiquitin Chain Formation by ERAD E3 Ligases. Mol Cell. 2013;50(4):528-539. 
doi:10.1016/j.molcel.2013.04.005 
42.  von Delbrück M, Kniss A, Rogov V V., et al. The CUE Domain of Cue1 Aligns Growing 
Ubiquitin Chains with Ubc7 for Rapid Elongation. Mol Cell. 2016;62(6):918-928. 
doi:10.1016/j.molcel.2016.04.031 
43.  Neuber O, Jarosch E, Volkwein C, Walter J, Sommer T. Ubx2 links the Cdc48 complex to ER-
associated protein degradation. Nat Cell Biol. 2005;7(10):993-998. doi:10.1038/ncb1298 
44.  Jarosch E, Taxis C, Volkwein C, et al. Protein dislocation from the ER requires 
polyubiquitination and the AAA-ATPase Cdc48. Nat Cell Biol. 2002;4(2):134-139. 
doi:10.1038/ncb746 
45.  Ye Y, Meyer HH, Rapoport TA. The AAA ATPase Cdc48/p97 and its partners transport 
proteins from the ER into the cytosol. Nature. 2001;414(6864):652-656. doi:10.1038/414652a 
46.  Braun S, Matuschewski K, Rape M, Thoms S, Jentsch S. Role of the ubiquitin-selective 
CDC48(UFD1/NPL4 )chaperone (segregase) in ERAD of OLE1 and other substrates. EMBO J. 
2002;21(4):615-621. doi:10.1093/emboj/21.4.615 
47.  Kreft SG, Wang L, Hochstrasser M. Membrane Topology of the Yeast Endoplasmic Reticulum-
localized Ubiquitin Ligase Doa10 and Comparison with Its Human Ortholog TEB4 (MARCH-VI). 
J Biol Chem. 2006;281(8):4646-4653. doi:10.1074/jbc.M512215200 
48.  Swanson R. A conserved ubiquitin ligase of the nuclear envelope/endoplasmic reticulum that 
functions in both ER-associated and Matalpha 2 repressor degradation. Genes Dev. 
2001;15(20):2660-2674. doi:10.1101/gad.933301 
49.  Smoyer CJ, Jaspersen SL. Patrolling the nucleus: inner nuclear membrane-associated 
degradation. Curr Genet. April 2019. doi:10.1007/s00294-019-00971-1 
50.  Boban M, Zargari A, Andréasson C, Heessen S, Thyberg J, Ljungdahl PO. Asi1 is an inner 
nuclear membrane protein that restricts promoter access of two latent transcription factors. J 
Cell Biol. 2006;173(5):695-707. doi:10.1083/jcb.200601011 
51.  Zargari A, Boban M, Heessen S, Andréasson C, Thyberg J, Ljungdahl PO. Inner Nuclear 
Membrane Proteins Asi1, Asi2, and Asi3 Function in Concert to Maintain the Latent Properties 
of Transcription Factors Stp1 and Stp2. J Biol Chem. 2007;282(1):594-605. 
doi:10.1074/jbc.M609201200 
52.  Boer M d. Stp1p, Stp2p and Abf1p are involved in regulation of expression of the amino acid 
transporter gene BAP3 of Saccharomyces cerevisiae. Nucleic Acids Res. 2000;28(4):974-981. 
doi:10.1093/nar/28.4.974 
53.  Forsberg H, Ljungdahl PO. Sensors of extracellular nutrients in Saccharomyces cerevisiae. 
Curr Genet. 2001;40(2):91-109. http://www.ncbi.nlm.nih.gov/pubmed/11680826. 
102  Appendix 
54.  Abdel-Sater F, El Bakkoury M, Urrestarazu A, Vissers S, Andre B. Amino Acid Signaling in 
Yeast: Casein Kinase I and the Ssy5 Endoprotease Are Key Determinants of Endoproteolytic 
Activation of the Membrane-Bound Stp1 Transcription Factor. Mol Cell Biol. 2004;24(22):9771-
9785. doi:10.1128/MCB.24.22.9771-9785.2004 
55.  Omnus DJ, Ljungdahl PO. Latency of transcription factor Stp1 depends on a modular 
regulatory motif that functions as cytoplasmic retention determinant and nuclear degron. Weis 
K, ed. Mol Biol Cell. 2014;25(23):3823-3833. doi:10.1091/mbc.e14-06-1140 
56.  Foresti O, Rodriguez-Vaello V, Funaya C, Carvalho P. Quality control of inner nuclear 
membrane proteins by the Asi complex. Science (80- ). 2014;346(6210):751-755. 
doi:10.1126/science.1255638 
57.  Khmelinskii A, Blaszczak E, Pantazopoulou M, et al. Protein quality control at the inner nuclear 
membrane. Nature. 2014;516(7531):410-413. doi:10.1038/nature14096 
58.  Metzger MB, Pruneda JN, Klevit RE, Weissman AM. RING-type E3 ligases: Master 
manipulators of E2 ubiquitin-conjugating enzymes and ubiquitination. Biochim Biophys Acta - 
Mol Cell Res. 2014;1843(1):47-60. doi:10.1016/j.bbamcr.2013.05.026 
59.  Dou H, Buetow L, Sibbet GJ, Cameron K, Huang DT. Essentiality of a non-RING element in 
priming donor ubiquitin for catalysis by a monomeric E3. Nat Struct Mol Biol. 2013;20(8):982-
986. doi:10.1038/nsmb.2621 
60.  Dou H, Buetow L, Sibbet GJ, Cameron K, Huang DT. BIRC7–E2 ubiquitin conjugate structure 
reveals the mechanism of ubiquitin transfer by a RING dimer. Nat Struct Mol Biol. 
2012;19(9):876-883. doi:10.1038/nsmb.2379 
61.  Koliopoulos MG, Esposito D, Christodoulou E, Taylor IA, Rittinger K. Functional role of TRIM 
E3 ligase oligomerization and regulation of catalytic activity. EMBO J. 2016;35(11):1204-1218. 
doi:10.15252/embj.201593741 
62.  Brzovic PS, Rajagopal P, Hoyt DW, King MC, Klevit RE. Structure of a BRCA1-BARD1 
heterodimeric RING-RING complex. Nat Struct Biol. 2001;8(10):833-837. 
doi:10.1038/nsb1001-833 
63.  Vodermaier HC. APC/C and SCF: Controlling Each Other and the Cell Cycle. Curr Biol. 
2004;14(18):R787-R796. doi:10.1016/j.cub.2004.09.020 
64.  Stewart MD, Ritterhoff T, Klevit RE, Brzovic PS. E2 enzymes: More than just middle men. Cell 
Res. 2016;26(4):423-440. doi:10.1038/cr.2016.35 
65.  Eletr ZM, Huang DT, Duda DM, Schulman BA, Kuhlman B. E2 conjugating enzymes must 
disengage from their E1 enzymes before E3-dependent ubiquitin and ubiquitin-like transfer. Nat 
Struct Mol Biol. 2005;12(10):933-934. doi:10.1038/nsmb984 
66.  Brown NG, Watson ER, Weissmann F, et al. Mechanism of Polyubiquitination by Human 
Anaphase-Promoting Complex: RING Repurposing for Ubiquitin Chain Assembly. Mol Cell. 
2014;56(2):246-260. doi:10.1016/j.molcel.2014.09.009 
67.  Wenzel DM, Lissounov A, Brzovic PS, Klevit RE. UBCH7 reactivity profile reveals parkin and 
HHARI to be RING/HECT hybrids. Nature. 2011;474(7349):105-108. doi:10.1038/nature09966 
68.  Pruneda JN, Stoll KE, Bolton LJ, Brzovic PS, Klevit RE. Ubiquitin in Motion: Structural Studies 
of the Ubiquitin-Conjugating Enzyme∼Ubiquitin Conjugate. Biochemistry. 2011;50(10):1624-
1633. doi:10.1021/bi101913m 
69.  Pruneda JN, Littlefield PJ, Soss SE, et al. Structure of an E3:E2∼Ub Complex Reveals an 
Allosteric Mechanism Shared among RING/U-box Ligases. Mol Cell. 2012;47(6):933-942. 
doi:10.1016/j.molcel.2012.07.001 
70.  Kostova Z, Mariano J, Scholz S, Koenig C, Weissman AM. A Ubc7p-binding domain in Cue1p 
activates ER-associated protein degradation. J Cell Sci. 2009;122(9):1374-1381. 
doi:10.1242/jcs.044255 
Appendix  103 
71.  Jaffray EG, Tatham MH, Naismith JH, Hay RT, Ring RNF. Structure of a RING E3 ligase and 
ubiquitin-loaded E2 primed for catalysis. Nature. 2012;489(7414):115-120. 
doi:10.1038/nature11376 
72.  Hershko A, Ciechanover A. THE UBIQUITIN SYSTEM. Annu Rev Biochem. 1998;67(1):425-
479. doi:10.1146/annurev.biochem.67.1.425 
73.  Kniss A, Schuetz D, Kazemi S, et al. Chain Assembly and Disassembly Processes Differently 
Affect the Conformational Space of Ubiquitin Chains. Structure. 2018;26(2):249-258.e4. 
doi:10.1016/j.str.2017.12.011 
74.  Bays NW, Gardner RG, Seelig LP, Joazeiro CA, Hampton RY. Hrd1p/Der3p is a membrane-
anchored ubiquitin ligase required for ER-associated degradation. Nat Cell Biol. 2001;3(1):24-
29. doi:10.1038/35050524 
75.  Richards FM. on the Enzymic Activity of Subtilisin-Modified Ribonuclease. Proc Natl Acad Sci. 
1958;44(2):162-166. doi:10.1073/pnas.44.2.162 
76.  Schumacher D, Lemke O, Helma J, et al. Broad substrate tolerance of tubulin tyrosine ligase 
enables one-step site-specific enzymatic protein labeling. Chem Sci. 2017;8(5):3471-3478. 
doi:10.1039/c7sc00574a 
77.  Agard NJ, Baskin JM, Prescher JA, Lo A, Bertozzi CR. A Comparative Study of Bioorthogonal 
Reactions with Azides. ACS Chem Biol. 2006;1(10):644-648. doi:10.1021/cb6003228 
78.  Rodrigo-Brenni MC, Morgan DO. Sequential E2s Drive Polyubiquitin Chain Assembly on APC 
Targets. Cell. 2007;130(1):127-139. doi:10.1016/j.cell.2007.05.027 
79.  Carvalho P, Goder V, Rapoport TA. Distinct Ubiquitin-Ligase Complexes Define Convergent 
Pathways for the Degradation of ER Proteins. Cell. 2006;126(2):361-373. 
doi:10.1016/j.cell.2006.05.043 
80.  FINGER A, KNOP M, WOLF DH. Analysis of two mutated vacuolar proteins reveals a 
degradation pathway in the endoplasmic reticulum or a related compartment of yeast. Eur J 
Biochem. 1993;218(2):565-574. doi:10.1111/j.1432-1033.1993.tb18410.x 
81.  Hampton RY, Gardner RG, Rine J. Role of 26S proteasome and HRD genes in the degradation 
of 3-hydroxy-3-methylglutaryl-CoA reductase, an integral endoplasmic reticulum membrane 
protein. Mol Biol Cell. 1996;7(12):2029-2044. http://www.ncbi.nlm.nih.gov/pubmed/8970163. 
82.  Lenk U, Sommer T. Ubiquitin-mediated Proteolysis of a Short-lived Regulatory Protein 
Depends on Its Cellular Localization. J Biol Chem. 2000;275(50):39403-39410. 
doi:10.1074/jbc.M006949200 
83.  Chen P, Johnson P, Sommer T, Jentsch S, Hochstrasser M. Multiple ubiquitin-conjugating 
enzymes participate in the in vivo degradation of the yeast MAT alpha 2 repressor. Cell. 
1993;74(2):357-369. http://www.ncbi.nlm.nih.gov/pubmed/8393731. 
84.  Finke K, Plath K, Panzner S, et al. A second trimeric complex containing homologs of the 
Sec61p complex functions in protein transport across the ER membrane of S. cerevisiae. 
EMBO J. 1996;15(7):1482-1494. http://www.ncbi.nlm.nih.gov/pubmed/8612571. 
85.  Habeck G, Ebner FA, Shimada-Kreft H, Kreft SG. The yeast ERAD-C ubiquitin ligase Doa10 
recognizes an intramembrane degron. J Cell Biol. 2015;209(2):261-273. 
doi:10.1083/jcb.201408088 
86.  Hampton RY, Bhakta H. Ubiquitin-mediated regulation of 3-hydroxy-3-methylglutaryl-CoA 
reductase. Proc Natl Acad Sci. 1997;94(24):12944-12948. doi:10.1073/pnas.94.24.12944 
87.  Ravid T, Kreft SG, Hochstrasser M. Membrane and soluble substrates of the Doa10 ubiquitin 
ligase are degraded by distinct pathways. EMBO J. 2006;25(3):533-543. 
doi:10.1038/sj.emboj.7600946 
 
104  Appendix 
88.  Hiller MM, Finger A, Schweiger M, Wolf DH. ER degradation of a misfolded luminal protein by 
the cytosolic ubiquitin-proteasome pathway. Science. 1996;273(5282):1725-1728. 
http://www.ncbi.nlm.nih.gov/pubmed/8781238. 
89.  Baldridge RD, Rapoport TA. Autoubiquitination of the Hrd1 Ligase Triggers Protein 
Retrotranslocation in ERAD. Cell. 2016;166(2):394-407. doi:10.1016/j.cell.2016.05.048 
90.  Pédelacq J-D, Cabantous S, Tran T, Terwilliger TC, Waldo GS. Engineering and 
characterization of a superfolder green fluorescent protein. Nat Biotechnol. 2006;24(1):79-88. 
doi:10.1038/nbt1172 
91.  Lees ND, Skaggs B, Kirsch DR, Bard M. Cloning of the late genes in the ergosterol 
biosynthetic pathway of Saccharomyces cerevisiae--a review. Lipids. 1995;30(3):221-226. 
http://www.ncbi.nlm.nih.gov/pubmed/7791529. 
92.  Boban M, Pantazopoulou M, Schick A, Ljungdahl PO, Foisner R. A nuclear ubiquitin-
proteasome pathway targets the inner nuclear membrane protein Asi2 for degradation. J Cell 
Sci. 2014;127(16):3603-3613. doi:10.1242/jcs.153163 
93.  Pantazopoulou M, Boban M, Foisner R, Ljungdahl PO. Cdc48 and Ubx1 participate in a 
pathway associated with the inner nuclear membrane that governs Asi1 degradation. J Cell 
Sci. 2016;129(20):3770-3780. doi:10.1242/jcs.189332 
94.  Fernandez-Rodriguez J, Marlovits TC. Induced heterodimerization and purification of two target 
proteins by a synthetic coiled-coil tag. Protein Sci. 2012;21(4):511-519. doi:10.1002/pro.2035 
95.  Kalderon D, Roberts BL, Richardson WD, Smith AE. A short amino acid sequence able to 
specify nuclear location. Cell. 1984;39(3 Pt 2):499-509. 
http://www.ncbi.nlm.nih.gov/pubmed/6096007. 
96.  UniProt: a worldwide hub of protein knowledge. Nucleic Acids Res. 2019;47(D1):D506-D515. 
doi:10.1093/nar/gky1049 
97.  Meusser B, Hirsch C, Jarosch E, Sommer T. ERAD: The long road to destruction. Nat Cell Biol. 
2005;7(8):766-772. doi:10.1038/ncb0805-766 
98.  Tan JME, Cook ECL, van den Berg M, Scheij S, Zelcer N, Loregger A. Differential use of E2 
ubiquitin conjugating enzymes for regulated degradation of the rate-limiting enzymes HMGCR 
and SQLE in cholesterol biosynthesis. Atherosclerosis. 2019;281:137-142. 
doi:10.1016/j.atherosclerosis.2018.12.008 
99.  Wood A, Krogan NJ, Dover J, et al. Bre1, an E3 ubiquitin ligase required for recruitment and 
substrate selection of Rad6 at a promoter. Mol Cell. 2003;11(1):267-274. doi:12535539 
100.  Hwang WW, Venkatasubrahmanyam S, Ianculescu AG, Tong A, Boone C, Madhani HD. A 
conserved RING finger protein required for histone H2B monoubiquitination and cell size 
control. Mol Cell. 2003;11(1):261-266. http://www.ncbi.nlm.nih.gov/pubmed/12535538. 
101.  Hibbert RG, Huang A, Boelens R, Sixma TK. E3 ligase Rad18 promotes monoubiquitination 
rather than ubiquitin chain formation by E2 enzyme Rad6. Proc Natl Acad Sci U S A. 
2011;108(14):5590-5595. doi:10.1073/pnas.1017516108 
102.  Sung P, Berleth E, Pickart C, Prakash S, Prakash L. Yeast RAD6 encoded ubiquitin 
conjugating enzyme mediates protein degradation dependent on the N-end-recognizing E3 
enzyme. EMBO J. 1991;10(8):2187-2193. http://www.ncbi.nlm.nih.gov/pubmed/2065660. 
103.  Walter T, Erdmann R. Current Advances in Protein Import into Peroxisomes. Protein J. 
2019;38(3):351-362. doi:10.1007/s10930-019-09835-6 
104.  Dove KK, Olszewski JL, Martino L, et al. Structural Studies of HHARI/UbcH7∼Ub Reveal 
Unique E2∼Ub Conformational Restriction by RBR RING1. Structure. 2017;25(6):890-900.e5. 
doi:10.1016/j.str.2017.04.013 
 
Appendix  105 
105.  Nakatani Y, Kleffmann T, Linke K, Condon SM, Hinds MG, Day CL. Regulation of ubiquitin 
transfer by XIAP, a dimeric RING E3 ligase. Biochem J. 2013;450(3):629-638. 
doi:10.1042/BJ20121702 
106.  Leto DE, Morgens DW, Zhang L, et al. Genome-wide CRISPR Analysis Identifies Substrate-
Specific Conjugation Modules in ER-Associated Degradation. Mol Cell. 2019;73(2):377-
389.e11. doi:10.1016/j.molcel.2018.11.015 
107.  Klemm EJ, Spooner E, Ploegh HL. Dual Role of Ancient Ubiquitous Protein 1 (AUP1) in Lipid 
Droplet Accumulation and Endoplasmic Reticulum (ER) Protein Quality Control. J Biol Chem. 
2011;286(43):37602-37614. doi:10.1074/jbc.M111.284794 
108.  Schulz J, Avci D, Queisser MA, et al. Conserved cytoplasmic domains promote Hrd1 ubiquitin 
ligase complex formation for ER-associated degradation (ERAD). J Cell Sci. 
2017;130(19):3322-3335. doi:10.1242/jcs.206847 
109.  Burr ML, Cano F, Svobodova S, Boyle LH, Boname JM, Lehner PJ. HRD1 and UBE2J1 target 
misfolded MHC class I heavy chains for endoplasmic reticulum-associated degradation. Proc 
Natl Acad Sci. 2011;108(5):2034-2039. doi:10.1073/pnas.1016229108 
110.  Boban M, Ljungdahl PO, Foisner R. Atypical Ubiquitylation in Yeast Targets Lysine-less Asi2 
for Proteasomal Degradation. J Biol Chem. 2015;290(4):2489-2495. 
doi:10.1074/jbc.M114.600593 
111.  Brzovic PS, Keeffe JR, Nishikawa H, et al. Binding and recognition in the assembly of an active 
BRCA1/BARD1 ubiquitin-ligase complex. Proc Natl Acad Sci. 2003;100(10):5646-5651. 
doi:10.1073/pnas.0836054100 
112.  Carvalho P, Stanley AM, Rapoport TA. Retrotranslocation of a Misfolded Luminal ER Protein 
by the Ubiquitin-Ligase Hrd1p. Cell. 2010;143(4):579-591. doi:10.1016/j.cell.2010.10.028 
113.  Ravid T, Hochstrasser M. Diversity of degradation signals in the ubiquitin–proteasome system. 
Nat Rev Mol Cell Biol. 2008;9(9):679-689. doi:10.1038/nrm2468 
114.  Wu K, Kovacev J, Pan Z-Q. Priming and Extending: A UbcH5/Cdc34 E2 Handoff Mechanism 
for Polyubiquitination on a SCF Substrate. Mol Cell. 2010;37(6):784-796. 
doi:10.1016/j.molcel.2010.02.025 
115.  Finley D, Ozkaynak E, Varshavsky A. The yeast polyubiquitin gene is essential for resistance 
to high temperatures, starvation, and other stresses. Cell. 1987;48(6):1035-1046. 
http://www.ncbi.nlm.nih.gov/pubmed/3030556. 
116.  Seufert W, Jentsch S. Ubiquitin-conjugating enzymes UBC4 and UBC5 mediate selective 
degradation of short-lived and abnormal proteins. EMBO J. 1990;9(2):543-550. 
http://www.ncbi.nlm.nih.gov/pubmed/2154373. 
117.  Rogov V V., Rozenknop A, Rogova NY, et al. A Universal Expression Tag for Structural and 
Functional Studies of Proteins. ChemBioChem. 2012;13(7):959-963. 
doi:10.1002/cbic.201200045 
118.  Berndsen CE, Wolberger C. A spectrophotometric assay for conjugation of ubiquitin and 
ubiquitin-like proteins. Anal Biochem. 2011;418(1):102-110. doi:10.1016/j.ab.2011.06.034 
119.  Bond SR, Naus CC. RF-Cloning.org: an online tool for the design of restriction-free cloning 
projects. Nucleic Acids Res. 2012;40(W1):W209-W213. doi:10.1093/nar/gks396 
120.  LAEMMLI UK. Cleavage of Structural Proteins during the Assembly of the Head of 
Bacteriophage T4. Nature. 1970;227(5259):680-685. doi:10.1038/227680a0 
121.  LOWRY OH, ROSEBROUGH NJ, FARR AL, RANDALL RJ. Protein measurement with the 
Folin phenol reagent. J Biol Chem. 1951;193(1):265-275. doi:14907713 
 
106  Appendix 
5.2 Abbreviations 
AAA    ATPase Associated with diverse cellular Activities 
APC    anaphase promoting complex 
APS    ammonium persulfate 
Asi    Amino acid sensor independent 
Atg8    Autophagy-related protein 8 
ATP    adenosine triphosphate 
BIRC7   baculoviral IAP repeat-containing protein 7 
BSA    bovine serum albumin 
bp    base pair 
BARD1   BRCA1-associated RING domain protein 1 
BRCA1   Breast Cancer 1 
Bre1    Brefeldin-A sensitivity protein 1 
CBL    Casitas B-lineage lymphoma 
Cdc48   Cell division cycle 48 
CHX    cycloheximide 
CPY    carboxypeptidase yscY 
CSP    chemical shift perturbation 
CUE    coupling of ubiquitin conjugation to ER degradation 
DBCO   dibenzocyclooctyne 
ddH2O   double deionized water 
Der1    Degradation in the endoplasmic reticulum 
DNA    deoxyribonucleic acid 
dNTPs   deoxynucleotide triphosphates 
Doa10   degradation of Matα 10 
DTT    dithiothreitol 
DUB    deubiquitinating enzyme 
E1    ubiquitin activating enzyme 
E2    ubiquitin conjugating enzyme 
E3    ubiquitin ligase 
Appendix  107 
ECL    Enhanced chemoluminescence 
E. coli    Escherichia coli 
EDTA    ethylenediaminetetraacetic acid 
ER    endoplasmic reticulum 
ERAD    ER-associated protein degradation 
g    gravitational acceleration 
GSH    reduced glutathione 
GST    glutathione-S-transferase 
h    hour(s) 
HA    hemagglutinin 
HECT    Homologous to the E6AP Carboxy-Terminus 
His6    hexahistidine 
Hmg2    3-hydroxy-3-methylglutaryl-coenzyme A reductase 
Hrd1    HMG-CoA reductase degradation 1 
Hrd3    HMG-CoA reductase degradation 3 
HRP    horseradish peroxidase 
IgG    immunoglobulin G 
IP    immunoprecipitation 
IPTG    isopropyl β-D-1-thiogalactopyranoside 
ISG15    Interferon-stimulated gene product 15 
kB    kilo base pairs 
kDa    kilodalton 
LB    lysogeny broth 
LMNG   lauryl maltose neopentyl glycol 
MAT    mating type 
MBq    megabecquerel 
min    minute(s) 
MWCO   molecular weight cut-off 
NEDD8  Neural precursor cell expressed, developmentally down-
regulated 8    
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Ni-NTA   nickel-nitrilotriacetic acid 
NMR    nuclear magnetic resonance 
Npl4    nuclear protein localization 4 
OD600    optical density at 600 nm 
PAGE    polyacrylamide gel electrophoresis 
PBS    phosphate-buffered saline 
PCNA    proliferating cell nuclear antigen 
PCR    polymerase chain reaction 
PDB    Protein Data Bank 
PEG    polyethylene glycol 
pH    potential of hydrogen 
PH    Plekstrin Homology 
PMSF    phenylmethylsulfonylfluoride 
PQC    protein quality control 
PrA    proteinase yscA 
PVDF    polyvinylidene fluoride 
Rad6    radiation sensitive 6 
RBR    RING-in-between-RING 
RING    really interesting new gene 
RNA    ribonucleic acid 
RNase   ribonuclease A 
rpm    revolutions per minute 
s    seconds 
S. cerevisiae   Saccharomyces cerevisiae 
SCF    Skp1-Cul1-F-box protein 
SD    synthetic defined 
SDS    sodium dodecyl sulfate 
SEC    size exclusion chromatography 
Sec61    secretory 61 
SEL1L   Suppressor enhancer of Lin12-like 
Appendix  109 
sfGFP    superfolder green fluorescent protein 
SOC    super optimal broth with catabolite repression 
SPAAC   strain-promoted azide-alkyne cycloaddition 
SUMO   Small ubiquitin-like modifier 
TAE    Tris-acetate buffer with EDTA 
TB    terrific broth 
TBT    Tris buffer with Tween 
TE    Tris-EDTA buffer 
TEMED   Tetramethylethylenediamine 
TRIM    tripartite motif 
Tris    Tris(hydroxymethyl)aminomethane 
U7BR    Ubc7 binding region 
Ub    ubiquitin 
Ub488    Alexa Fluor™ 488-labeled UbS20C 
Ub2    di-ubiquitin 
Ub3    tri-ubiquitin 
UBA    ubiquitin-associated 
UBC    ubiquitin conjugating enzyme catalytic core 
UBD    ubiquitin binding domain 
Ubx2    ubiquitin regulatory X 2 
UBZ    ubiquitin-binding zinc fingers 
Ufd1    ubiquitin fusion degradation protein 1 
UIM    ubiquitin-interacting motif 
Usa1    U1-Snp1 associating 
UV    ultraviolet 
v/v    volume for volume 
w/v    weight per volume 
WT    wild type 
Yos9    yeast OS-9 
YPD    yeast extract peptone dextrose 
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5.4 Presentations 
 
2019 Cancer Club Lecture Series of the MDC, invited speaker 
2018 FASEB SRC, Ubiquitin & Cellular Regulation, Snowmass, CO, USA, 
invited speaker and poster presentation 
2017 SignGene Symposium, Ubiquitin in Protein Homeostasis and 
Autophagy, Neuruppin, Germany, invited speaker 
2017 Cold Spring Harbor Meeting, The Ubiquitin Family Meeting, Cold Spring 
Harbor, NY, USA, invited speaker 
2017 SignGene Symposium, Frontiers in Cell Signaling and Gene 
Regulation, Potsdam, Germany, poster presentation 
2016 SignGene Winterschool, High Precision, High Throughput: 
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